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ABSTRACT 
This thesis examines the use of hydroxypropylmethylcellulose (HPMC), sodium 
carboxymethylcellulose (NaCMC) or ethylcellulose, alone or in combination with 
other adjuncts, to control the release of propranolol hydrochloride from matrices. 
Gels were characterized by U tube viscometry and their cloud points of gels. The 
properties of polymers and their mixture in matrices or in gels were investigated 
by differential scanning calorimetry (DSC). Compendial dissolution methodology 
was used to determine drug release from matrices and their release exponents. 
Propranolol hydrochloride increased the solubility of HPMC and altered the water 
distribution in their gels. The release of propranolol hydrochloride from HPMC 
matrices was dependent on the square root of time. Release exponents were - 0.6, 
indicating that diffusion and erosion contributed to drug release. 
The release rates of propranolol hydrochloride from NaCMC matrices decreased as 
the NaCMC content increased. Addition of propranolol hydrochloride to NaCMC 
gels produced an insoluble complex which, in matrices, controlled the drug release. 
The interaction between propranolol hydrochloride and NaCMC was confirmed by 
DSC and dialysis. The viscosity grade of NaCMC affected the drug release. NaCMC 
matrices showed fast erosion. The release of sodium ions from matrices containing 
NaCMC was enhanced propranolol hydrochloride, confirming the occurrence of the 
interaction in matrices. The release of propranolol hydrochloride from NaCMC 
matrices was not dependent on either the square root of time or time. Large 
increases in release rates from matrices containing NaCMC in acidic media implied 
the polymer was unable to gel provide or a sustained release of propranolol 
hydrochloride at low pH. 
A synergistic increase in viscosity in gels containing HPMC and NaCMC probably 
played a minor role in propranolol release from matrices containing both polymers. 
NaCMC decreased the cloud point of HPMC. Drug release from matrices 
containing HPMC and NaCMC was very complicated, but zero order release was 
achieved from matrices containing 285 mg of 1: 3 HPMC : NaCMC. Addition of 
HPMC to NaCMC matrices suppressed an initial burst release of propranolol. The 
release of propranolol hydrochloride from matrices containing HPMC and NaCMC 
was dependent on pH. 
Ethylcellulose was capable of binding = 14% w/w water. Matrices containing 
ethylcellulose 7 cP (<125 pm) showed lower release rates than matrices containing 
ethylcellulose 10 cP, or at greater particle sizes. Compaction pressure generally did 
not affect drug release. The release exponent from matrices containing 
ethylcellulose was 0.44 - 0.49 indicating diffusion predominated drug release. 
Admixture of ethylcellulose with HPMC did not change the release exponent (0.59 
<n <0.61) from that of HPMC alone, whereas the exponents of 
NaCMC: ethylcellulose matrices was altere. Addition of ethylcellulose to HPMC 
increased the initial uptake of water. 
The incorporation of a complex of propranolol and ß-cyclodextrin failed to retard 
the release of drug or alter the release exponent. 
M. A. Dabbagh 
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CHAPTER 1 INTRODUCTION 
This chapter provides an introduction to controlled release drug delivery and 
a discussion on controlled release matrices. Cellulose derivatives, especially 
cellulose ether polymers, and factors that influence drug release from these 
matrices are discussed. Finally, the aims and objectives of the work described 
in this thesis are presented. 
1.1 CONTROLLED RELEASE SYSTEMS 
Historically, the oral route of administration has been the most utilized route 
for both conventional and novel drug delivery systems. There are many 
obvious reasons for this, not the least of which are acceptance by the patient 
and ease of administration. Conventional drug delivery systems are known 
to provide prompt release of drug. This may lead to high peak drug 
concentrations beyond therapeutic levels and approaching toxic levels (Grass 
and Robinson, 1990). 
Many drugs have an inconveniently short duration of action and over the 
years many attempts have been made to overcome this problem by slowing 
their rate of absorption (Prescott, 1985). If the drug is excreted at a rapid 
rate, the levels decline below the therapeutic level within a few hours, 
thereby necessitating frequent dosing. This results in widely fluctuating drug 
levels. This may not only compromise efficacy of the drug and produce toxic 
(1) 
side effects but may also result in poor compliance. 
Sustained-release drug delivery systems have received considerable attention 
from the pharmaceutical and device-manufacturing industries because these 
systems offer overwhelming advantages over conventional drug delivery 
systems. Some 40 years ago, oral 'slow release' products started to be 
marketed and significant advances were made with prolonged action 
parenteral formulations and implants (Prescott, 1985). It is only within the 
past few years that the full potential and wide range applicability of 
sustained release technology has been realized. In a report, Higuchi et al 
(1983) stated "the approach to the design of oral drug delivery systems is 
evolving rapidly, both quantitatively and qualitatively, so that the situation 
is considered to be on the threshold of being revolutionary". All evidence 
seems to support this statement because the field of oral sustained release 
is definitely advancing at a rapid pace (Shah, 1988). 
With wider appreciation of pharmacokinetic principles and the introduction 
of therapeutic drug monitoring, it has become apparent that the advantages 
of rate-control are not restricted to prolongation of drug action. With 
controlled, constant drug-input, greater selectivity of drug action and reduced 
toxicity might be achieved by avoiding the succession of peaks and valleys of 
drug concentration associated with conventional therapy. This concept of 
'steady state' or 'zero-order' pharmacokinetics has far-reaching implications 
and opens up a whole new area of promise in drug therapy (Prescott, 1989). 
(2) 
Figure 1.1 shows comparative blood drug profiles obtained following the 
administration of conventional, sustained release and zero-order controlled 
release dosage forms. If drug release kinetics can be controlled, the plasma 
concentration of a drug can be maintained in the therapeutically appropriate 
range and harmful side effects can be reduced (Li et al, 1987; Grass and 
Robinson, 1990). 
Figure 1.1: Plasma drug concentration profiles for conventional tablet or 
capsule, sustained release or zero-order controlled release formulations (after 
Li et al, 1987). 
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1.1.1 Advantages and disadvantages of controlled release systems 
1.1.1.1 Advantages of controlled release systems 
Although, controlled release dosage forms are often more expensive than 
conventional formulations, they are more attractive dosage forms because 
they offer some clinical and practical advantages (Welling and Dobrinska, 
1987; Baker, 1987a; Ritschel, 1989) such as: 
a- patient compliance by reduction in the frequency of dosing with the 
use of sustained or controlled delivery systems, 
b- causing a reduction in the fluctuation of circulating drug levels, 
c- a reduction in costs by a reduction in dosages, 
d- achieving a more uniform pharmacological response, 
e- a reduction in side effects by keeping the plasma drug levels within 
the therapeutic range. 
1.1.1.2 Disadvantages of controlled release systems 
Controlled release dosage forms have several disadvantages (Welling and 
Dobrinska, 1987). Therefore, the advantages must be weighed against the 
potential disadvantages in any specific clinical application. The disadvantages 
which can be encountered in the use of solid polymeric delivery devices may 
include: 
a- high cost due to the expense of a particular polymer-drug formulation 
or its fabrication, 
(4) 
b- poor in vitro-in vivo correlation, due to poor biocompatability of the 
polymer used, 
c- toxicity of the polymer or any biodegradation of the polymer, 
d- reduced potential for accurate dose adjustment, 
e- increased potential for first pass clearance, 
f- failure of the dosage forms would release the drug instantly and since 
sustained dosage forms generally contain a much greater amount of 
drug, the total drug content could become available for absorption and 
toxicity may result (Ritschei, 1989; Grass and Robinson, 1990). 
1.1.2 Drugs suitable for oral controlled release dosage forms 
The selection of a drug candidate for the design of a sustained release system 
depends largely upon pharmacological, therapeutic and pharmaceutical 
considerations. The criteria for the selection of a suitable drug candidate are: 
a- short biological half life, 
b- narrow therapeutic index, 
c- efficient gastrointestinal absorption, 
d- small daily dose, 
f- no first pass metabolism, and 
g- marketing benefits (Shah, 1988). 
Therapeutic compounds with short half-lives are excellent candidates for 
formulation into a sustained-release preparation since this can reduce their 
dosing frequency and hopefully increase patient compliance (Shah, 1988). 
(5) 
Drugs with very short half-lives will require excessively large amounts of 
drugs in each dosage unit to maintain sustained effects. This creates a 
prohibitive situation, forcing the dosage form itself to become too large to be 
administered, therefore creating a limitation to the amount of drug that can 
be practically incorporated into such a system. In general, drugs with half- 
lives shorter than 2 hours, are poor candidates for sustained release 
preparations. Compounds with relatively long half-lives, generally greater 
than 8 hours, are not used in sustained-delivery since their effect is already 
sustained (Li et al, 1987). On the other hand, the transit time of most dosage 
forms in the gastrointestinal tract is in the range of 8 to 12 hours, making it 
difficult to increase the absorptive phase beyond this time frame. The 
maximum half-life for absorption should be approximately 3 to 4 hours, 
otherwise the device will pass out of the potential absorptive regions before 
release is complete (Grass and Robinson, 1990). Furthermore, drugs that 
have a relative narrow therapeutic index will be more efficacious and less 
toxic if administered in a sustained release form (Shah, 1988; Grass and 
Robinson, 1990). 
If a drug undergoes an extensive first-pass metabolism that is saturable 
during the adminstration of conventional fast-release dosages, then systemic 
availability may be decreased due to non-saturation of the clearance 
mechanisms following formulation into a sustained release dosage form. 
However, if hepatic clearance is not saturated during the use of conventional 
dosage forms, slower absorption of drug should not cause a reduction in the 
(s) 
systemic availability (Welling and Dobrinska, 1987). 
1.1.3 Terminology 
There is a considerable confusion in the terminology between "controlled 
release" and "sustained release". Unfortunately these terms have been often 
used interchangeably (Chien, 1992). 
Madan (1985) described 32 terms that relate to prolonged drug release. The 
United State Pharmacopoeia / National Formulary (USP 23/NF 18,1995) has 
also proposed modified release to describe all non-conventional, slow-release 
systems and have classified them into delayed release and extended release 
dosage forms. It is thus necessary, to provide a short explanation of the 
terminology used. 
1.1.3.1 Delayed Release 
The term " delayed release" is used to describe systems where it is not 
intended for the drug to be released immediately after administration. 
Delayed-release products, such as enteric-coated products, are designed to 
delay the release of the drug until the dosage forms reaches the intestinal 
tract. These products are used to prevent side effects associated with the 
release of the drug in the stomach or to protect the drug from degradation in 
the acidic gastric environment (Madan, 1985). 
(7) 
1.1.3.2 Sustained Release 
The term "sustained release" has existed in the medical and pharmaceutical 
literature for many decades. It has been constantly used to describe a 
pharmaceutical dosage form formulated to retard the release of a therapeutic 
agent such that its appearance in the systemic circulation is delayed and/or 
prolonged and its plasma profile is sustained in duration (Chien, 1992). 
Sustained release dosage forms carry the delayed-release concept a step 
further and these products are primarily designed to decrease the frequency 
with which the patient has to take the dosage form to obtain the desired 
effect. 
1.1.3.3 Controlled Release 
The term "controlled release" on the other hand, has a meaning that goes 
beyond the scope of sustained drug release. It also implies a predictability 
and reproducibility in the drug release kinetics, which means that the release 
of drug ingredients from a controlled-release drug delivery system proceeds 
at a rate profile that is not only predictable kinetically, but also reproducible 
from one unit to another (Chien, 1992; Li et al, 1987). The term controlled 
release has gained recognition because it implies that the rate of release is 
controlled by the delivery system itself and not by the external conditions of 
pH, enzymes, ions, intestinal motility, etc (Ritschel, 1989). 
1.1.4 Application of controlled-release technology 
The ideal controlled release system maintains drug levels at a constant value 
(8) 
within the desired therapeutic range for a specified time period. By tailoring 
the polymers appropriately, or by using different drug incorporation 
procedures, drugs can now be released in a far more precise and prolonged 
manner than with sustained-release methods. However, polymers are 
essential for producing controlled-release dosage forms, as formulation aids 
and for governing the drug release (Doelker, 1987). Controlled-release 
polymer technology has been used not only in the pharmaceutical industry, 
but also in agriculture (e. g. fertilizers), biology (e. g. growth factors) and to 
deliver pesticides (Langer, 1980; Prasad and Kalyanasundaram, 1993). 
Ritschel (1989) investigated different controlled release dosage forms and 
different devices for various routes of adminstration. The length of duration 
of these products are shown in figure 1.2. 
Although polymers, especially hydrophilic ones, are employed in various 
pharmaceutical dosage forms such as ophthalmic inserts (Langer, 1980; Li et 
al, 1987; Baker, 1987a), nasal delivery systems (Lin et al, 1992), pessaries 
(McKenzie and Embrye, 1977), suspensions (Sprockel et al, 1989), parenteral 
systems (Leung et al, 1987; Tice and Cowsar, 1984), transdermal systems 
(Brown and Langer, 1988), and capsules (Paggy, 1988; Rao and Ritschel, 
1992; Hussain et al, 1994), the scope of this thesis will concentrate on the 
applications of cellulose ethers in oral controlled release matrix tablets. 
(9) 
Figure 1.2: Schematic diagram of the types of controlled release delivery 
systems/devices, route of administration and length of duration of action 
(after Ritschel, 1989). 
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1.2 CLASSIFICATION OF ORAL CONTROLLED DRUG DELIVERY 
SYSTEMS 
A drug delivery device is a prefabricated system that releases a 
predetermined volume or amount independent of the drug used over a period 
of 12 to 24 hour (Ritschel, 1989). Over the past 50 years, a number of 
techniques have been developed and employed to sustain the delivery of 
medication to the systemic circulation following oral administration (Hui et 
al, 1987; Li et al, 1987). 
There are three basic types of polymeric devices. The most common one, due 
to its relative ease of production and low cost compared to the other methods 
of sustained or controlled delivery, is the diffusion-controlled system which 
has classically been of primary importance in the oral delivery of medications 
(Grass and Robinson, 1990). The second type, dissolution-controlled systems, 
is commonly employed in the production of enteric-coated dosage forms. In 
the last type, the use of polymers is to provide chemically-controlled systems 
which depend upon chemical reaction to release the drug from the implant. 
There are many other sustained and controlled release systems which have 
received a more limited but increasing amount of attention as candidates for 
oral products. 
The choice of an oral sustained /controlled release system is limited by the 
aqueous solubility of the drug. Diffusional systems will be poor choices for 
slightly soluble drugs since the driving force for diffusion, the concentration 
(11) 
in aqueous solution, will be low. In contrast, such drugs may be effectively 
incorporated in matrix systems (Li et al, 1987). However, the main controlled 
release devices are: 
1.2.1 Membrane-controlled reservoir systems 
The reservoir type device has been in use for some time in the U. S. A. and 
was recently re-introduced in the U. K. by the company Duncan Flockhart, to 
deliver salbutamol for asthma sufferers (Verrall, 1988). These systems are 
characterized by a core of drug, the reservoir, surrounded by a polymeric coat 
which controls the release rate. The active drug is contained within the inert 
polymer (Linhardt, 1989). These devices are diffusion-controlled and a 
schematic diagram of a reservoir device is given in figure 1.3. 
Figure 1.3: Schematic representation of a reservoir diffusional device (after 
Baker, 1987a) 
Agent (core) 
Membrane (polymer coat) 
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Reservoir devices have the advantage of providing a constant rate of release 
over a substantial portion of their lifetime (Baker and Lonsdale, 1974; Baker, 
1987a). Since the amount of drug contained in the reservoir is far greater 
than the usual dose needed, any error in production or any accidental damage 
to the dosage forms that would directly expose the reservoir core to the 
intestinal fluids could expose a potentially toxic dose of the drug to the 
patient (Grass and Robinson, 1990). Therefore, any failure in this system 
could be catastrophic. A reservoir device is more expensive and its fabrication 
is more difficult than a matrix system (Baker, 1987a). 
Sutinen et al (1992; 1993), using silicone reservoir devices containing 
propranolol hydrochloride, reported that the drug release followed zero-order 
kinetics and was essentially independent of the composition of the dissolution 
media. 
1.2.2 Diffusion-controlled monolithic systems 
Much discussion revolves around the innovative work of Higuchi (1961) which 
used polymeric matrices to deliver drugs (Chandrasekaran et al, 1983). In a 
monolithic matrix system the active agent is homogeneously dissolved or 
dispersed throughout the polymer itself, as represented in figure 1.4. In this 
model, the drug in the outside layer of the matrix exposed to fluid is 
dissolved first and then diffuses out of the matrix. This process continues 
with the interface between the solution and the solid drug moving towards 
the interior (Grass and Robinson, 1990). 
(13) 
Figure 1.4: Schematic representation of a matrix diffusional system (after 
Grass and Robinson, 1990) 
G0-41010 
0 Agent 
Polymer 
Malfiv 
The release pattern depends on the geometry of the system, the identity and 
nature of the polymer or other carrier material, and the loading of the agent. 
The advantage of this type of system is that it is easy to manufacture and 
therefore more cost effective. However, one disadvantage is that it cannot 
produce zero-order drug release (Baveja et al, 1987; Grass and Robinson, 
1990). 
1.2.3 Osmotic systems 
These systems are devices in which the active agent, present alone or with 
an osmotic driving agent, is surrounded by a semi-permeable membrane 
having a single delivery orifice (figure 1.5). Water from the environment is 
continuously imbibed across the semi-permeable membrane by osmosis to 
produce a fluid drug suspension; the continuous membrane controls the influx 
of water which drives the formulation through the orifice (Theeuwes and 
(14) 
Eckenhoff, 1980). In recent years, several devices have been developed that 
utilize osmotic effects to control the release of the active agent (Theeuwes, 
1989). Osmotic devices of various designs have found their largest application 
in oral tablet formulations (Baker, 1987a). 
Figure 1.5: A schematic representation of an osmotic pump device for drug 
delivery (after Theeuwes and Eckenhoff, 1980). 
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1.2.4 Mechanical Pumps 
Mechanical pumps can be miniaturized to deliver an active agent at a 
constant rate over a prolonged period. Several such devices use batteries as 
the power source, but pumps have been made that use the elastic tension of 
stretched rubber balloons or the vapour pressure of low-boiling liquids as the 
power source. Most of these pumping devices have limited use and are 
(15) 
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employed predominantly in pharmaceutical applications, where their expense 
can be justified (Baker, 1987a). 
1.2.5 Chemically controlled systems 
Kim et al (1980) reviewed devices in which the drug is covalently bound to 
a polymer matrix. In this system the drug is usually bound as a pendant 
group, e. g., poly (amino acid) with a steroid pendant group (Linhardt, 1989). 
1.3 ORAL SUSTAINED RELEASE MATRICES 
Slow release dosage forms generally contain a much greater amount of drug 
than conventional forms and, unlike them, these systems do not disintegrate 
(Melia, 1991). If the system fails and undergoes disintegration, all of the dose 
will be released immediately causing acute toxicity. Therefore, great care 
must be taken in the formulation and design of sustained release dosage 
forms. 
Since zero-order release is the most appropriate release pattern, several 
studies (Baveja and Ranga Rao, 1986; Baveja et al, 1987,1988a, b; Colombo 
et al, 1987; Ranga Rao et al, 1989) have attempted to achieve a zero-order 
release of drug, which is independent of time and the amount of drug in the 
systems. Therefore, many systems based on polymers have been introduced 
in the literature, all aiming to achieve zero-order release. 
(16) 
1.3.1 Matrices 
A matrix is defined as a well-mixed composite of ingredients fixed into a 
shape by tableting or by the use of hard shell capsules (Alderman, 1984). 
Basically, in these systems the drug is homogeneously dispersed throughout 
the polymer mass (Baker, 1987a). The most commonly used polymers for oral 
sustained release devices are swellable polymers (Melia, 1991). A variety of 
other excipients may optionally be included to aid tableting properties (Ford 
et al, 1987). The release pattern from these systems depends on the geometry 
of the system, the identity and nature of the polymer or other carrier 
material and the loading of the agent. However, the materials used in 
controlled release devices should be inert, remain intact during transit 
through the gastrointestinal tract and provide a sustained release over a 
reasonable length of time. 
The importance of the choice of matrix material has been illustrated by many 
studies (Baker, 1987a; Shah, 1988; Chien, 1992). Because the use of a 
polymeric controlled release device exposes the polymer to an aqueous 
environment, its interaction with water is of considerable importance. 
According to the nature of polymer-water interactions, polymers can be 
broadly classified into hydrophobic polymers, hydrophilic polymers, 
water soluble polymers and hydrogels (Heller, 1987a). 
1.3.1.1 Hydrophobic polymers 
These polymers are essentially water impermeable and when placed in an 
(17) 
aqueous environment, will absorb very little water. Clearly, there is no fixed 
value for the amount of absorbed water below which a polymer is hydrophobic 
and above it which is deemed hydrophilic. However, Heller (1987b) suggested 
that hydrophobic polymers should absorb less than 5% water and hydrophilic 
polymers more than 5% w/w. Structural parameters that contribute to 
polymer hydrophobicity are chain stiffness and a high degree of crystallinity. 
Fatty matrices such as carnauba wax, stearyl alcohol, beeswax, glyceryl 
monostearate and stearic acid are the basis of typical hydrophobic matrix 
materials (Shah, 1988). In addition, cellulose acetate phthalate, 
methylhydroxypropylcellulose phthalate and ethylcellulose are substances 
that are insoluble in water but soluble in organic solvents (Grosse, 1990). 
1.3.1.2 Hydrophilic polymers 
Hydrophilic matrix dosage forms are attractive to the formulator, because 
they offer potential advantages such as low cost of manufacture, simplicity 
of formulation, direct compression of the drug blend, high drug loading and 
a wide choice of polymers that can be used to control drug release (Doelker, 
1987; Melia, 1991). 
Amongst the various hydrophilic polymers, cellulose ethers, in particular 
different grades of hydroxypropylmethylcellulose (HPMC), sodium 
carboxymethylcellulose (NaCMC) or hydroxypropylcellulose (HPC), have been 
investigated (Ford et al, 1985a, b; Baveja, 1987; Ranga Rao et al, 1988a , b; 
Melia, 1991). 
(18) 
1.3.1.3 Water-soluble polymers 
Some polymers are freely soluble in water, even though they are of very high 
molecular weight. Examples of such polymers include poly (vinyl alcohol), 
poly (acrylic acid), poly (N-vinylpyrrolidone), poly acrylamide and poly 
(ethylene oxide) (Heller, 1987a). The release of different drugs through slabs 
of poly (vinyl alcohol) and poly (N-vinylpyrrolidone) was studied by 
Korsmeyer et al (1983a) and Colombo et al (1985; 1987). 
1.3.1.4 Hydrogels 
In drug delivery systems, the term "hydrogel" is typically reserved for 
polymeric materials that can absorb a significant amount of water (more than 
20% of their dry weight) while maintaining a distinct three-dimensional 
structure (Gehrike and Lee, 1989). These polymers are highly hydrophilic or 
are water soluble polymers that have been crosslinked by means of covalent 
bonds. Therefore, hydrogels cannot dissolve due to their covalent crosslinks. 
Gehrike and Lee (1989) stated that hydrogels have four key properties: 
swelling degree, biocompatibility, permeability and swelling kinetics. They 
reported that their high water content leads to good biocompatibility and that 
the permeability of hydrogels to water, drugs and other solutes is easily 
adjusted over a broad range by changing the gel precursor, crosslinker, or 
conditions of synthesis. 
1.3.2 Methods of matrix preparation 
Compressed hydrophilic matrices are prepared either by direct compression, 
(19) 
wet granulation or by slugging (dry granulation). All comparative studies 
show, however, that only slight differences in the release profiles are 
observed between the various methods of preparation (Doelker, 1987). 
1.3.2.1 Direct compression 
One of the most important characteristics of hydrophilic polymers is their 
compressibility which makes them capable of being easily blended with active 
agents and of being easily compressed (Alderman, 1984; Ford et al, 1985a, b; 
1987; Baveja et al, 1987; Porter, 1989). In contrast to other types of matrices 
or to conventional tablets, the compression force used to make hydrophilic 
matrices does not play a significant role in affecting their release rates (Ford 
et al, 1987). 
1.3.2.2 Wet granulation 
Granulation technology play an important role in the formulation of solid 
dosage forms (Sheskey et al, 1994). However, when extended drug release 
times are required, polymer concentration must be increased or higher 
molecular weight polymers must be chosen to achieve the desired release 
profiles. This situation occasionally results in powders that, although 
compressible, demonstrate unacceptable flow characteristics and would be 
burdensome when tableting on high-speed production equipment (Sheskey et 
al, 1994). Therefore, a granulation method is required to provide adequate 
flow for efficient tablet manufacturing. In the wet granulation process, the 
components are combined and formed into granules with a binder solution 
(20) 
and then sized and / or dried at the desired particle size. Liquids used for 
granulation include alcohols, hydroalcoholic mixtures, mixtures of alcohols 
and chlorinated solvents or water that may or may not contain a portion of 
the polymer (Doelker, 1987). 
1.4 MECHANISM OF DRUG RELEASE FROM HYDROPHILIC MATRICES 
Although the formation and manufacture of compressed hydrophilic matrices 
may be simple, the mechanism of drug release is a complex phenomenon 
resulting from the interplay of many different physicochemical processes 
(Melia, 1991). In general, when a hydrophilic matrix is placed in a dissolution 
medium, a gelatinous layer is formed at the tablet surface. The gel layer that 
forms, is an aggregate mass of water-soluble polymer, drug and excipients 
experiencing various degrees of hydration or solution (figure 1.6). As a result 
of these processes, two fronts are established (Hui et al, 1987; Harland et al, 
1988). At the swelling front (glassy polymer/gel interface), the hydration, 
swelling and coalescence of individual polymer particles occur. The gel layer 
so formed swells as additional water is absorbed. At the eroding front 
(gel/dissolution medium interface), polymer chain disentanglement and 
concomitant dissolution of the hydrated matrix occur. The distance between 
the swelling and eroding fronts, the gel layer thickness, has been termed the 
diffusion layer thickness or diffusional pathlength (Harland et al, 1988; Conte 
et al, 1993). This distance is dependent on drug solubility and the relative 
rates at which the swelling and eroding fronts move in relation to each other. 
With this general picture, the drug release mechanism of controlled release 
(21) 
Figure 1.6: Diagrammatic representation of a hydrophilic matrix tablet 
undergoing dissolution (after Alderman, 1984). 
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matrix tablets can be rationalized as being due to a coupling of diffusion and 
erosion release mechanisms. However, since hydrophilic matrices are capable 
of absorbing water while simultaneously releasing an enclosed drug, the 
release rate of the drug is modified by the degree of hydration of the 
drug/polymer device and the nature and concentration of the drug modifies 
the rate and extent of hydration (Good, 1981). 
1.4.1 Drug release from matrices 
The kinetics of release of a drug dispersed in a polymeric matrix are of 
general interest in the context of controlled drug delivery. It is usually 
desirable that the amount released is proportional to time. 
A number of workers have modified and interpreted the dissolution rates 
from polymeric matrices mathematically. Such studies include those by 
Higuchi (1963), Schwartz (1968), Lapidus and Lordi (1968), Bamba et al 
(1979), Korsmeyer et al (1983a), Korsmeyer and Peppas (1983), Ritger and 
Peppas (1987), Harland et al (1988) and Ford et al (1991). 
Korsmeyer et al (1983a) used a simple empirical equation, to describe general 
solute release behaviour from controlled release polymeric matrices (Equation 
1.1): 
M. 
= K1 tn Equation 1.1 
M. 
(23) 
Where: M/M., is the fraction of the drug released, Kl is a constant 
incorporating structural and geometric characteristics of the controlled 
release device, t is the release time and n is the release exponent, indicative 
of the mechanism of drug release. 
Peppas (1985) claimed that this equation could adequately be used to analyze 
the first 60% of a release curve, regardless of geometric shape and also 
showed that two competing release mechanisms were the limits of this 
phenomenon. He stated that the value of the exponent n is conditioned by the 
diffusion mechanism ruling the process. Ritger and Peppas (1987) described 
models of drug release from a planar sheet and gave more details about the 
terminology of Case-I transport (Fickian diffusion), Case-II transport 
(Relaxation) and Non-Fickian behaviour which is the coupling of diffusion and 
relaxation behaviour. They interpreted the values of n (table 1.1) which give 
an indication of the mechanism of drug release. Peppas (1985) had previously 
stated that n was 0.5 for Fickian diffusion, 0.5 <n>1 for non-Fickian 
transport and a value of n=1.0 meant that the drug release is independent 
of time (zero-order release). When n>1 super Case-II transport is apparent. 
Ritger and Peppas (1987) reported that Case-II transport was dependent on 
the geometry of matrices and only equalled zero-order release for films. The 
values of n which were equivalent to Case-II transport for cylinders and 
spheres were 0.89 and 0.85 respectively. This means that even if Case-II 
transport was achieved for these devices, zero-order release could not be 
achieved. Fickian diffusion from cylinders is defined by n=0.451(Ritger and 
(24) 
Peppas, 1987). 
Table 1.1: Diffusional exponent and mechanism of diffusional release from 
various swellable controlled release systems (after Ritger and Peppas, 1987) 
Diffusional exponent (n) 
Thin Cylindrical Spherical Drug release 
Film sample sample mechanism 
0.5 0.45 0.43 Fickian diffusion 
0.5<n<1.0 0.45<n<0.89 0.43<n<0.85 Anomalous (non-Fickian) 
transport 
1.0 0.89 0.85 Case-II transport 
In order to describe drug release from matrices containing HPMC and 
additionally, the influence of temperature on release rate, Ford et al (1991) 
interpreted the mechanisms of drug release by using and modifying a number 
of equations. Ford et al (1987) claimed that equation 1.1 is based on the 
assumption that release occurs as soon as the matrix is placed in contact with 
fluid, but since a lag time in initial release of drugs was observed, a lag 
period needed to be introduced into the equation. Therefore, Ford et al (1991) 
modified equation 1.1 to account for a lag period (1) prior to release to give 
equation 1.2. 
Q= K2 (t-I)° Equation 1.2 
(25) 
In equation 1.2,1 is the lag time, Q is the percentage of drug released at time 
t, K2 is a kinetic constant and n is the dill lsional exponent for drug release. 
The lag time generally occurs as a result of a delay in the release of the drug 
from a dosage form. In spite of the obvious significance of lag time as an 
important parameter in characterizing the release kinetics of a drug, it has 
been ignored by several researchers including Baveja (1987) and Ranga Rao 
et al (1989). 
Higuchi (1963) described equation 1.3, stating that a plot of the amount of 
drug release versus the square root of time would be linear if drug release 
from the matrix was diffusion-controlled release. 
Q=K3 t0. b+C Equation 1.3 
In equation 1.3, K3 is the root time release rate constant and C is a constant. 
Several other investigators have reported equations that have been used to 
describe drug release from matrices. For instance, Catellani et al (1988) and 
Harland et al (1988) used equation 1.4 to describe drug release from matrices 
under Fickian or relaxation mechanisms. 
Mt/M = klt°' + k2t Equation 1.4 
(26) 
The right side of this equation contains the two limiting cases involved in the 
control of drug release from matrices, i. e., Fickian diffusion, by which the 
first 60% of the release is linearly related to the square root of time and the 
polymer relaxation transport by which, if penetrant uptake is linearly related 
to time and diffusion of the drug is faster, zero-order drug release may be 
obtained. The values of kl and k2 in equation 1.4 express the relative 
contributions of the Fickian and relaxation mechanisms respectively. 
Peppas and Sahlin (1989) derived equation 1.5 by introducing a second term 
to represent case II transport into equation 1.1. 
Mt/M = kt +k ten Equation 1.5 
Where the constants k and k' represent, in a manner analogous to equation 
1.4, the relative contributions of Fickian and relaxation mechanisms 
respectively. The value of the Fickian diffusional exponent n may be 
determined directly from the aspect ratio of the compact. Ford et at (1991), 
by introducing lag times in equation 1.5, derived equation 1.6. 
Q= k(t-1)° + k' (t-1)2n Equation 1.6 
Ford et al (1991) emphasised that all equations must include a value of lag 
time. 
(27) 
1.4.2 Zero-order release 
One of the most important research problems in controlled release technology 
is the development of monolithic (matrix type) polymeric formulations, which 
can release drugs at a constant rate over a period of time. These systems are 
commonly known as zero-order release systems (Korsmeyer and Peppas, 
1983). 
Whether the matrix releases drug via swelling control or erosion (or both), it 
is almost impossible to achieve a zero-order release (Langer, 1980). However, 
admixtures of non-ionic and ionic polymers may allow zero-order release. This 
has been attributed (Baveja et al, 1987), in the case of matrices containing 
HPMC and NaCMC, to a high degree of cross-linking between the non-ionic 
HPMC and anionic NaCMC (Walker and Wells, 1982) leading to a synergistic 
increase in gel viscosity at the tablet periphery. This was claimed to decrease 
the rate of advancement of the swelling front into the glassy matrix resulting 
in a slow diffusion of the drug. As the swelling front advances into the glassy 
polymer, the rubbery state of the polymer (i. e., the gel at the tablet 
periphery), which is devoid of the drug, undergoes attrition. When these two 
rates are equal, the diffusional path length for the drug remains constant and 
zero-order release will be seen. Therefore, by optimizing the ratio of total 
polymer to drug and also the ratio between HPMC and NaCMC in the tablet, 
a constant diffusional path length for the drug may be maintained so that 
zero-order release rate can be extended for the desired length of time (Baveja 
et al, 1987). 
(28) 
Since zero-order release is the most appropriate release pattern, several 
investigators (Baveja et al, 1987; 1988 a, b; Ranga Rao et al, 1989; 
Padmalatha Devi et al, 1989; Danckwerts, 1994) have tried to achieve a zero- 
order release of drug which is independent of the amount of drug in the 
systems. 
Korsmeyer et al (1983b) have shown that air incorporated during tableting 
is entrapped in the gel layers of hydrophilic matrix tablets and results in a 
prolongation of drug release. They claimed that this would result in the drug- 
release profile moving away from the square root of time kinetics and 
towards zero-order release. This phenomenon has been exploited by Hashim 
and Li Wan Po (1987) who showed that incorporating small quantities of 
effervescent mixtures into hydrophilic matrix tablets, prolonged zero-order in 
vitro drug-release profiles can be prepared. 
Daly et al (1984) reported that by incorporating 15% w/w of the anionic 
surfactant, sodium dodecyl sulphate (SDS) into HPMC matrices, zero-order 
in vitro release of chlorpheniramine maleate was obtained for 6 hours. 
Padmalatha Devi et al (1989) developed zero-order release matrix tablets of 
oxprenolol hydrochloride by mixing drug, HPMC and NaCMC at the ratio of 
1: 0.4: 1.6. They claimed that zero-order release was accomplished with 
swelling and erosion control of the polymer matrix. 
(29) 
Shenouda et al (1990) reported zero-order release by using a system which 
contained a core in a cup. The core consisted of the drug, dyphylline, and 
HPMC while, the cup consisted of HPMC and poly(ethyloxazoline). They 
examined different ratios of the drug in both the cup and the core. An 
apparent zero-order release was observed when 80% of the drug content was 
included in the core and 20% in the cup. A similar system was used by 
Danckwerts (1994) for caffeine and ibuprofen. HPMC K4M and HPMC K15M 
was used in the core matrix and carnauba wax and ethylcellulose in the cup. 
Danckwerts (1994) claimed that zero-order release was obtained between 8 
to 23 hour. 
1.5 CELLULOSE DERIVATIVES 
The importance of cellulose derivatives has increased in recent years because 
of economic factors that have adversely affected the supply and pricing of 
natural gums and low viscosity products such as starch derivatives (Rekhi 
and Jambhekar, 1995) 
Cellulose, is one of the most abundant natural polymers. Cellulose and its 
derivatives are generally recognized as the safest and most acceptable 
polymer for use in food and pharmaceutical products. The reason for this is 
that these substances have a neutral taste and that they are remarkably non- 
toxic (Grosse, 1990). 
The structural formula of a part of the cellulose molecule is given in figure 
(30) 
1.7. It is composed of anhydroglucose rings linked in the 1,4-position to form 
13-glucosides. Investigations have shown that in native cellulose numerous 
anhydroglucose units are combined to form a single molecule. Chain length 
determination is very difficult and average values are only given, which are 
referred to as the average degree of polymerization (DP). The DP is fixed by 
nature and varies with each raw material (Grosse, 1990; Kumar and Banker, 
1993). 
Figure 1.7: Chemical constitution of cellulose 
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The anhydroglucose rings contain three hydroxyl groups, a primary group at 
the C-6 position and two secondary groups at the C-2 and C-3 positions 
(figure 1.7) which are capable of undergoing chemical reactions such as 
esterification or etherification. Products can be prepared in which, one, two 
or three hydroxyl groups per anhydroglucose unit have undergone reaction. 
The term degree of substitution (DS), is used to identify the average number 
of sites reacted per ring. It ranges from 0 to 3. 
Pure cellulose, despite its free hydroxyl groups, does not dissolve in water, 
due to active hydrogen bonding across the hydroxyl groups on the cellulose 
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backbone (Kumar and Banker, 1993). Substitution of the hydroxyl groups 
with, for example, acetyl groups, decreases the crystallinity by reducing the 
regularity of the polymer chains and increases the interchain hydrogen 
bonding (Baker, 1987b). The various chemically-modified cellulose products 
used in food, cosmetic, pharmaceutical, medical and related applications can 
be grouped into three classes, based on their methods of preparation (Grosse, 
1990). These are: hydrated cellulose, cellulose esters and cellulose 
ethers. 
Hydrated cellulose: The familiar examples of hydrated cellulose are 
cellophane and viscose rayon (Grosse, 1990). 
Cellulose esters: This group of cellulose derivatives can be prepared by 
treating cellulose with inorganic or organic acids or acid anhydrates. Kumar 
and Banker (1993) classified this group into 2 subgroups (enteric cellulose 
esters and non-enteric cellulose esters). The most important polymers 
belonging to the enteric cellulose esters are: cellulose acetate phthalate 
(CAP), hydroxypropylmethylcellulose phthalate (HPMCP) and 
hydroxypropylmethylcellulose acetate succinate (HPMCAS). Oral dosage 
forms coated with these polymers are intended to remain intact in the 
stomach and to rapidly dissolve and release the drug in the upper intestine 
(The United State Pharmacopoeia / National Formulary, USP 23/NF 18, 
1995). Major examples of the non-enteric cellulose esters include: cellulose 
acetate (CA), cellulose sodium phosphate (CSP) and cellulose acetate butyrate 
(32) 
(CAB) which, due to their high water permeability, are used in osmotic 
devices (Baker, 1987b). 
Cellulose ethers: Cellulose ethers are widely used in pharmaceutical 
applications (Korsmeyer, 1983; Grosse, 1990; Melia, 1991). This group of 
cellulose derivatives can be classified into two subgroups: water-insoluble 
cellulose ethers such as ethylcellulose and another class of compounds, the 
water-soluble cellulose ethers. The latter group, has a wide field of 
applications and, due to its importance and special interest, several polymers 
were chosen from it for examination. Examples are discussed in the next 
section. 
1.5.1 Cellulose ethers 
Cellulose ethers are popular as matrix polymers since they are cheap, easy 
to prepare, can accommodate a large percentage of the drug and drug release 
is not-greatly influenced by the processing variables (Alderman, 1984; 
Doelker, 1987). The various cellulose ethers currently described in the United 
State Pharmacopoeia / National Formulary CUSP 23/NF 18,1995) are: 
methylcellulose (MC), hydroxyethylcellulose (HEC), hydroxypropylcellulose 
(HPC), hydroxypropylmethylcellulose (HPMC), sodium carboxymethylcellulose 
(NaCMC), calcium carboxymethylcellulose (CaCMC) and ethylcellulose (EC). 
The structures of these polymers are shown in Figure 1.8. Except EC, all the 
other cellulose ethers are water soluble. The applications of cellulose ethers 
have been the subject of many reviews (Greminger and Krumel, 1980; 
(33) 
Doelker, 1987; Melia, 1991; Kumar and Banker, 1993). Among the cellulose 
ethers, HPMC, HPC, MC and NaCMC are the most popular in controlled 
release dosage forms (Ranga Rao and Padmalatha Devi, 1988; Melia, 1991). 
Figure 1.8: Typical structures of cellulose ether polymers (after Kumar and 
Banker, 1993) 
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1.5.2 Preparation 
The preparation of cellulose ethers dates back to 1912 (Lilienfeld, 1913) and, 
since then, there have been several articles describing the developments in 
the processes and the reactions involved (Greminger and Krumel, 1980). The 
most common method to prepare cellulose ethers is by nucleophilic 
substitution (Kumar and Banker, 1993). The cellulose ether is prepared by 
the reaction of cellulose pulp with caustic soda to form alkali cellulose. The 
(34) 
alkali cellulose is then reacted under controlled conditions with an 
alkylhalide and alkylene oxide to form the cellulose ether. The alkali cellulose 
can be prepared by treating cellulose with a base. Sodium hydroxide is 
usually used, but other alkali metal hydroxides can also be utilized. The 
alkali treatment also causes swelling and decrystallization of cellulose and 
consequently increases the number of accessible regions in the cellulose 
(Kumar and Banker, 1993). 
1.5.3 Hydroxypropylmethylcellulose (HPMC) 
Hydroxypropylmethylcelluloses, are commercially available in various grades, 
under several tradenames, including MethocelTM E, F and K from The Dow 
Chemical Co., U. S. A. Their nonproprietary names are HPMC 2208, HPMC 
2906 and HPMC 2910 (USP 23/NF 18,1995), Hypromellose (in the British 
Pharmacopoeia, 1993) and "Hydroxypropyl Methylcellulose" (Lin et al, 1986). 
The various grades available under a given trade-name represent differences 
in methoxyl and hydroxypropoxyl content as well as molecular weight. The 
methoxyl content ranges from 16.5 to 30% w/w and the hydroxypropoxyl 
content ranges from 4 to 32% w/w (Greminger and Krumel, 1980). 
Commercial designations of the various HPMCs are based on the viscosities 
of their 2% aqueous solutions at 20°C. The viscosities range from 15 cP to 
30,000 cP and represent number average molecular weights ranging from 
about 10,000 to over 150,000, as calculated from the data in "Handbook of 
Methocel Cellulose Ether products" (The Dow Chemical Co., 1974). The 
Methocel K products, owing to their reduced methoxyl content, are claimed 
(35) 
to have the fastest hydration rates and therefore, are suitable for use in 
preparing controlled release matrix tablets (Alderman, 1984). 
Doelker (1987), Ranga Rao and Padmalatha Devi (1988), Hogan (1989) and 
Melia (1991) reviewed the use of HPMC in pharmaceuticals. One of the most 
important aspects of HPMC that governs its performance in a sustained 
release matrix is the rate of polymer hydration. Rapid gel formation on the 
tablet surface is critical for preventing excessive dose dumping and even 
immediate dissolution of the tablet core itself (Ford and Mitchell, 1995). In 
addition, this group of polymers exhibit a range of physical, chemical and 
biological properties which makes them attractive as drug delivery system 
(Knuth et al, 1993). 
1.5.4 Sodium carboxymethylcellulose (NaCMC) 
Sodium carboxymethylcellulose (NaCMC) is a hydrophilic swellable polymer 
and is manufactured by reacting sodium monochioroacetate with alkali 
cellulose (Batdorf and Rossman, 1973). NaCMC is one of the few ionic 
cellulose ether derivatives and therefore it is easily identified by its poorly- 
soluble copper salt, which rapidly precipitates (Grosse 1990). NaCMC 
products are commercially available from AqualonTM (France) under the trade 
name Blanose. Their nonproprietary names are carboxymethylcellulose 
sodium (in the United State Pharmacopoeia / National Formulary, USP 
23/NF 18,1995), carmellose sodium or sodium carboxymethylcellulose (in the 
British Pharmacopoeia, 1993) and "Carboxymethylcellulose Sodium" (Bruno 
(36) 
et al, 1986). By varying the length of the cellulose chain and the degree of the 
cellulose substitution, DS, sodium carboxymethylcellulose with different 
properties can be obtained. The highest theoretical DS value is 3, but for 
commercial products it is much lower, e. g., 0.6-0.8 (Aggeryd and Olin, 1985). 
Bonferoni et al (1993) suggested that NaCMC in gastric juice reverts to the 
unionized form which is characterized by poor hydration and solubility 
properties. Sodium carboxymethylcellulose has been used as a base for 
controlled release matrices (Huber and Christenson, 1968; Lapidus and Lordi, 
1968; Baveja et al, 1985). 
Huber and Christenson (1968) reported that NaCMC is a useful gum since 
it hydrates readily and rapidly at body temperature. Early work by Lapidus 
and Lordi (1968) showed that the release rate of chlorpheniramine was 
significantly lower than that of sodium salicylate from NaCMC matrices and 
attributed this response to a drug : polymer interaction between the 
chiorpheniramine and the carboxymethylcelluse. Baveja et al (1985) reported 
a successful sustained release dosage form of diethylcarbamazine citrate from 
matrices containing 1: 7 drug: NaCMC. 
Due to the interaction of NaCMC with some drugs (Tucker et al, 1988; Ranga 
Rao et al, 1988b) and being insoluble at the pH of stomach contents (Batdorf 
and Rossman, 1973; Bonferoni et al, 1992) the potential of using NaCMC 
alone as a matrix tablet is very limited. 
(37) 
1.5.5 Ethylcellulose (EC) 
Ethylcellulose is a water-insoluble polymer, but dissolves in a wide variety 
of organic solvents (e. g., esters, aromatic hydrocarbons, alcohols, chlorinated 
solvents). The viscosities of its solutions increase with an increase in 
molecular weight and concentration. Concentrated solutions of ethylcellulose 
are usually prepared in binary solvent systems consisting of appropriate 
ratios of an aromatic hydrocarbon solvent (e. g., toluene) and ethyl alcohol. 
The minimum value for ethoxyl content is at about 48.5% ethoxyl substitution 
(Kumar and Banker, 1993). Ethylcellulose is available, for instance, as three 
types of ethoxyl substitution from Dow Chemical Co. (Trade name EthocelR, 
grade S, M or HE). 
Ethylcellulose has been used as a controlled-release carrier (Stamm and 
Tritsh, 1986; Shaikh et al, 1987a, b; Porter, 1989; Aoki et al, 1992a, b; 
Upadrashta et al, 1993; Hernandez et al, 1994). Primarily however, 
ethylcellulose is used as a coating or film forming agent (Borodkin and 
Tucker, 1975; Donbrow and Friedman, 1975; Shaikh et al, 1987a, b). 
The release of soluble drugs from ethylcellulose matrices has been studied by 
several workers (Stauffer, 1985; Stamm and Tritsh, 1986; Shaikh et al, 
1987a, b). Stauffer (1985) described that diffusion of a water-soluble drug out 
of a porous matrix (ethylcellulose) can be compared to the "ant in the 
labyrinth". This will be discussed in greater detail in chapter 7. 
(38) 
1.6 FACTORS AFFECTING DRUG RELEASE FROM HYDROPHILIC 
MATRICES 
A review of current literature has shown that many technological factors can 
affect the release of drugs from hydrophilic matrices (Langer, 1980; Doelker, 
1987; Capan, 1989). In order to prevent immediate release of drug from the 
tablet, which is necessary to achieve controlled release, the polymer(s) in the 
matrix must hydrate rapidly to form a protective gel layer. The physical 
properties of the gelatinous layer formed in tablets or capsules control drug 
dissolution. The choice of matrix material, amount of drug incorporated in 
matrix, matrix additives, the hardness of the matrix, density variation and 
tablet shape may affect the release rate (Capan, 1989). The following 
parameters are the major factors influencing the hydration rate of the gel 
layer. 
1.6.1 HPMC in hydrophilic matrices 
1.6.1.1 Viscosity of polymer 
The effect of viscosity grade of polymers on drug release has been the subject 
of many reports (Huber and Christenson, 1968; Lapidus and Lordi, 1968; 
Korsmeyer, 1983; Daly et al, 1984; Ford et al, 1985a, b, 1987; Pagay, 1988; 
Baveja et al, 1988a; Wan et al, 1991; Colombo et al, 1992 and Cheong et al, 
1995). The viscosities of HPMCs are used as an indication of their molecular 
weight. Alderman (1984) suggested that the viscosity grade of HPMC 
(39) 
incorporated into the matrices would alter the release rates of drug. This was 
related to the molecular weight of the polymers and he claimed that 
increasing the viscosity would increase the gel layer viscosity and thereby 
slow drug diffusion. Ford et al (1985a), examining four viscosity grades of 
HPMC, showed that the lowest viscosity grade (HPMC K100) gave the 
highest release rates of promethazine hydrochloride, whereas three other 
grades (HPMC K4M, HPMC K15M, HPMC K100M) behaved similarly. 
Salomon et al (1979) reported that the viscosity grade of HPMC only affected 
the lag time for potassium chloride diffusion to become quasi-stationary but 
did not affect the rate of release. Ford et al (1985 b) showed that both the lag 
time and release rate were unaffected by the viscosity grade of the polymer 
for HPMC K4M, HPMC K15M and HPMC K100M. 
Cheong et al (1992) investigated the effect of viscosity grade of Metolose K4, 
K15, K30, K50 and K100 (from Shin-Etsu Chemical, Japan) on the release of 
propranolol hydrochloride. They claimed that in matrices of higher HPMC 
content (50-75% w/w), the effect of viscosity on drug release was not apparent 
whereas, in the range of 5-25% w/w the viscosity grade controlled the release 
of the drug. 
1.6.1.2 Polymer particle size 
The particle size of HPMC has been identified as an important factor 
influencing the performance in hydrophilic matrices. Alderman (1984) 
(40) 
reported that the dissolution of riboflavin from matrices prepared with the 
coarsest particle size of HPMC K4M was too fast whereas, tablets made from 
a fine particle size (<150 µm) hydrated quickly and provided sustained 
release. 
Mitchell et al (1993d) studied the release of propranolol hydrochloride from 
matrices containing 57,95,140 or 285 mg of HPMC K15M, reported that at 
low HPMC contents, a coarse particle size (< 355 pm) gave faster propranolol 
release than a smaller particle size (<75 pm). They claimed that as the 
HPMC content increased, the effect of particle size became less important 
and for matrices containing 285 mg HPMC, there was no difference in release 
rates between unsieved and other particle size fractions of the polymer. 
1.6.1.3 Effect of substitution tune of polymer 
In a comprehensive study on the use of HPMC and MC in hydrophilic 
devices, Alderman (1984) concluded that different substitution levels of 
HPMC gave rise to different drug release profiles. These widely accepted 
ideas have subsequently been challenged by Mitchell et al (1990a) who used 
DSC to elucidate water uptake by four grades of cellulose ether, commercially 
available as methylcellulose A4M, HPMC E4M, HPMC F4M and HPMC 
K4M, each manufactured by Dow Chemicals, U. S. A. and equivalent to USP 
types methylcellulose, hydroxypropylmethylcellulose (HPMC) 2910, HPMC 
2906 and HPMC 2208. Mitchell et al (1990a; 1993a) and Ford and Mitchell 
(1995) published data to suggest there was no difference in the rates of water 
(41) 
uptake between the different grades. 
Dahl et al (1990) found that if polymer particle size and other variables were 
kept constant, the release of naproxen was directly related to the 
hydroxypropyl substitution irrespective of the source of the polymer. Dahl et 
al (1990) claimed that satisfactory and reproducible dissolution profiles for 
naproxen was obtained only with tablets manufactured with HPMC 
containing greater than 7.5% hydroxypropyl content. 
1.6.1.4 Added excipients 
Formulation of matrix tablets may require the addition of excipients to alter 
the size of the tablet, to provide lubrication, to change the colour or to replace 
a portion of the polymer to modify drug release rate. The effects of excipients 
on the release rates of various drugs have therefore been studied by authors 
such as Lapidus and Lordi (1968), Alderman (1984), Ford et al (1987) and 
Pagay (1988). 
Lapidus and Lordi (1968) showed that the addition of lactose increased the 
release rate of chlorpheniramine maleate more than the equivalent amount 
of calcium phosphate. Ford et al (1987) investigated the effects of adding 
soluble materials such as lactose and insoluble materials such as calcium 
phosphate on the dissolution of promethazine hydrochloride and reported that 
only tablets containing low quantities of HPMC and high diluent quantities, 
displayed apparent differences in release rates between the two excipients, 
(42) 
despite their vastly differing solubilities. 
Ford et al (1991a) evaluated the influence of sodium dodecyl sulphate on the 
release of propranolol hydrochloride from HPMC matrix tablets and reported 
that the surfactant reduced the release rate of propranolol hydrochloride by 
the in situ formation of propranolol dodecyl sulphate. Ford et al (1991a) also 
showed that the release rates of propranolol hydrochloride from tablets 
containing cetrimide increased despite an increase in viscosity of HPMC gels 
containing cetrimide. 
Feely and Davis (1988) reported that ion exchange resins incorporated into 
the matrix delayed the release of oppositely charged drugs, but drug release 
rate was dependent on the ionic strength of the medium. A similar study 
showed that the release of chlorpheniramine maleate from HPMC matrices 
is slowed by anionic surfactants and that this effect was primarily due to the 
formation of an insoluble complex rather than increased HPMC viscosity, as 
had previously been proposed (Daly et al, 1984). 
1.6.1.5 Effect of drug incorporated in matrix 
The influence of the amount of drug incorporated in a matrix is interesting 
and of practical importance in the field of sustained release tablets. This can 
be a very important factor as frequently it is desirable to produce different 
matrices containing different concentrations of the same drug to provide a 
variety of dosage schedules. 
(43) 
Baveja et al (1988b) examined the formulation of 6 structurally related water- 
soluble broncodilatators namely phenylpropanolamine hydrochloride, 
ephedrine hydrochloride, salbutamol sulphate, terbutaline sulphate, 
reproterol hydrochloride, and aminophylline into HPMC matrices. They 
determined the release rates from compressed matrices of HPMC and 
observed that, although all the drugs had similar aqueous solubility (freely 
soluble), they gave different release rates. They attributed this phenomenon 
to the different molecular weights and molecular sizes of the drugs. 
1.6.1.6 Effect of drug/polymer ratio 
Ford et al (1985a, b) reported that the drug : HPMC ratio is the most 
important factor affecting the rate of release from matrices containing HPMC. 
Ford et al (1985a) considered the effects of some formulations variables on 
the release ofpromethazine hydrochloride from HPMC matrices and produced 
a straight line relationship between the drug release rate against the 
reciprocal polymer content and the following relationship was derived from 
experimental results: 
R=M3+C Equation 1.7 
Where R= Higuchi-type release rate (% min'"), M= slope of the derived line, 
W= weight of HPMC (mg) in tablet, C= constant. 
Similarly Baveja et al (1988b), using propranolol hydrochloride, alprenolol 
(44) 
hydrochloride, oxprenolol hydrochloride and metoprolol tartrate incorporated 
in HPMC K4M, NaCMC or their mixture, at different drug / polymer ratios, 
reported that when the proportion of HPMC in the matrix increased, the time 
to release 50% (T50%) of drug increased. Baveja et al (1988a) confirmed that 
the equation 1.6 proposed by Ford et al (1985a) was valid for HPMC matrices. 
1.6.1.7 Effect of drug particle size 
Ford et al (1985d) stated that the particle size of drugs was important only 
in the case of insoluble drugs, i. e., indomethacin. They reported that the 
release rates of promethazine hydrochloride from HPMC matrices were 
unaffected by particle size, except in the extreme case where the polymer : 
drug ratio was low and the particle size of drug was high (Ford et al, 1985a, 
b). 
1.6.1.8 Compression pressure 
Studies investigating the effect of compression pressure or tablet crushing 
strength on release rates have yielded different results. Ford et al (1985a) 
used pressures ranging from 93 to 1395 MNm 2 for compressing HPMC 
matrices containing promethazine hydrochloride and reported that the release 
rates were not affected by the applied pressure. Hashim and Li Wan Po 
(1987) similarly showed that varying the compression pressure from 148 to 
448 MNni 2 did not affect the release rate of potassium chloride from HPMC 
matrices. Similarly, Huber and Christenson (1968), Lapidus and Lordi (1968), 
Salomon et al (1979) and Conte et al (1993) reported that tablet hardness or 
(45) 
compaction pressure did not affect the release characteristics of soluble drugs 
from different hydrophilic polymers. However, Korsmeyer et al (1983b) 
reported that compression pressures ranging from 28 to 280 MNm a affected 
release during the first four hours and that this could be ascribed to the 
presence of entrapped air in the matrices. 
1.6.1.9 Effect of electrolytes on drug release 
Changes in the hydration state of a polymer in solution are manifested 
primarily by changes in solution viscosity and cloud point. The effect of ions 
on the degree of hydration of cellulose ethers have been studied by Lapidus 
and Lordi (1968), Klug (1971), Marriott and John (1973), Sarkar (1979) and 
Mitchell et al (1990b, 1993a). 
Lapidus and Lordi (1968) were the first to note the effect of ionic strength on 
matrix integrity and drug release. They demonstrated the rapid release of 
chlorpheniramine from HPMC 2208 matrices in solution containing 0.2 M 
sodium sulphate or magnesium sulphate. Mitchell et al (1990a) investigated 
the effect of electrolytes on HPMC gels and reported that electrolytes reduced 
the hydration of HPMC gels and, consequently, decreased the cloud point of 
the gel. This study was similar to the report of Fagan et al (1989) that 
certain ionic salts and drugs may cause complete failure of sustained release 
formulations and this has been attributed to a depression of the gelation 
temperature of the polymer. Mitchell et al (1990b) investigated the effects of 
various ions and concentrations on the disintegration time and dissolution of 
(46) 
propranolol hydrochloride from HPMC 2208 matrices. They also showed that 
under certain conditions, premature disintegration of the matrix could occur, 
resulting in the immediate release of all drug in the matrix. 
Another study suggested that simple anions might be more important than 
cations in lowering the cloud point of HPMC, and that increasing the ionic 
strength of the dissolution medium caused drug dissolution rates to slow, 
with a minimum being reached just before disintegration occurred (Mitchell 
et al, 1990b). It was concluded that even small amounts of electrolytes in the 
dissolution media might therefore affect drug-release rates from HPMC 
matrices. Propranolol hydrochloride, a drug which increases the cloud point 
of HPMC, appeared to affect HPMC hydration at low water content and it 
was concluded that a propranolol : polymer interaction might also play a role 
in controlling the development of gel structure in HPMC matrices during 
hydration (Mitchell et al, 1989). Mitchell et al (1990b) suggested that the 
nearer the dissolution temperature is to the gelation temperature, the greater 
the contribution of erosion to the dissolution mechanism, suggesting an 
increased fragility of the gel network as the thermal gelation point is 
approached. 
Johnson et al (1993) investigated the effect of varying the ionic strength of 
solutions containing sodium chloride on the physical integrity of pure and 
binary compacts of HPC of different particle sizes and molecular weights. 
They claimed that a fine particle size of the polymer was more resistant to 
(47) 
the influences of ionic strength changes than a coarse particle size. 
1.6.1.10 Effect of pH of dissolution medium 
It has been shown that the use of the salt of an acidic or basic drug can lead 
to precipitation of an insoluble layer on the surface of a dissolving tablet and 
this can hinder further dissolution. Lapidus and Lordi (1968) reported that 
the release rates of chlorpheniramine maleate from matrices containing 
HPMC were affected by the pH of media. In contrast, Alderman (1984) 
claimed that HPMC matrices were relatively free from problems induced by 
pH, i. e., the polymer is stable. A decrease in release at pH 7.5 was attributed 
to a decrease in the solubility of chlorpheniramine near its pKa value. 
Ford et al (1985c) showed that the dissolution rates of promethazine 
hydrochloride from matrices composed of HPMC were high at a pH of 1 or 3 
but dropped considerably in media of pH 7 or above. This was attributed to 
the formation of the insoluble, unionized form of promethazine which has a 
pKa of 9.1, rather than to a specific pH effect on HPMC. 
Pagay (1988) showed that the release rates from HPMC matrix formulations 
were controlled by the presence of buffering agent and not by the pH of the 
dissolution medium. He determined that nearly 40% of a weakly basic drug 
was released from HPMC within the first hour. Bonferoni et al (1992) 
concluded that, in the case of polyelectrolyte polymers, both the hydration 
and gelation properties of the polymer and the ionic interactions between 
(48) 
polymer and drug are likely to be affected by the dissolution medium 
characteristics, such as ionic strength and pH. 
1.6.1.11 Effect of temperature 
Lapidus and Lordi (1968) reported that an increase in temperature of 
dissolution media will alter the texture of the gel layer around a matrix, 
subsequently increasing the diffusion coefficient of the drug and will also 
increase the rate of erosion of the matrix. Mitchell et al (1990c), using 
promethazine hydrochloride incorporated in HPMC K15M, reported that at 
low levels of polymer content, a zero-order release may be obtained when the 
thermal gelation temperature of the matrix is near to the dissolution 
temperature. 
1.6.1.12 Effect of tablet shape 
Salomon et al (1979) obtained zero-order release by coating potassium 
chloride tablets with HPMC and reported that, at a constant polymer to drug 
ratio, an increase in thickness of tablet slightly increased the drug release 
rate. Ford et al (1985a) demostrated that the square root of time release rate 
of promethazine hydrochloride from HPMC matrices was proportional to the 
surface area of the tablet, since release rates decreased as the tablet surface 
area decreased. 
1.6.2 NaCMC in hydrophilic matrices 
Some factors affecting the release of drugs from NaCMC matrices have been 
(49) 
studied. These include: 
1.6.2.1 Effect of pH of dissolution medium 
Baveja et al (1987) studied the release of three ß-blocker drugs namely 
propranolol hydrochloride, metoprolol tartrate and alprenolol hydrochloride 
from HPMC, NaCMC and their mixtures. They reported that the release of 
drugs from matrices containing NaCMC alone was linear at pH 3, but the 
release rate increased in phosphate buffer solution pH 7.4. Baveja et al (1987) 
claimed that increase in release rate may be due to increase in erosion rate 
of NaCMC. Similar observations were reported by Ranga Rao et al (1988a). 
Bonferoni et al (1992) reported that since NaCMC has a pKa value of 4.3, the 
solubility of NaCMC would be lower in acidic medium than in distilled water. 
1.6.2.2 Interaction with drugs 
Interaction of drugs with NaCMC have been studied by Tucker et al (1988) 
and Ranga Rao et al (1988b). Tucker et al (1988) reported an interaction 
between propranolol hydrochloride and NaCMC and claimed that one 
propranolol cation would be bound to each carboxyl anion of the NaCMC. 
Ranga Rao et al (1988b) using DSC showed an interaction between pindolol 
and NaCMC and claimed that the produced mass might be governing the 
release of drug. 
1.6.3 Mixtures of HPMC and NaCMC in hydrophilic matrices 
Walker and Wells (1982) reported that when NaCMC is blended with a non- 
(50) 
ionic polymer (such as HPMC), a synergistic effect occurs whereby the 
resultant viscosity is considerably higher than anticipated, due to hydrogen 
bond-induced cross-linking. Baveja and Ranga Rao (1986) were the first to 
suggest the use of both anionic and non-ionic cellulose ethers in matrix 
tablets. These observation have been utilized in several other studies (Baveja 
et al, 1987,1988a and b, 1989; Ranga Rao and Padmalatha Devi 1988). 
The release profiles of freely soluble drugs from hydrophilic matrices 
normally follow the classic square root of time relationship, i. e., the release 
rate decreases with time. Therefore, Baveja et al (1987) reported that zero- 
order release from matrices containing only one hydrophilic polymer is 
difficult to achieve, but admixtures of ionic and non-ionic polymers may allow 
zero-order release. 
Drug release from anionic/non-ionic cellulose ethers has been studied 
extensively by Baveja et al, (1987,1988a, b) and Ranga Rao et al, (1990). 
Baveja et al (1987), using a series of soluble ß-blocker drugs, showed that 
incorporating NaCMC into an HPMC matrix tablet reduced the initial burst 
of drug release and by optimizing the ratios of HPMC, NaCMC and drug, the 
shape of the dissolution profile could be changed from a root-time relationship 
to one where almost 100% drug was released by zero-order kinetics. 
Ranga Rao et al (1990) also showed that a range of freely soluble cationic 
drugs were released more slowly from NaCMC: HPMC combinations than 
(51) 
from HPMC alone, whereas for sodium saccharin (the only freely soluble 
anionic drug studied), the reverse was true. 
In addition, Ranga Rao et al (1989) formulated zero-order release tablets, 
containing very soluble drugs such as alprenolol hydrochloride and metoprolol 
tartrate by using a combination of NaCMC and hydroxypropylcellulose (HPC). 
They reported that the erosion rate of the matrix was fairly constant and was 
about 2.5 times higher when alprenolol hydrochloride (as model drug), 
NaCMC and HPC were present compared to the matrices containing the 
same ratio of the drug and polymer but only HPC. Similarly the release of 23 
drugs with various solubilities and molecular weights from matrices of HPMC 
and NaCMC was studied by Ranga Rao et al (1990). 
Baveja and Ranga Rao (1986) using centperazine, aerosil 200, NaCMC and 
HPMC in the ratio of 1: 0.7 :4: 4, showed that the release of centperazine 
was also independent of the pH of the dissolution media. 
1.7 AIMS AND OBJECTIVES 
The aims of this thesis were to examine how the dissolution rates and the 
kinetics of their release from HPMC matrices could be modified by including 
other materials into the matrices. Sodium carboxymethylcellulose and 
ethylcellulose were chosen initially because they offer some advantages that 
have been discussed in previous sections. During the last few years, studies 
have been published on the uses of HPMC, NaCMC or EC alone in matrix 
(52) 
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tablets, but few studies have been carried out to investigate the physio- 
chemical properties of admixtures of these polymers. The objectives of the 
present work are as follows, using propranolol hydrochloride as a model drug: 
- To investigate the characterization of HPMC, NaCMC or EC on their 
own and their admixtures in order to obtain a better understanding of 
how these polymers function in hydrophilic matrices. 
- To study various physical properties of HPMC, NaCMC or their 
mixtures and discover what effects propranolol hydrochloride had on 
their properties. The studies investigated the hydration and erosion of 
the polymers and their interaction with propranolol hydrochloride. 
- To characterize the mechanisms and the kinetics of drug release from 
matrices containing HPMC, NaCMC, EC or their mixtures, to 
determine under which circumstances and to what extent the ratio of 
the polymers could be of assistance in controlling drug release and 
providing zero-order release. 
- To study the effects of the viscosity grade of NaCMC, alone and in 
combination with HPMC, on drug release. 
- To study the effect of pH of the dissolution medium on drug release 
from matrices containing NaCMC and HPMC. 
(53) 
To study of the use of ß-cyclodextrin in matrices. It is well known that 
ß-cyclodextrin complexes with a number of drugs and it is hoped that 
this property would make it possible to achieve a modified drug 
release. 
(54) 
CHAPTER 2 MATERIALS AND GENERAL EXPERIMENTAL 
This chapter describes the materials and basic techniques which were used 
throughout this study. 
2.1 MATERIALS 
2.1.1 Cellulose ethers 
2.1.1.1 Hydroxypropylmethvlcellulose 
Hydroxypropylmethylcellulose type 2208 (MethocelTM K4M), of 4000 cP 
viscosity, manufactured by Dow Chemicals (U. S. A. ), was used. The apparent 
viscosity of an aqueous 2% solution of this polymer given by the 
manufacturer in their product description was 3500-5650 cP. The percent of 
methoxyl content and hydroxypropoxyl content of this polymer were 19-24 
and 7-12 respectively. Details of this polymer are presented in table 2.1. 
2.1.1.2 Sodium carboxymethvlcellulose 
Sodium carboxymethylcellulose type Blanose 7H4XF, was supplied by 
Aqualon (France). 7H4XF is the coding for Blanose in which 7 means the 
typical degree of substitution is approximately 0.7, H means high viscosity, 
4 means 4000 mPa. s maximum viscosity, X means fine particle size and F 
means food grade. The apparent viscosity of an aqueous 1% solution of this 
polymer given by the manufacturer in their product description was 3400 cP. 
(55) 
Two different viscosity types of NaCMC, (Courlose P 800 B. P., and Courlose 
P 350 B. P. ) were manufactured and supplied by Courtaulds Fine Chemicals 
(U. M). Their apparent viscosities of an aqueous 1% solution of these polymers 
were 600-1120 cP and 262-490 cP for Courlose P 800 B. P., and Courlose P 
350 B. P. respectively. For the sake of simplicity the different viscosity grades 
of NaCMC polymers are coded: Blanose for high viscosity grade, P 800 for 
medium viscosity grade and P 350 for low viscosity grade. Details of their 
batch numbers and degree of substitution are shown in table 2.1. 
2.1.1.3 Ethylcellulose 
Two grades of ethylcellulose were used. Ethylcellulose 7 cP (Ethocel STD 7 
PREM), had a viscosity of 5.6-8.4 cP as a 5% solution in 80% w/w toluene/ 
20% w/w ethanol at 25°C (certificate of analysis by Dow Chemical, U. S. A. ). 
Ethylcellulose 10 cP (Ethocel STD 10 PREM), had a viscosity of 9-11 cP as a 
5% solution in 80% w/w toluene/20% w/w ethanol at 25°C. Both types were 
manufactured by Dow Chemicals (U. S. A. ). Their batch numbers and degree 
of substitution are presented in table 2.1. 
2.1.2 ß-Cyclodextrin 
ß-Cyclodextrin, (lot No. K15973927), manufactured by Merck (Germany) was 
used. Its molecular formula is C42 H70 035, molecular weight is 1135, melting 
point is 290-300°C. Its aqueous solubility at 25°C is 1.85% w/v (Merck Index, 
1989). 
(56) 
2.1.3 Magnesium stearate 
Magnesium stearate manufactured by BDH, Poole, Dorset, was used 
throughout the study. 
2.1.4 Lactose 
Lactose monohydrate B. P. (<105 pm) manufactured by Zeparox, Barclo Whey 
Product U. K., was used. 
Table 2.1: The batch number and degree of substitution of cellulose ether 
polymers used for matrices or preparation of gels 
Polymer Batch Number Degree of 
Substitution 
HPMC K4M MM92031903K 1.36-1.42 
Blanose 22-8623 0.73 
P 800 T895 0.7-0.85 
P 350 T516 0.7-0.85 
EC 7 cP 930654 0.44-0.51 
EC 10 cP 920029 0.44-0.51 
(57) 
2.1.5 Propranolol hydrochloride 
Propranolol hydrochloride <125 pm, which is a beta-adrenoceptor blocking 
agent, was used as a model drug throughout the study. Its structure is given 
in figure 2.1 and its characteristics are as below: 
Figure 2.1: The structure formula of propranolol hydrochloride 
OH 
H 
0, ý CH3 " HC1 1 
It is a white powder, with the molecular weight of 295.8, the molecular 
formula is C16H21NO2. HC1. Its melting point is 164°C and its solubility is 1 in 
20 parts of water at 25°C (British Pharmacopoeia, 1993). The pKa of 
propranolol hydrochloride is 9.5 (Clark's Isolation and Identification of Drugs, 
1986). 
2.2 EXPERIMENTAL METHODS 
The basic methods which were used throughout the study are discussed in 
this section. 
2.2.1 Characterisation of polymers 
Hydroxypropylmethylcellulose and NaCMC were characterized by 
determining their viscosities, cloud points and water distribution in their gels 
and their admixtures. The water uptakes of HPMC, NaCMC and their 
(58) 
mixtures were also determined. 
2.2.1.1 Preparation of gels 
Quantities of gels (50 g) containing HPMC, NaCMC or their mixtures, at 
concentrations from 0.01 to 0.5% w/w for viscosity determination, from 1 to 
5% w/w for cloud point determination and from 5 to 20% w/w for evaluating 
the water distribution in their gels, were prepared according to the methods 
of Mitchell et al (1993b). The required amounts of polymer powder were 
dispersed into approximately one third of the required volume of freshly 
glass-distilled water previously heated to 80°C and stirred until the polymer 
particles were thoroughly wetted. Then the remaining amounts of water (at 
ambient temperature) were added and dispersed. When the gels had cooled 
to ambient, the weights were checked and more water added if needed. The 
gels were covered and stored at 4°C for 24 hours in a refrigerator. This 
method was used to prepare all gels which were used in chapters 4 and 5. 
2.2.1.2 Viscosity determination 
Viscosities were determined using U-tube viscometers, at 37°C, according to 
the British Standard method for the determination of viscosity of liquids 
(British Standard 188,1975). The U-tube viscometer grade A for low viscosity 
gels (0.01 - 0.05% w/w), grade B for gels containing higher concentrations of 
polymer (0.1-0.5% w/w) and grade D for viscosity determination from gels 
containing mixtures of the two polymers at 0.5% w/w were used. Prior to the 
work, all viscometers were cleaned with distilled water, dried using acetone 
(59) 
and calibrated against water at 20°C and 37°C. The viscometers were 
suspended vertically in a water bath maintained at the required temperature. 
The viscometers were placed in the bath for 30 minutes to allow the sample 
to reach temperature equilibrium with the bath liquid. Pressure was then 
applied to raise the meniscus of samples to about 5 mm above the timing 
mark. The flow time was the time taken for the bottom of the meniscus to 
pass between the two timing marks. The dynamic viscosity of water at 20°C 
was taken to be 1.002 cP (British Standard 188: 1975). The time taken was 
a mean of three successive measurements, which were within 0.5% of each 
other. This method was used in section 4.2. 
2.2.1.3 Determination of cloud point 
Cloud points of HPMC gels were determined by the methods of Mitchell et 
al (1990b). After preparing the gels as described in section 2.2.1.1, and 
keeping them at 4°C for 24 hours to hydrate, the samples were transferred 
to disposable cuvettes 1 cm pathlength (Kartell, U. K. ). Any air bubbles 
entrapped in the gels were removed by centrifugation at 2000 rpm in a 
centrifuge (Auto Bench Centrifuge, Baird & Tatlock, U. K. ) for 5 minutes to 
prepare homogeneous gels. The samples were placed in a water bath (Grant 
Instruments Ltd., U. K. ) with a temperature regulator. The temperature was 
gradually increased from 40°C to 75°C. Initially readings were taken at 
intervals of 5°C which were then reduced near the cloud point to 1°C 
intervals. The samples were measured spectrophotometrically at 800 nm, 
using a Phillips spectrophotometer (PU8625), against a 2% w/w aqueous gel 
(60) 
as a reference which had been maintained at room temperature. The 
temperature at which the light transmission reached 50% of the reference 
was taken as the cloud point temperature of the solution (Sarker, 1979; 
Mitchell et al, 1990b). This method was used in sections 4.3 and 5.2. 
2.2.2 Differential Scanning Calorimetry (DSC) 
2.2.2.1 Aims of using DSC 
A Perkin-Elmer differential scanning calorimeter DSC-7 (Beaconsfield, U. K. ), 
with automatic cooling facilities was used throughout the study. This 
equipment was controlled by a Perkin-Elmer TAC-7. The equipment was 
calibrated using indium and zinc. The objectives of the studies using DSC 
were: 
a) to determine the water distribution of gels containing HPMC, NaCMC or 
their mixtures, 
b) to determine the effect of propranolol hydrochloride on water distribution 
of the gels containing HPMC, 
c) to determine the rate of water uptake by the polymers or their 
combinations, 
d) to evaluate any interactions between propranolol hydrochloride with 
NaCMC or ß-cyclodextrin. 
2.2.2.2 Calibration of DSC 
DSC was used in two different conditions with the cooling block set at -80°C 
(61) 
or at ambient. In order to determine free water in the gels or wafers, prior 
to the calibration, the DSC cooling block was cooled to -80°C using liquid 
nitrogen. Indium, DHf 29.7 mJg', melting point, 156.16°C (Standard 
156.60°C) and zinc, melting point, 416.27°C (Standard 419.47°C) were used 
as calibrants. Peak areas were automatically calculated by the instrument. 
The calculated peak area of indium and the melting temperatures of indium 
and zinc were given to the DSC as calibration data. Finally in order to 
investigate the interaction between propranolol hydrochloride and NaCMC 
or ß-cyclodextrin, prior to the work, a similar calibration was performed at 
ambient (without liquid nitrogen) and the heating rate was 3°C mini'. 
2.2.2.3 State of water in gels 
Since the distribution of water within matrices is very important and 
modifies the matrix structure (Mitchell et al, 1989), the state of water in gels 
was evaluated. 
Gels (50 g) containing 5,10,15 or 20% w/w of HPMC K4M, NaCMC or their 
1: 1 mixtures, were prepared as described in section 2.2.1.1. Samples, (5-10 
mg) were accurately weighed into aluminium sample pans (40 µl, Perkin- 
Elmer). After sealing the sample pans, they placed in the DSC holder and 
were cooled from 20°C to -30°C at a controlled rate of -5°C mini' using liquid 
nitrogen as coolant. This rate was used because Mitchell et al (1993a) 
reported that fast cooling of HPMC K15M gels could produce double 
endotherms; slow cooling (5°C min') resulted in only one endotherm around 
(62) 
0°C, for the melting of ice. Then the samples were scanned at 10°C mil' to 
30°C in order to measure the enthalpy of melting of the free water at 
approximately 0°C. Empty sample pans were used as reference. Melting 
enthalpies were determined in at least triplicate for each gel concentration. 
This method was used in sections 4.4 and 5.2.2. 
2.2.2.4 Water uptake by polymer 
Since a study of water uptake by polymers could provide knowledge of the 
imbibing of water by the polymers, the following study was performed using 
HPMC K4M, NaCMC (Blanose), ethylcellulose, ß-cyclodextrin, lactose or their 
mixtures. 
Mixtures of polymer powders were prepared in a glass jar using a tumbler 
mixer for 15 minutes. For this study, approximately 10 mg samples (HPMC 
K4M, NaCMC, ethylcellulose, ß-cyclodextrin, lactose, 1: 1 HPMC : NaCMC, 1: 1 
HPMC : ethylcellulose, 1: 1 HPMC : ß-cyclodextrin or 1: 1 HPMC : lactose) 
were manually compressed into wafers of 6.35 mm diameter, using flat-faced 
punches and die and a Manesty F3 single punch tableting machine according 
to the method of Mitchell et al (1993a). The wafers and the aluminium 
sample pans (Perkin-Elmer, 6.35 mm diameter) were accurately weighed 
separately. Approximately 10 mg double distilled water (approximately 
equivalent to the wafer weight) was placed in the pan and the wafers were 
placed above the water in the pan. A loosely fitting aluminium lid (6.35 mm 
diameter, Perkin-Elmer) was placed on top of the wafer to prevent water loss 
(63) 
by evaporation. The pans were left unsealed and were kept at room 
temperature for 1,5,15 or 30 minutes. After storage for the prescribed time, 
the pans and their contents were placed into the sample compartment of a 
Perkin-Elmer DSC-7 differential scanning calorimeter which was maintained 
at 20°C and wafers were immediately chilled to -30°C at a controlled rate of 
-10°C min 1 using liquid nitrogen. This cooling rate was performed to freeze 
any unbound water and prevent the production of double peaks (Mitchell et 
al, 1993c). Samples were scanned from -30°C to 20°C at 5°C min' and the 
enthalpy of fusion of unbound ice measured. 
In order to investigate the water uptake of the polymers at the temperature 
of the dissolution studies, a similar method was used for HPMC, NaCMC or 
their 1: 1 mixture, except that the pans containing the wafers and water were 
held in the sample compartment of the Perkin-Elmer DSC-7 differential 
scanning calorimeter at 37°C for 1,5,15 or 30 minutes prior to analysis. 
The means of at least 3 determinations were used to calculate the water 
uptake for each type of disc. The quantity of bound water was then calculated 
from the difference between the weight of water in the pan and the amount 
of unbound water equivalent to the observed enthalpy of fusion. This method 
was used in sections 4.5,7.6 and 8.6. 
2.2.3 Determination of propranolol solubility 
Propranolol hydrochloride has a pKa of 9.5 (Clark's Isolation and 
(64) 
Identification of Drugs, 1986) and its solubility is markedly dependent on pH. 
Therefore it was necessary to determine the solubility of propranolol 
hydrochloride in the different media which were used throughout this study. 
2.2.3.1 UV calibration of propranolol hydrochloride 
The UV spectrum for a propranolol hydrochloride solution is shown in figure 
2.2. The UV absorbance for a solution containing 0.1 mg/mL propranolol 
hydrochloride was determined at 288 nm (1.847 ± 0.03, n=3) and its E 1%, 1 
cm value determined experimentally and used in this study, was 184.7. 
Figure 2.2: UV spectrum of an aqueous solution containing propranolol 
hydrochloride (0.1 mg/mL). 
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The W absorbances of different concentrations of propranolol hydrochloride 
( 0.0 to 0.1 mg/niL) in freshly distilled water at 288 nm were determined 
(figure 2.3). The best fit equation for the Beer's law plot of the UV absorbance 
versus drug concentrations, is given by equation 2.1. 
Y= 18.11 C+0.054 (r=0.9994) Equation 2.1 
Figure 2.3: Calibration curve of propranolol hydrochloride in distilled water 
at 288 nm. Mean (n=3) :t SD 
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In this equation, Y is the absorbance at 288 nm and C is the concentration 
of propranolol hydrochloride (mg/mL). This equation was used for calculation 
(66) 
0.00 0.09 0.04 0.09 0.08 0.10 
of propranolol solubility throughout the study (chapters 6 and 8). 
2.2.3.2 Determination of solubility 
Samples (1 g) of propranolol hydrochloride powder were placed into 5 mL test 
tubes with 3 mL of distilled water, 0.1 M hydrochloric acid, phosphate buffer 
solution pH 6.8 or alkaline borate buffer solution pH 9.4 according to the 
method of Shivanand and Sprockel (1993). The formulae of the buffers are 
presented in appendix 1. The test tubes were placed in a shaker bath 
(Companstat 882942, England), at 37°C for seven days. Then the suspended 
solid was allowed to settle and the supernatant was sampled and filtered 
through a Whatman No. 1. The first 1 mL of the filtrate was discarded. The 
drug concentration was determined spectrophotometrically at 288 nm after 
appropriate dilution. The mean of three determinations was used to calculate 
the solubility of propranolol hydrochloride in each media. This method was 
used in sections 6.3 and 8.5. 
2.2.4 Preparation of matrices 
Flat-faced tablets, 12.7 mm diameter, were directly compressed on a Manesty 
F3 single punch tableting machine (Manesty Machines Ltd. U. K. ) at 182 
MNm'2. Compaction was accomplished by direct compression of blends 
containing propranolol hydrochloride <125 pm, polymers and magnesium 
stearate that had been mixed for 15 minutes using a tumbler mixer. This 
method was also used to prepare matrices containing ethylcellulose, 
HPMC: ethylcellulose, NaCMC: ethylcellulose and HPMC: ß-cyclodextrin. 
(67) 
2.2.5 Dissolution Methodology 
Dissolution was measured by a Pharmatest (GmbH, Germany) dissolution 
tester and a Hewlett Packard HP8452A Diode Array spectrophotometer. The 
USP XXII (Apparatus I) was used, rotating at 100 rev miri', in 1000 mL 
distilled water maintained at 37°C. Propranolol hydrochloride was monitored 
at 288 nm. The mean of six determinations was used to calculate the drug 
release for each formulation. 
(68) 
CHAPTER 3 DISSOLUTION OF PROPRANOLOL 
HYDROCHLORIDE FROM MATRICES CONTAINING 
HYDROXYPROPYLMETHYLCELLULOSE AND 
SODIUM CARBOXYMETHYLCELLULOSE 
3.1 INTRODUCTION 
Matrices containing solely hydroxypropylmethylcellulose (HPMC) generally 
provide a controlled drug release which approximates to square root of time 
kinetics (Ford et al, 1985a, b; 1987). Since zero-order release is the most 
desired release pattern, several investigators (e. g., Baveja et al, 1987; 1988 
a, b; Ranga Rao et al, 1989; Padmalatha Devi et al, 1989) have tried to 
achieve a zero order release of drug from hydrophilic matrices. This release 
is characterized by being independent of time and the amount of drug 
remaining in the systems. Baveja et al (1987) reported that the major 
disadvantage of hydrophilic swellable polymers is that zero-order release has 
not generally been observed but they advocated the use in matrices of 
admixtures of HPMC and sodium carboxymethylcellulose (NaCMC) to provide 
a near zero-order release of propranolol hydrochloride. Similarly, Ranga Rao 
et al (1989) claimed that the admixture of a non-ionic hydrophilic polymer 
such as HPMC and an ionic polymer such as NaCMC may allow zero-order 
release of soluble drugs. 
However, it is well known that the viscosity grade of HPMC does not 
normally affect the drug release (Ford et al, 1985a, b) and that admixture of 
(69) 
HPMC and NaCMC would produce a synergistic increase in the viscosity of 
their gels (Walker and Wells, 1982) which could be used to modify drug 
release (Ranga Rao et al, 1989). This increase in the viscosity of the two 
polymers was confirmed by Manion et al (1990) who derived equations which 
predicted the total viscosity of mixed aqueous solutions of anionic and 
nonionic cellulose ethers and showed that the enhanced viscosity observed in 
the mixture might be explained in terms of coil expansion of the anionic 
polymer. However, there seems to have been few studies on the performance 
of these polymers in controlling drug release. This investigation evaluates if 
changes in the viscosity grade of NaCMC in its admixtures with HPMC, lead 
to zero-order release of drugs. 
3.1.1 Aims and objectives 
The main aim of the studies presented in this chapter was to investigate how 
HPMC, NaCMC or their combinations affect the dissolution rate of 
propranolol hydrochloride from matrices. The other aim was to study the 
effect of the viscosity grade of NaCMC on the drug release. For this purpose, 
matrices containing different viscosity grades of NaCMC, on their own and 
in admixture with HPMC, were made and the dissolution rates of propranolol 
hydrochloride were examined. 
3.1.2 Experimental 
3.1.2.1 Materials 
Propranolol hydrochloride, HPMC, NaCMC, and magnesium stearate used in 
(70) 
the matrix tablets are described in the section 2.1. 
3.1.2.2 Tablet preparation 
Tablets were prepared containing 160 mg propranolol hydrochloride (<125 
pm), 0.75% w/w magnesium stearate as lubricant and 57,71,95,140, or 285 
mg of HPMC K4M, NaCMC (Blanose) or their 1: 3,1: 1 or 3: 1 blends at 182 
MNni 2 as described in section 2.2.4. Matrices containing 57,95,140 or 285 
mg of NaCMC P 800 or NaCMC P 350 or their admixture with HPMC K4M 
in the ratio of 1: 1 were similarly made. 
3.1.2.3 Dissolution methodology 
Dissolution studies were carried out at 37°C as described in section 2.2.5. 
3.1.2.4 Statistical analyses of release 
In order to investigate the kinetics of drug release from matrices, attempts 
were made to fit the data corresponding to 5- 60% release to equations 1.1, 
1.2 and 1.3 which were discussed in section 1.4.1. Equations 1.1 and 1.2 are 
popularly used to determine the release exponent (n) of drug release from the 
matrices. Fitting the data points, to equations 1.1 and 1.2 was carried out 
using a computer program. The program uses a non-linear least-squares 
fitting method to determine the optimum values for the parameters presented 
in each equation (Ford et al, 1991). For the purpose of comparison, the data 
in this study were also fitted to equation 1.3, which is a simplified form of an 
equation produced by Higuchi (1963). Data were fitted to equation 1.3 by 
(71) 
linear regression. These equations are summarized below: 
@=K1 t° Equation 1.1 
K2 ( t-1)° Equation 1.2 
Q= K3 t°'s +C Equation 1.3 
All the terms in these equations, have been discussed thoroughly in section 
1.4.1. However, there is a difference between the values of n from equation 
1.1 and 1.2. Equation 1.1 is based on the assumption that release occurs as 
soon as the matrix is placed in contact with fluid and thus predicts an 
intercept at the origin (Ford et al, 1991) whereas, equation 1.2 includes a 
value of lag time and thus the plot would not pass through the origin. 
Therefore the value of n from equation 1.2 is defined as "lag time corrected". 
The release rates from all matrices were calculated from linear regression of 
the data corresponding to 5 to 60% propranolol hydrochloride release on the 
basis of the square root of time. This was initially attempted irrespective of 
curve shape. Therefore, the release rates from matrices containing low 
polymer content, especially for NaCMC, are approximate values (due to the 
few data points obtained between 5 and 60% release). As the polymer content 
in the matrices increased, the value of release rates could be obtained more 
accurately. The values of T50% (time for 50% drug released) were calculated 
from the time for 50% of drug to be released as minutes. 
(72) 
3.2 RESULTS AND DISCUSSION 
3.2.1 Release of propranolol hydrochloride from matrices containing 
HPMC K4M 
The release profiles, of propranolol hydrochloride from tablets containing 
different quantities of HPMC are shown in figure 3.1. All dissolution data 
were plotted as a function of the square root of time. An increase in HPMC 
content resulted in a decrease in the release rates. A similar dependence of 
the release rates on the drug : HPMC ratio in the matrices has been observed 
for HPMC matrices containing propranolol hydrochloride (Ford et al, 1985b; 
Mitchell et al, 1993d). The release rates, on the basis of the square root of 
time, are given in table 3.1. 
The values of K, and n based on equation 1.1 and K2, n and 1 based on 
equation 1.2 are presented in the table 3.2. It is seen that the value of n is 
about 0.6, indicating diffusion control (Ford et al, 1991). Similar values of n 
of 0.64 (Ford et al, 1987) and 0.63 (Ranga Rao et al, 1990) were found for 
propranolol hydrochloride release from matrices containing HPMC K15M and 
HPMC K4M matrices, respectively. Perez-Marcos et al (1994), using HPMC 
K4M and carbopol, reported values of 0.698,0.646 and 0.608 for propranolol 
hydrochloride release kinetics from matrices containing 40,90 and 140 mg 
HPMC K4M respectively. 
The data in table 3.2 gave an estimate of the value of n based on equations 
(73) 
Figure 3.1: Release of propranolol hydrochloride from matrices containing 
different amounts of HPMC K4M (results are the means ± SD of 6 
determinations) plotted as a function of the square root of time 
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1.1 and 1.2. It was observed that, although the values of n from both 
equations were similar, equation 1.2 gave the lowest sums of squares of 
errors (ss). Previously, Ford et al (1991) reported that the sums of squares of 
errors, are a measure of the discrepancies between the observed data and the 
values which were predicted by a particular model. Therefore, this value 
gives an initial guide to the quality of a model; the greater the sum of 
squares, the poorer the model (Ford et al, 1991). However, due to the lower 
values of the sum of squares, equation 1.2 gave the best fits for the data from 
matrices containing HPMC K4M. Several authors have published methods for 
assessing changes in the sums of squares with increased number of variables, 
e. g., Schwartz, (1978) introduced an information criterion. The lowest value 
for the information criterion is the most appropriate for each set of data and 
therefore equation 1.2 was generally more appropriate than equation 1.1. 
3.2.2 Release of propranolol hydrochloride from matrices containing 
NaCMC 
Figures 3.2,3.3 or 3.4 show the release profiles of propranolol hydrochloride 
from matrices containing different amounts of NaCMC (Blanose), NaCMC P 
800 or NaCMC P 350 respectively. Since matrices containing NaCMC tended 
to release the drug as a function of time rather than square root of time, the 
release data are plotted as a function of time. The release rates, based on the 
square root of time and irrespective of the curve shape, are given in table 3.3. 
Since the data colud not be fitted to equation 1.2 for some of the matrices 
containing NaCMC, equation 1.1 was used. The values of K, and n based on 
(77) 
this equation are also presented in the table 3.3. As mentioned in section 
3.1.2.4, due to fast release of matrices with low polymer content, the release 
rates from NaCMC are approximate estimates. 
In matrices containing NaCMC (Blanose), the dissolution rates increased 
from 3.1 to 27.1% minn as the content of NaCMC (Blanose) was lowered 
from 285 to 57 mg. Similarly the dissolution rate from matrices containing 
NaCMC P 800, increased from 3.9 to 28.8% min (table 3.3). The largest 
differences observed in release rates were from matrices containing 95 mg of 
different kinds of NaCMC. Matrices containing 95 mg of NaCMC P 800 or 
NaCMC P 350 showed similar release rate (> 26% min's) whereas the rates 
from matrices containing 95 mg NaCMC (Blanose) were 4.6% mizi'. 
However, it is seen that the release rates from matrices containing NaCMC 
(Blanose) are slower than other kinds of NaCMC at similar concentrations. 
The rank order of release rate was NaCMC (Blanose) < NaCMC P 800 < 
NaCMC P 350, which was dependent on their viscosity grades. 
Since matrices containing 71 mg of NaCMC (Blanose) showed very fast 
release, matrices containing 71 mg of NaCMC P 800 or NaCMC P 350 were 
not investigated. The release profiles were considerably different to those 
from matrices containing HPMC. The amount of drug released at any time 
decreased as the proportion of any of the kinds of NaCMC in the matrices 
increased. A similar dependence of release rates on the drug : NaCMC ratio 
has been observed for NaCMC matrices containing propranolol hydrochloride 
(78) 
Figure 3.2: Release of propranolol hydrochloride from matrices containing 
different amounts of NaCMC (Blanose) plotted as a function of time. Results 
are the means ± SD of 6 determinations. 
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Figure 3.3: Release of propranolol hydrochloride from matrices containing 
different amounts of NaCMC P 800 plotted as a function of time. Results are 
the means ± SD of 6 determinations. 
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Figure 3.4: Release of propranolol hydrochloride from matrices containing 
different amounts of NaCMC P 350 plotted as a function of time. Results are 
the means ± SD of 6 determinations. 
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(Baveja et al, 1987) or pseudoephedrine hydrochloride (Baveja et al, 1989). 
However, the matrices containing 57 or 71 mg NaCMC showed a fast release 
of propranolol hydrochloride, due to their disintegration. More than 65% of 
the drug in the matrices was released during the initial 6 minutes of contact 
with dissolution media. The data indicate that the matrices containing 
NaCMC released their drug by one of two release mechanisms depending on 
the polymer content. Matrices containing 57,71 or 95 mg NaCMC were 
probably unable to provide a protective gel layer around themselves; matrices 
containing more than 95 mg were able to do so and therefore showed 
controlled drug delivery. It seems that a NaCMC content of about 95 mg was 
required before even some control of drug release was accomplished. The 
values of n based on equation 1.1 from matrices containing 95 mg NaCMC 
(Blanose) were 0.94 between 5-40% and 0.24 between 40-60% release, 
indicating a significant difference in drug release mechanism during the two 
periods from these matrices. 
When the release data from matrices containing 285 mg NaCMC (Blanose) 
were plotted against time (figure 3.2) instead of square root of time (figure 
3.5), the data between the range of 5-80% could be regarded as linear 
(r=0.999). This indicates that square root of time kinetics did not accurately 
describe the propranolol hydrochloride release from matrices containing 285 
mg NaCMC. The values n for matrices containing 285 mg NaCMC were near 
1 confirming the near zero-order release from these matrices. In contrast, 
(83) 
Figure 3.5: Release of propranolol hydrochloride from matrices containing 
different amounts of NaCMC (Blanose) plotted as a function of time. Results 
are the means ± SD of 6 determinations. 
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matrices containing 140 mg tended to release their drug by anomalous 
release. The lowest value for n (0.33) was obtained for matrices containing 71 
mg NaCMC (Blanose) which showed fast release of propranolol hydrochloride 
due to disintegration of these matrices. 
For further comparison of release data from matrices containing the different 
kinds of NaCMC, equation 1.3 was used to give estimates of release rates and 
intercepts from matrices containing 140 or 285 mg NaCMC. Low polymer 
content (57,71 and 95 mg) of NaCMC P 800 or NaCMC P 350 showed fast 
release (more than 80% during 6 minutes) and therefore it was impossible to 
accurately estimate values of K3. From the data in table 3.4, it was observed 
that as the polymer content or its viscosity grade increased, the release rates 
decreased and so did the intercept, indicating a lag time before drug release. 
Table 3.4: Estimated values of release rate (K3) and intercept (%) from 
matrices containing 140 or 285 mg different kinds of NaCMC based on 
equation 1.3. 
Parameters Blanose (mg) P 800 (mg) P 350 (mg) 
140 285 140 285 140 285 
Slope (K3) 3.83 3.10 4.47 3.90 6.10 5.21 
Intercept (°lo) -16.5 -30.2 -12.6 -25.6 -4.93 -24.10 
r` 0.993 0.999 0.986 0.991 0.975 0.993 
r* Regression coefficient between 5-60% drug release, based on time 
(85) 
3.2.3 Release of propranolol hydrochloride from matrices containing 
HPMC and NaCMC 
3.2.3.1 The effect of HPMC and NaCMC (Blanose) on drug release 
The release profiles of propranolol hydrochloride from matrices containing 57, 
71 or 95 mg polymer and different ratios of HPMC and NaCMC (Blanose) are 
shown in figures 3.6,3.7 and 3.8 respectively. The values of the release rates 
for all matrices consist of different ratios of HPMC and NaCMC (Blanose) 
are presented in table 3.1. It was observed that from these matrices, the 
dissolution rates increased as the proportion of NaCMC increased. This might 
be potentially due to a higher erosion rate of these matrices compared to 
matrices containing HPMC alone (Rangs Rao et al, 1990). Ranga Rao et al 
(1990) reported that the erosion rates of matrices containing 50% drug 
(metoprolol tartrate or alprenolol hydrochloride) and 50% of 1: 1 HPMC : 
NaCMC or 1: 1 hydroxypropylcellulose : NaCMC were much higher compared 
to matrices containing HPMC or hydroxypropylcellulose alone. 
The release profiles of propranolol hydrochloride from matrices containing 
140 or 285 mg polymer are shown in figures 3.9 and 3.10 respectively. In 
matrices containing 140 mg polymer, the dissolution rates decreased as the 
NaCMC content increased to 75% of the total polymer (1: 3 HPMC : NaCMC). 
In matrices containing 285 mg total polymer, a minimum in rates (1.3 ± 0.1) 
occurred for matrices containing 1: 1 HPMC : NaCMC (Blanose). This 
decrease in release rate might have been due to the formation of a complex 
(86) 
Figure 3.6: The effect of HPMC : NaCMC (Blanose) ratio on the release of 
propranolol hydrochloride from matrices containing 57 mg polymer. Results 
are the means ± SD of 6 determinations. 
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Figure 3.7: The effect of HPMC : NaCMC (Blanose) ratio on the release of 
propranolol hydrochloride from matrices containing 71 mg polymer. Results 
are the means ± SD of 6 determinations. 
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Figure 3.8: The effect of HPMC : NaCMC (Blanose) ratio on the release of 
propranolol hydrochloride from matrices containing 95 mg polymer. Results 
are the means ± SD of 6 determinations. 
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Figure 3.9: The effect of HPMC : NaCMC (Blanose) ratio on the release of 
propranolol hydrochloride from matrices containing 140 mg polymer. Results 
are the means ± SD of 6 determinations. 
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Figure 3.10: The effect of HPMC : NaCMC (Blanose) ratio on the release of 
propranolol hydrochloride from matrices containing 285 mg polymer. Results 
are the means ± SD of 6 determinations. 
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between the cationic drug (propranolol hydrochloride) and the anionic 
NaCMC (Ranga Rao et al, 1990). A similar theory was proposed for the 
release of chlorpheniramine maleate from matrices containing NaCMC (Feely 
and Davis, 1988). Ranga Rao et al (1990), using propranolol hydrochloride 
(100 mg) incorporated in matrices containing HPMC and NaCMC (50 mg: 50 
mg), reported that the release rate was much slower than matrices containing 
drug : HPMC (in ratio 1: 1). This was attributed to a complex between 
propranolol hydrochloride and NaCMC. 
Table 3.5 shows the values of Kl and n, from matrices containing different 
ratios of HPMC : NaCMC, calculated from the range of 5-60% drug release 
and based on equation 1.1. It can be seen in the table 3.5, the value of the 
release exponent (n) is not related to the polymer content. The lowest value 
(0.33) was obtained for matrices containing 57 mg total polymer at the ratio 
of 1: 3 HPMC : NaCMC. For other formulations, the value of n was greater 
than 0.52 indicating predominately diffusional release mechanisms (Ford et 
al, 1991). It is clearly apparent that by further increasing the proportion of 
the NaCMC, the value of n increased, a value of 1.07 being attained for 
HPMC : NaCMC (in the ratio 1: 3) indicating near zero-order release. Ranga 
Rao et al (1990) reported a value of 0.2522 for matrices containing 100 mg 
propranolol and 100 mg polymer (1: 1 HPMC : NaCMC). 
Research efforts during recent years have focused on the design of zero-order 
delivery systems which will release drug at a constant, predetermined rate. 
(92) 
Table 3.5: Values of kinetic constants (K), release exponents (n) for drug 
release between 5-60% release determined irrespective of curve shape, from 
matrices containing different ratios and different contents of HPMC and 
NaCMC (Blanose) based on equation 1.1 
HPMC: NaCMC 
ratio Kl n 
75% HPMC: 25% NaCMC 
57 mg 2.45 0.69 
71 mg 2.12 0.68 
95 mg 1.90 0.68 
140 mg 1.44 0.67 
285 mg 0.91 0.62 
50% HPMC: 50% NaCMC 
57 mg 5.73 0.61 
71 mg 5.48 0.53 
95 mg 2.80 0.61 
140 mg 1.39 0.62 
285 mg 0.16 0.79 
25% HPMC: 75% NaCMC 
57 mg 25.30` 0.33* 
71 mg 9.61 0.52 
95 mg 4.14 0.55 
140 mg 1.07 0.59 
285 mg 0.035 1.07 
* This value is an approximation, due to the low number of data points. 
(93) 
In order to ascertain the zero-order release from matrices containing 285 mg 
of HPMC : NaCMC (Blanose), the drug release was alternatively evaluated 
by calculating the instantaneous release rate and plotting it as a function of 
time (figure 3.11). The matrix tablets containing HPMC alone had an initial 
burst release, whereas the release rates from those consisting of 1: 3 HPMC 
: NaCMC (Blanose) did not change, confirming near zero-order release 
kinetics. Colombo et al (1992), using similar plots, interpreted the kinetics of 
drug release from matrices of different surface areas. They suggested that the 
least variable release rate indicated zero-order or near zero-order release. 
Figure 3.12 is a three dimensional graph, for data based on equation 1.1, to 
illustrate the inter-relationships between the value of n (tables 3.2 and 3.3), 
HPMC and NaCMC (Blanose) content. As the NaCMC (Blanose) content 
increased, the value of n tended to increase. However, as the HPMC content 
increased, the value of n increased until a content of 95 mg after which 
increasing HPMC content did not affect its release expontent (n). 
Since matrices containing 285 mg of 1: 1 HPMC and NaCMC (Blanose) gave 
the minimum release rate (table 3.1) and a high value of n (0.79) (table 3.5), 
the effects of NaCMC types on the release of propranolol hydrochloride from 
matrices containing HPMC : NaCMC P 800 and HPMC : NaCMC P 350 were 
investigated. 
(94) 
Figure 3.11: Instantaneous propranolol hydrochloride release rates versus 
time from matrices containing 285 mg different ratios of HPMC : NaCMC 
(Blanose). Results are the means ± SD of 6 determinations. 
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3.2.3.2 The effect of mixture of HPMC and different kinds of NaCMC on drug 
release 
Figures 3.13,3.14 and 3.15 show the release of propranolol hydrochloride 
from matrices containing 95 mg, 140 mg and 285 mg total polymer consisting 
of 1: 1 HPMC : NaCMC (Blanose), HPMC : NaCMC P 800 or HPMC : NaCMC 
P 350 respectively. The release rates of all formulations and also the release 
kinetics and T60%s are shown in table 3.6. A comparison of figures 3,13,3.14 
and 3.15 indicates that as the polymer content increased the linearity of the 
curves for whole period of drug release increased and matrices tended to 
release their drug more slowly. For instance, the regression coefficients from 
1: 1 HPMC K4M : NaCMC (Blanose) were 0.865,0.950 or 0.999 for matrices 
containing 95,140 or 285 mg polymer respectively, by treating the data as a 
function of time. 
The data in table 3.6 indicate that as the viscosity of NaCMC decreased the 
value of release exponent from matrices containing 285 mg total polymer 
decreased from 0.81 to 0.72, whereas this relationship between the viscosity 
of NaCMC and the release exponent was not observed for matrices containing 
less than 285 mg polymer content (57,95 or 140 mg). 
3.3 CONCLUDING REMARKS 
The dissolution profiles of propranolol hydrochloride from HPMC-NaCMC 
matrices were very complicated. The results confirmed that the use of either 
HPMC or NaCMC alone could not provide a zero-order release of propranolol 
(97) 
Figure 3.13: Release of propranolol hydrochloride from matrices containing 
95 mg total polymer consist of 1: 1 HPMC K4M : different kinds of NaCMC 
as function of time. Results are the means ± SD of 6 determinations. 
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Figure 3.14: Release of propranolol hydrochloride from matrices containing 
140 mg total polymer consist of 1: 1 HPMC K4M : different kinds of NaCMC 
as function of time. Results are the means ± SD of 6 determinations. 
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Figure 3.15: Release of propranolol hydrochloride from matrices containing 
285 mg total polymer consist of 1: 1 HPMC K4M : different kinds of NaCMC 
as function of time. Results are the means ± SD of 6 determinations. 
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hydrochloride and showed clearly that near zero-order release was only 
achievable within a narrow range of HPMC : NaCMC ratios. 
The release rates from matrices consisting of NaCMC P 800 were slightly 
faster than Blanose and slower than P 350, indicating that the release rates 
were dependent on the viscosity grades of NaCMC. The rank order of drug 
release was NaCMC (Blanose) < NaCMC P 800 < NaCMC P 350. Admixture 
of HPMC with the different viscosity grades of NaCMC caused a decrease in 
the total release of propranolol hydrochloride. The effect of viscosity grade of 
NaCMC on drug release was clearly seen in figure 3.15. 
Since the mechanisms of drug release from matrices consisting of HPMC and 
NaCMC appeared to be very complicated, it was necessary to characterize the 
properties of HPMC, NaCMC and their mixtures. This will be discussed in 
the next chapter. 
(102) 
CHAPTER 4 CHARACTERIZATION OF 
HYDROXYPROPYLMETHYLCELLULOSE, SODIUM 
CARBOXYMETHYLCELLÜLOSE AND THEIR MIXTURES 
4.1 INTRODUCTION 
As discussed in chapter 3, the release profiles from matrices containing 
HPMC, NaCMC or their mixtures were very complicated. Matrices containing 
HPMC showed Higuchian release; their release rates were linear with the 
square root of time. Matrices containing NaCMC gave different behaviour to 
HPMC. Although it is accepted that the viscosity grade of HPMC does not 
effect the release of soluble drugs (Ford et al, 1985a, b; Chenog et al, 1992), 
the viscosity grade of NaCMC had a pronounced effect on drug release. Since 
drug release from hydrophilic matrices, especially HPMC, is controlled by 
factors including the water distribution into the polymer (Ford and Mitchell, 
1995), the extent of swelling (Rajabi-Siahboomi et al, 1993), the cloud point 
(Mitchell et al, 1993c) and the hydration process (Ford and Mitchell, 1995), 
it was considered necessary to study these parameters for HPMC, NaCMC 
and their mixtures. 
4.1.1 Aims and objectives 
The purpose of the studies described in this chapter was to characterize 
HPMC, NaCMC and their mixtures by examining the viscosity of their 
aqueous solutions, the cloud points of their solutions, the water distribution 
(103) 
of their gels and the water uptake into their compressed wafers. 
4.2 VISCOSITY 
Viscosity is an expression of the resistance to flow of a system under an 
applied stress (Martin et al, 1983). The more viscous a liquid, the greater the 
applied force required to make it flow at a particular rate. Aqueous solutions 
of cellulose ethers display non-Newtonian behaviour and give rheological 
behaviour typical of linear polymers, i. e. the viscosity increases drastically 
with increase in the polymer concentration (Doelker, 1987). The viscosity of 
polymer solutions also depends on the molecular weight of the polymer 
(Alfrey, 1947; Doelker, 1987). The viscosity data from an aqueous solution can 
be used to obtain the molecular weight of material comprising the disperse 
phase (Martin et al, 1983) and also they provide a measure of the size or 
extension in space of the polymer molecules (Alfrey, 1947). However, due to 
the entanglement and association of polymer chains, aqueous solutions of 
high molecular weight cellulose ethers are shear-thinning, that is their 
apparent viscosities decrease with increase in rate of shear (Greminger and 
Krumel, 1980). 
Viscosity is one of the most widely utilized characteristics for characterization 
of polymers and it is important to the design of many oral controlled release 
dosage forms (Doelker, 1987). Many types of viscometers have been discussed 
in detail by Martin et al (1983). Amongst them, the United States 
Pharmacopoeia / National Formulary (USP 23/NF 18,1995) suggested a 
(104) 
capillary apparatus for determining the viscosity of solutions of 
methylcellulose or polymers. 
4.2.1 Theoretical background 
4.2.1.1 Definitions and symbols 
Several coefficients of viscosity may be defined including dynamic viscosity, 
kinematic viscosity, specific viscosity, intrinsic viscosity and reduced viscosity. 
The dynamic viscosity (ii) of a liquid is the tangential force on unit area of 
either of two parallel planes at unit distance apart when the space between 
the planes is filled with the fluid and one of the planes moves relatively to 
the other with unit velocity in its own plane (British Standard 188; 1975). Its 
Standard International (SI) unit is Poise (Pa. s. ). The kinematic viscosity (v) 
of a liquid may be defined as the dynamic viscosity divided by the density of 
the fluid (p). Its SI unit is Stokes (St). The smaller units of dynamic and 
kinematic viscosities are centipoise (cP) and centistokes (cSt) respectively 
(Marriott, 1988). 
By determining the viscosity at various concentrations (c) and knowing the 
viscosity of the medium (1o), the specific viscosity (%P), reduced viscosity 
(symbol 1i /c) and intrinsic viscosity ((l]) (dL/g) of a polymer solution may be 
determined. Specific viscosities, may be calculated using equation 4.3 and the 
obtained results may be used to determine the other viscosities. 
(105) 
4.2.1.2 Equations describing viscosity 
The dynamic viscosity of a solution may be determined using equation 4.1 
and U-tube viscometry (British Standard 188; 1975). 
11-ct Equation 4.1 
where: il = the dynamic viscosity of the sample (cP), C= the viscometer 
constant and t= the flow time (seconds). 
The specific viscosities, yep, may be calculated at any given polymer 
concentration using equation 4.2 (Arwidsson and Nicklasson, 1989; 1990): 
sp = 
11 
- 110 
1 
110 
Equation 4.2 
0 
Where: 1= the dynamic viscosity of the polymer solution and r= the 
dynamic viscosity of solvent. 
The reduced viscosity (%Vc or'Ired) can be calculated by dividing the specific 
viscosity by concentration. Extrapolation of reduced viscosities to zero 
concentration, gives the intrinsic viscosity which eliminates the effect of the 
buildup of the reduced viscosity due to intermolecular entanglements (Martin 
et al, 1983). 
Alfrey (1947) suggested that the specific viscosity of a polymer solution can 
(106) 
be satisfactorily related to its concentration by the first two terms of a power 
series (Equation 4.3). 
lisp = al. c + a2. c2 Equation 4.3 
where the first coefficient, al, is ordinarily called the "intrinsic viscosity" and 
represented by the symbol [i]. The second coefficient, a2, reflects the 
interaction among solute molecules and is related to the equation 4.4. 
a2=k`[ ]2 Equation 4.4 
k` is a Huggins interactions constant for a given chemical species of polymer 
in a given solvent and is independent of the molecular weight of the polymer. 
The application of intrinsic viscosity ([il]) and interaction constant k` has been 
suggested as a tool for selecting appropriate solvent mixtures for different 
polymers (Arwidsson and Nicklasson, 1989; 1990). The two parameters [ill 
and k' are both indirect means of measuring the ability of a solvent system 
to dissolve a polymer. Therefore, the intrinsic viscosity is high in "good" 
solvents and low in "poor" solvents (Alfrey, 1947). The value of k' gives an 
indication of the polymer-polymer and polymer-solvent interactions, such that 
a positive slope is produced for a polymer which interacts weakly with a 
solvent. The slope becomes less positive or sometimes negative with increase 
in interaction (Huggins, 1942; Mitchell et al, 1993c). 
(107) 
The intrinsic viscosity [ri] and the interaction constant k` may be calculated 
by means of linear regression analysis of the data in a plot of reduced 
viscosity (i8p/c) versus polymer concentration according to equation 4.5, which 
is a modified form of equation 4.3 (Arwidsson and Nicklasson, 1989; 1990). 
T , 
/c Wired = [, q] + k` [rß]2 c Equation 4.5 
In this equation, 11, P = specific viscosity, c= concentration 
(g/dL), [ii] = 
intrinsic viscosity (dUg) and k' = Huggins interactions constant. 
Figure 4.1 shows a theoretical plot of reduced viscosity versus polymer 
concentration. Extrapolation of the plot to the ordinate-aids gives the intrinsic 
viscosity [ii] and the Huggins interaction constant can be calculated by 
dividing the gradient by the square of the value obtained for the intrinsic 
viscosity (equation 4.4). k' and (ill are obtained on the understanding that 
this equation is valid at low concentrations only. The reduced viscosity can 
be represented by equation 4.6. 
1) 
Equation 4.6 lisp _o 
CC 
(108) 
Figure 4.1: Typical plot of reduced viscosity versus concentration, showing 
that extrapolation to the ordinate-axis, gives the intrinsic viscosity of the 
polymer solution (after Martin et al, 1983). 
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4.2.2 Experimental 
4.2.2.1 Solution preparation 
The following gels were prepared and tested according to the methods 
described in section 2.2.1.1: 
- low concentration gels containing 0.01,0.02,0.025,0.03,0.04 or 0.05% w/w 
of HPMC K4M, NaCMC or their 1: 1 mixture, 
(109) 
- gels containing HPMC : NaCMC at ratios of 0.4 : 0.1,0.3 : 0.2,0.25: 0.25, 
0.2 : 0.3 or 0.1 : 0.4 (% w/w). 
4.2.2.2 Method of viscosity determination 
The method described in section 2.2.1.2 for the determination of viscosity was 
used. The value of the kinematic viscosity of water, experimentally 
determined at 37°C using a U-tube grade A viscometer, was 0.710 cS. The 
dynamic and kinematic viscosities of water at 20°C were taken to be 1.0020 
cP and 1.0038 cSt respectively (British standard 188,1975). 
4.2.3 Results and discussion 
4.2.3.1 Viscosity of hvdroxypropylmethylcellulose and sodium 
carboxymethvlcellulose 
Figure 4.2 shows the results of the kinematic, specific and reduced viscosities 
of HPMC gels. Figure 4.3 shows the reduced viscosities of gels containing 
NaCMC (Blanose), NaCMC (P 800) or NaCMC (P 350). The corresponding 
values and data obtained for kinematic and specific viscosities are presented 
in the table 4.1. As the concentration of HPMC or NaCMC increased, their 
kinematic and specific viscosities increased, whereas in the case of NaCMC 
gels the reduced viscosities showed different behaviour. The results of 
kinematic, specific and reduced viscosities of the different grades of NaCMC 
(Blanose, NaCMC P 800 and NaCMC P 350) showed that the viscosity ranked 
as Blanose >P 800 >P 350 which probably was due to differences in their 
(110) 
molecular weights. In contrast to HPMC gels, NaCMC gels, especially those 
containing NaCMC P 350, did not obey equation 4.5. 
The deviation from linearity for the reduced viscosities of NaCMCs in figure 
4.3 is probably due to the pseudoplastic nature of their gels (Kumar and 
Bankar, 1993; Doelker, 1987). Doelker (1987) reported that, because of 
entanglement and association of the polymer chains, aqueous solutions of 
cellulose ethers are pseudoplastic and their apparent viscosities decrease with 
increased rate of shear. This phenomenon is generally more pronounced at 
higher shear-rate conditions and for higher viscosity type materials (Doelker, 
1987). However, solutions of the low-molecular-weight NaCMCs, have low 
viscosities and are less pseudoplastic than the solutions of high-molecular 
weight NaCMCs (Batdorf and Rossman, 1973). 
The determination of the reduced viscosities of polymers is valid at low 
concentrations of polymer (Martin et al, 1983; Alfrey, 1947). This fact is 
clearly seen in table 4.1 in which the reduced viscosities of NaCMC (Blanose) 
at 0.03 and 0.04% w/w are similar, whereas their kinematic and specific 
viscosities have increased. The reduced viscosity of NaCMC P 350 decreased 
as the concentration increased above 0.03% w/w. Similar findings for gelatin 
were reported by Gautam and Schott (1994) who investigated the 
physicochemical properties of gelatin and reported that its reduced viscosity 
decreased as the concentration of polymer increased. 
(111) 
Figure 4.2: The effect of concentration on the kinematic, specific and reduced 
viscosities of HPMC K4M gels (results are the means ± SD of three 
determinations) 
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Figure 4.3: The effect of concentration on the reduced viscosities of gels 
containing NaCMC (Blanose), NaCMC (P 800) or NaCMC (P 350) obtained 
at 37°C (results are the means t SD of three determinations) 
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4.2.3.2 Viscosity of mixed HPMC and NaCMC 
Figure 4.4 shows the results of reduced viscosities of HPMC, NaCMC 
(Blanose) or their 1: 1 mixture at low concentrations (50.05% w/w). The results 
for the kinematic, specific and reduced viscosities of their 1: 1 mixtures are 
presented in table 4.2. The estimates of the intrinsic viscosities and Huggins 
constants from gels containing HPMC K4M, the three kinds of NaCMC and 
the mixture of 1: 1 HPMC and NaCMC (Blanose), which were calculated from 
the linear portions of figures 4.3 and 4.4 can be seen in table 4.3. 
The data in table 4.3 indicate that the value of k` for the 1: 1 mixture was 
intermediate between HPMC and NaCMC. Arwidsson and Nicklasson (1989) 
reported that the low values for interaction constant, k`, indicate that a low 
interaction between polymer and solvent. So, these data confirm that the 
NaCMC could absorb water more readily than HPMC, or in other words, it 
would appear that water is a better solvent for NaCMC than HPMC K4M or 
their 1: 1 mixture. Alternatively Marriott (1988) reported that a positive slope 
was produced for a polymer which interacted weakly with the solvent. 
Therefore, the high value for the NaCMC slope in table 4.3 again implies that 
water is a desirable solvent for NaCMC. Amongst three different kinds of 
NaCMC, NaCMC P 350 gave the lowest value of k'(0.033) calculated from 
linear portion of its curve (figure 4.3). 
At low concentrations (50.05% w/w) of the polymers (figure 4.4), the reduced 
viscosities of the 1: 1 mixtures were intermediate between the reduced 
(115) 
Figure 4.4: The effect of concentration on the reduced viscosities of gels 
containing HPMC K4M, NaCMC (Blanose) or their 1: 1 mixture obtained at 
3 7°C (results are the means ± SD of three determinations) 
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Table 4.2: The kinematic (11), specific (dap) and reduced viscosity (r1, p/c) of the 
1: 1 HPMC : NaCMC (Blanose) mixture at 37°C (results are the means ± SD 
of three determinations) 
1: 1 HPMC : NaCMC 
Concentration 
(% w/w) 
TI 
(Centistoke) 
lisp rep/c 
0.01 1.19 ± 0.01 0.67±0.02 67.10±1.56 
0.02 1.80 ± 0.01 1.53 ± 0.01 76.53 ± 0.33 
0.025 2.17 ± 0.03 2.06 ± 0.04 82.25 ± 1.59 
0.03 2.62 ± 0.02 2.69 ± 0.04 89.57 ± 1.07 
0.04 3.48 ± 0.03 3.90 ± 0.04 97.53 ± 1.00 
0.05 4.35 ± 0.05 5.13 ± 0.07 102.63 t 1.46 
viscosities of the individual polymers. This would tend to indicate a lack of 
interaction between the polymer molecules in dilute solutions, because both 
polymers, in solution, are separated and are unable to interact together. 
When the concentrations of polymers were increased, between 0.1 - 0.5% w/w, 
the 1: 1 mixtures had higher reduced viscosities than either of the pure 
polymers. The reason for the increase in reduced viscosity might be due to 
(117) 
Table 4.3: The intrinsic viscosity [i], gradient and interaction constant, k`, for 
HPMC K4M, NaCMC (Blanose) and their 1: 1 mixture and also NaCMC P 800 
or NaCMC P 350 at 37°C 
Polymer [r] (dUJg) gradient k' 
HPMC K4M 5.16 70.9 2.663 
NaCMC (Blanose) 156.00 2445.0 0.100* 
1: 1 HPMC: Blanose 59.10 920.0 0.263 
NaCMC P 800 108.00 1309.0 0.112' 
NaCMC P 350 89.10 263.0 0.033* 
From linear portions of plots in figure 4.3 (0.01 to 0.03% w/w) 
interaction between the two polymers, especially since the carboxyl groups of 
CMC may promote stronger hydrogen bonding between the carboxyl groups 
on NaCMC and the hydroxyl groups on the HPMC (Walker and Wells, 1982). 
The data in table 4.4, show the increase in viscosity when admixtures of the 
two polymers were examined at higher concentrations. As the NaCMC 
concentrations in gels containing admixtures with HPMC increased, the 
viscosities increased more than anticipated, indicating a synergistic increase 
in viscosity. For instance, gels containing 0.1% w/w HPMC or 0.4% w/w 
NaCMC (Blanose) had reduced viscosities of 8.1 and 303.9 respectively 
(11$) 
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whereas, their mixture had a reduced viscosity of 483.6 (table 4.4) which is 
about 55% higher than the sum of their individual viscosities. 
Walker and Wells (1982) reported that when HPMC was blended with 
NaCMC a synergistic effect occurred whereby the resultant viscosity was 
considerably higher than anticipated. Doelker (1987) stated that although 
NaCMC was macroscopically compatible with nonionic cellulose ethers, it 
does interact with them, so that a synergistic effect on viscosity is observed. 
Mannion et al (1990), showed that there was good agreement between 
predicted and observed values of viscosities of aqueous solutions of HPMC 
and NaCMC. They considered that the enhanced viscosity observed in their 
mixtures might be explained in terms of coil expansion of the anionic 
polymer. 
4.3 CLOUD POINTS OF GELS CONTAINING 
HYDROXYPROPYLMETHYLCELLULOSE, SODIUM 
CARBOXYMETHYLCELLULOSE OR THEIR MIXTURE 
4.3.1 Theoretical background 
Lapidus and Lordi (1968) reported that the hydration of cellulose ethers is 
affected by temperature. In solution at lower temperatures, molecules are 
hydrated and there is little polymer-polymer interaction other than simple 
entanglement (Sarker, 1979). As the temperature increases, the polymer loses 
its water of hydration and at the same time the relative viscosity decreases. 
(120) 
Eventually, when a sufficient but not complete dehydration of the polymer 
occurs, a polymer-polymer association takes place and the system approaches 
an infinite network structure reflected by a sharp rise in relative viscosity 
(Sarker, 1979). Gelation of methylcellulose or HPMC in solution is primarily 
caused by hydrophobic interactions between molecules containing methoxyl 
substitution. The temperature at which this occurs is known as the thermal 
gelation point (TGP) (Sarker, 1979). Another phenomenon observed in HPMC 
gels with increase in their temperature is a precipitation of the polymer 
molecules. This property may be measured by light transmission (Mitchell et 
al, 1990b). 
Sarker (1979) showed that when the temperature of a methylcellulose 
solution increased, the light transmission remained at 100% until at some 
elevated temperature, it began to decrease with increasing temperature. 
Sarker (1979) defined the temperature at which light transmission reached 
97.5% and 50% of its optimal value as incipient precipitation temperature 
(IPT) and cloud point (CP), respectively. The cloud point may also be defined 
as the lowest temperature at which turbidity is developed when a dilute 
solution of a polymer is heated slowly (Klug, 1971). 
The thermal gelation of Methocel polymers is the most interesting of its 
unique properties and are due to the modifications made to the celluloses 
during their manufacturing (Van Coillie, 1989). The uniqueness of this 
property comes from the reversibility of the thermal gelation process when 
(121) 
aqueous solutions of either methylcellulose or HPMC are heated (Sarker, 
1979). The reversibility of thermal gelation also has been called sol-gel 
transformation which would occur within a narrow range of temperature. 
Figure 4.5 shows a typical relationship between viscosity and temperature for 
a methylcellulose solution during the sol-gel transformation. When the 
temperature is increased, the viscosity of the solution decreases until the 
temperature reaches the incipient gelation temperature (1PT) at which there 
is a sharp rise in viscosity, indicating gelation (Sarker, 1979). The gel 
remains as long as the temperature is kept high enough. On the other hand, 
the cooling curve looks quite different. Viscosity and other properties 
alternatively return to those of the starting solution. This process is 
reversible on cooling resulting in a solution with the original viscosity (Klug, 
1971). 
The mechanisms involved in this phase separation phenomenon are the 
emergence of interactions between polymeric chains and the weakening of 
hydrogen bonding between the water molecules and polymers (Doelker, 1987). 
Sarker (1979) confirmed that hydroxypropyl group in HPMC is responsible 
for producing the cloud point and reported that at low concentrations of 
HPMC it is possible to produce a turbid solution before gelation occurs whilst 
at higher concentrations a gel is produced before turbidity. 
Mitchell et al (1990b) demonstrated that factors such as the cloud point of the 
(122) 
cellulose ether, the type of ether and gel strength, may influence the 
performance and properties of gels containing HPMC or methylcellulose. 
Additionally there are similar reports by Fagan et al (1989) and Klug (1971), 
but there are no published works, known to the author, which demonstrate 
the effect of temperature on gels containing HPMC and NaCMC. Therefore 
the aim of this part of work was to study the effect of temperature on the 
cloud points of gels containing HPMC and NaCMC and compare them. 
Figure 4.5: Gelation behaviour of a 2% w/v aqueous solution of 
methylcellulose (Methocel A100) on heating at 0.25°C / minute as measured 
by changes in dynamic viscosity with temperature (after Sarker, 1979). 
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4.3.2 Experimental 
4.3.2.1 Gel preparation 
Gels containing 0.5,1,1.5,2,3,4 and 5% (w/w) HPMC K4M, NaCMC 
(Blanose) or their 1: 1 mixtures were prepared as described in section 2.2.1.1. 
4.3.2.2 Cloud point determination 
The cloud points of the gels were determined by the methods described in 
section 2.2.1.3. 
4.3.3 Results and Discussion 
4.3.3.1 Cloud points of HPMC K4M and NaCMC (Blanose) 
Figure 4.6 shows the effect of temperature on the light transmission of gels 
containing between 0.5 and 5% w/w HPMC K4M. When the temperature 
increased, the light transmission of HPMC gels decreased and a precipitation 
was observed. Table 4.5 shows the values of cloud point of the gels. As seen 
in table 4.5, there was a difference of more than 8°C between the cloud points 
of gels containing 0.5 and 5% w/w of HPMC. 
The light transmission of gels containing up to 5% NaCMC (Blanose) 
remained unchanged with increase in the temperature up to 50°C. As the 
temperature increased above 50°C, in contrast to HPMC gels, the light 
transmission increased to in excess of 100%. As the concentration of NaCMC 
in the gels increased, the observed light transmission became lower. A 
(124) 
maximum light transmission of 132% was observed at 75°C, for gels 
containing 0.5% w/w. At this temperature the light transmission for gels 
containing 5% was 105%. 
Figure 4.6: The effect of temperature on the light transmission of gels of 
different concentrations of HPMC K4M (results of at least 3 readings) 
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Table 4.5: Effect of concentration on the cloud point temperatures of HPMC 
K4M gels (results are obtained from at least 3 tests) 
Concentration (%w/w) Cloud Point (°C) 
0.5% > 75°C 
1% 72 - 73 
1.5% 71 - 72 
2% 71 - 72 
3% 70 - 71 
4% 70 
5% 67 - 68 
The possible reason for the increase in light transmission is that the 
methoxyl substitution is responsible for gelation, and the hydroxypropyl 
substitution is also responsible for altering the gelation characteristics 
significantly (Sarker, 1979). For example, hydroxyethyl methylcellulose, 
which contains a high degree of methoxyl and a low degree of hydroxyethyl 
substitution, is known to exhibit gelation, but the polymer containing a high 
degree of hydroxyethyl and a low degree of methoxyl substitution does not gel 
(Sarker, 1979). Also, Sarker (1979) reported that the type of substitution is 
important in determining the gelation properties of cellulose ethers. For 
(126) 
example, carboxymethyl cellulose, sulfoethyl cellulose and hydroxyethyl 
cellulose are all non-gelling polymers. Klug (1971) reported a value of >100'C 
for the cloud point of gels containing 1% w/w of NaCMC that is in accordance 
with the above findings. 
4.3.3.2 Cloud points of gels containing 1: 1 HPMC K4M : NaCMC (Blanose) 
Although, NaCMC alone did not have a cloud point, its mixture with HPMC 
K4M showed a decrease in cloud point. Only gels containing 0.5,1,2 and 3% 
w/w polymer were tested. Gels containing more than 3% w/w were not 
examined due to their high viscosity that made it impossible to fill the 
cuvette. 
Figure 4.7 shows the effect of temperature on the light transmission of gels 
containing 1: 1 HPMC : NaCMC. Gels containing 1,2 or 3% w/w polymer gave 
the cloud points of about 73,66 or 65 respectively which are lower than the 
HPMC gel alone of equivalent concentrations, 1,2 or 3% HPMC respectively 
(table 4.5). Gels containing 0.5% w/w total polymer had light transmissions 
of more than 100% at 74°C. The reason for this finding might be the 
interaction between the carboxyl groups of NaCMC and hydroxyl groups of 
HPMC which provided a competition for the distribution of water in the gels 
(Walker and Wells, 1982). 
(127) 
Figure 4.7: The effect of temperature and polymer concentration (% w/w) on 
the light transmission of gels containing 1: 1 HPMC : NaCMC (Blanose). 
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4.4 THE DISTRIBUTION OF WATER IN GELS CONTAINING 
HYDROXYPROPYLMETHYLCELLULOSE, SODIUM 
CARBOXYMETHYLCELLULOSE OR THEIR MIXTURES 
4.4.1 Theoretical background 
The state of water in hydrogels is a subject of some controversy. When a 
hydrophilic polymer is placed in water, a gel is formed and water is absorbed 
and becomes bound to the polymer. In a tablet the gel consists of both free 
and bound water. There are many reports in the literature about the 
condition of water in a hydrogel; their discussion usually centres on the 
distribution of free and bound water in the gels. However, the states of water 
are often described in terms of their observable freezing and/or melting 
behaviour because each state has a different physical property (Korsmeyer, 
1983). 
There are many methods which have been used to investigate the different 
states of water in gels such as differential scanning calorimetry (DSC) 
(Yasuda et al, 1972; Ohno et al, 1983; Fielden et al, 1988; Mitchell et al, 
1989; 1993a; Ford and Mitchell, 1995), nuclear magnetic resonance (Yasuda 
et al, 1972; Sung, 1986), thermal gravimetric analysis (TGA) (Yasuda et al, 
1972; Fielden et al, 1988), cryogenic scanning electron microscopy (Melia et 
al, 1990) and dilatometry (Lee et al, 1975). Since DSC has various advantages 
over other methods, i. e. the ability to evaluate the water content of a small 
sample rapidly and quantitatively, it was chosen to measure bound and free 
(129) 
water in gels. 
The uses of thermal analysis in analyzing polymers have been reviewed by 
Gedde (1990) and more extensively by Ford and Timmins (1989). Aizawa and 
Suzuki (1971), Aizawa et al (1972) and Lee et al (1975) described models of 
gel structures which displayed three different states of water. These were 
bound water, free water and a weakly bound, interfacial water. Also 
Taniguchi and Horigome (1975) suggested four different states of water 
contained in cellulose acetate membranes, which are: completely free water, 
free water weakly interacting with polymer, bound water which can contain 
salts and bound water which rejects salts. Bound water can be defined as 
water that is incapable of freezing at 0°C, because of interaction with the 
polymer. Korsmeyer (1983) suggested that water tightly bound to the polymer 
will not be able to contribute much to solvation of another diffusing species 
whereas free water in the gel provides a good environment for solute 
transport. 
Yasuda et al (1972), utilizing DSC, nuclear magnetic resonance (NMR) and 
permeability measurements of water on poly(glycerol methacrylate), showed 
that there were only two kinds of water based on DSC measurements (bound 
and free water) whereas, their permeability measurements suggested the 
existence of an intermediate state of water in the gel (loosely bound water). 
Also, Sung et al (1986) described that the amount of bound water within a gel 
was constant and once all the binding sites from polymer were occupied, any 
(130) 
added water would be either lightly bound or free. Similarly Haldankar and 
Spencer (1989) studied poly(acrylic acid) by DSC and explained their results 
in terms of a three-state model, where the water in the hydrated polymer was 
identified as "nonfreezing", "freezing with a constant melting temperature" 
and "freezing with a melting temperature dependent on water content". They 
claimed that the melting point of the last type of water increased from -10°C, 
gradually approaching 0°C at high hydration. However, all the authors are 
agreed that free water makes up a significant amount of the water content 
in gels. 
4.4.2 Methodology 
Previously Mitchell et al (1989; 1993a) demonstrated that the scans of HPMC 
gels depended on the gel conditions prior to their testing by Differential 
Scanning Calorimetry (DSC) or Differential Thermal Analysis (DTA). Two 
endotherms were displayed by HPMC gels which had been previously cooled 
rapidly. One was consistent with the melting of unbound water at 0°C and 
the other showed a peak temperature in the range 5-25°C. Mitchell et al 
(1989) reported that only an endotherm at 0°C was seen in samples that were 
cooled at -5°Cmin'. Since the slow cooling of the gels prevents the formation 
of the secondary peak (Mitchell et al, 1989), all gels were cooled at -5°Cmin' 
and then heated at 10°Cmiri 1. 
(131) 
4.4.3 Experimental 
4.4.3.1 Gel preparation 
The gels used in this study were prepared using HPMC K4M, NaCMC 
(Blanose) or their 1: 1 mixture, as described in section 2.2.1.1. 
4.4.3.2 Method of determination 
The enthalpy of melting at approximately 0°C of the free water was 
determined as described in section 2.2.2.3. 
4.4.4 Results and Discussion 
Figure 4.8 shows typical DSC scans of gels containing 5-20% w/w of HPMC 
K4M. Similarly figures 4.9 and 4.10 show typical DSC scans of gels 
containing 5-20% w/w NaCMC (Blanose) and 1: 1 mixture of HPMC: NaCMC 
respectively. Their enthalpies are presented in table 4.6. The enthalpies from 
all gels decreased as the concentration of the polymers in the gels increased. 
The onset temperatures for the melting of water in the gels decreased from 
approximately -5°C to approximately -15°C, as the concentration of gels 
increased from 5% w/w to 20% w/w, indicating a probable degree of 
interaction (binding) of water to the cellulose ether. 
As previously described, there are at least two thermodynamically different 
types of water in gels, bound and free. Bound water within a gel is constant 
(Sung et al, 1986) but free water within a gel depends on the concentration 
(132) 
Figure 4.8: The DSC scans of gels containing 5,10,15 or 20% w/w HPMC 
K4M obtained at 10°C/min following cooling at -5°C/min. 
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of polymer. Once all binding sites are occupied any excess water is either 
loosely bound or free. The decrease in the onset temperatures might be due 
to a weak interaction of the water with the polymer chain, which with 
increasing the temperature, was reduced. Careful examination of figures 4.8, 
4.9 and 4.10 reveals that as the concentration of gels increased, the sharpness 
of the peak decreased again indicating interaction between water and the 
polymer. 
(133) 
Figure 4.9: The DSC scans of gels containing 5,10,15 or 20% w/w NaCMC 
(Blanose) obtained at 10°C/min following cooling at -5°C/min. 
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As the concentration of polymer increased, the quantity of free water 
decreased as shown by the decrease in melting enthalpy of free water (table 
4.6). In the case of HPMC K4M gels, extrapolation to zero enthalpy gave the 
intercept value as 46.6 ± 1.3% HPMC K4M and 53.4% water, that is equal 
to 114.8 ± 5.0 g water per 100 g HPMC K4M. By considering the molecular 
(134) 
Figure 4.10: The DSC scans of gels containing 5,10,15 or 20% w/w mixture 
of 1: 1 HPMC : NaCMC (Blanose) obtained at 10°C/min following cooling at 
-5°C/min. 
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weight of water to be 18.02, it was calculated that the number of moles of 
non-freezing water was 6.4 ± 0.3 moles of water per 100 g of HPMC K4M. 
This point represents the minimum ratio of water to HPMC that is required 
for water to occupy the binding sites of HPMC K4M. Previously, Mitchell et 
al (1991b) gave values of 58.5% : 41.5 and 61.8% : 38.2 HPMC K15M: 
(135) 
x 
U 
as 
.9 
O 
ru 
r-ý 
C) 
h0 
O 
CII 
Cam" 
h0 
10 
OQ 
. ýi 
O 
O 
ihr 
V 
O 
v 
it 
aý 
0 
a 
b 
ti aý 
0 
a 
w 0 
aý 
aý 
.G H 
cý 
aý 
9 
d 
aý 
0 
0 
0 
U 
U 
Cd Z 
d+ r; N 
c+ý o c) 
a +1 +1 +1 
r+ ao 
°0 ö C) ý 
0 0 
c '- 
r. . -i ao 
+I +I +I 
r-q c c 
rn 
00 cyi 
+ 
+1 +1 
y CD Go cq 
-: 
C; C6 Q t ý N 
C V 
cc N ti 
+I +I +I 
to d; 
N 
cq 
N 
a0 cA o0 
cri C14 cri Q) +1 +1 +1 
Cd cq GV Gil 
4 4 r4 r r cq c c- 
cý cc cc 
W z 
t n' ö V 
C4 p., 
º'ti 
ý p., 
z 
r-+ 
UR 
LO 
A 
C-1 W 
b 14 
Ö 
O 
y 
dy 
C"i a 
14 
II 
(136) 
water for two hour and 24 hour old gels respectively. Joshi and Wilson (1992) 
studied HPMC E5 by DSC and explained their results in terms of a three- 
state model, where the water in the hydrated polymer was identified as type 
I (free water melting at 0°C), type II (water loosely bound to hydrophilic 
groups on the polymer which melted below 0°C) and type III (tightly bound 
water which did not freeze). Joshi and Wilson (1993) reported a value of 6.2 
1.3 moles bound water per polymer repeating unit of HPMC E5. However, 
Ford and Mitchell (1995) gave values of 8.5 and 6.6 moles water per polymer 
repeating unit of HPMC K15M gels stored for 2 hours and 24 hours 
respectively. 
The difference in the results obtained from the present study with those of 
Mitchell et al (1991b), might be due to different polymer types and the 
percentage of HPMC in the gels examined. Mitchell et al (1991b) examined 
gels containing 0-40% w/w HPMC K15M and Joshi and Wilson (1993) used 
HPMC E5 whereas the polymer used in this study was HPMC K4M a 
concentrations between 0-20% w/w. 
In the case of NaCMC gels, the intercept value for zero enthalpy of gels 
containing NaCMC and water was obtained as 48.2 ± 2.1% NaCMC (Blanose) 
and 51.8% water. From this value it can be calculated that the amount of 
water required to fully hydrate 100 g of NaCMC (Blanose) is 107.9 ± 7.2 g 
water which is equal to 6.0 -t 0.4 mole water. The extrapolated concentration 
of NaCMC gels which would provide a zero enthalpy compared to the HPMC 
(137) 
gels, indicates that NaCMC might require less amount of water for hydration 
than HPMC. 
The Tukey's statistical test for multiple comparisons was used to assess the 
significant differences in the data of the melting enthalpies and the 
concentrations of gels containing HPMC, NaCMC or their 1: 1 mixture. For 
the gels containing HPMC K4M and NaCMC (Blanose) at similar 
concentrations there were significant differences (p <0.05) in the melting 
enthalpies of gels containing 10 and 20% w/w polymer whereas there were no 
significant differences at the other concentrations (5 and 15% w/w). 
In the case of the 1: 1 mixture of HPMC : NaCMC, the extrapolation to zero 
enthalpy gave an intercept value of 49.7 ± 1.8% polymer and 50.3% water. 
This amount is equal to 5.6 ± 0.3 mole water per 100 g of 1: 1 polymer. The 
zero-enthalpy for the mixture indicates that the amount of required water for 
full hydration was probably less than those for the individual polymers. A 
significant difference (Tukey's test) was observed only between gels 
containing 15% w/w of HPMC and 15% of 1: 1 HPMC : NaCMC. No other 
statistical differences between the 1: 1 mixture and the HPMC or NaCMC gel 
were observed at equivalent concentration. 
The reason for the decrease in the amount of water required for hydration of 
1: 1 HPMC : NaCMC gels, even though not significant statistically, might be 
the interaction between the two polymers. Klug (1971) stated that much of 
(138) 
the water absorbed by hydrophilic polymers is held chemically by hydrogen 
bonding at oxygen atoms in these polymers. Therefore, since the carboxyl 
groups of NaCMC tended to bind with hydroxyl groups of HPMC, the free 
hydroxyl groups of the polymers would decrease which subsequently would 
cause a decrease in the amount of bound water. 
The decrease observed in the cloud points of gels containing 1: 1 HPMC : 
NaCMC, is probably due to the higher solubility of NaCMC compared to 
HPMC (Klug, 1971; Doelker, 1987). This property would probably cause more 
water to be absorbed by NaCMC and subsequently less water would be left 
for the HPMC content to absorb, water preferentially binding to the NaCMC. 
4.5 WATER UPTAKE OF HYDROXYPROPYLMETHYLCELLULOSE 
AND SODIUM CARBOXYMETHYLCELLULOSE 
4.5.1 Theoretical background 
Mitchell et al (1991a: 1993a) showed that fast hydration of a polymer is 
critical to good sustained-release action in most hydrophilic matrices. 
Retardation of drug release is accomplished via the production of a gel layer 
around the matrix when placed in contact with water. Therefore, the speed 
at which the polymer absorbs water and forms a gel layer after its initial 
contact with water is of great importance. Lucisano et al (1989) also reported 
that two aspects of HPMC govern its performance in a sustained release 
matrix, polymer hydration rate and viscosity of the polymers. However, Ford 
(139) 
and Mitchell (1995) confirmed the importance of the polymer hydration rate 
in the successful formulation of a sustained release delivery system. 
Although, there is some literature on water uptake or swelling of HPMC 
matrices (Mitchell at al, 1990a; 1993c; Alderman, 1984; Ford and Mitchell, 
1995), relatively little has been reported addressing the influence of the rate 
of NaCMC hydration on the drug release. 
Mitchell et al (1993a) showed that the speed of water uptake by a polymer 
played a significant role in the properties of matrices containing HPMC 
K15M. Furthermore, from the data described in section 4.4, approximately 
equal parts of water : polymer were required to give complete hydration of 
the polymer. Therefore, in order to understand the mechanism of hydration 
and to determine the speed of water uptake into the polymers, this study was 
carried out using equal parts of water and the polymers, i. e., HPMC K4M, 
NaCMC (Blanose) or their 1: 1 mixture. 
4.5.2 Experimental 
4.5.2.1 Preparation of wafers 
Wafers were made using approximately 10 mg of unsieved HPMC K4M, 
NaCMC (Blanose) or their 1: 1 mixture as described in section 2.2.2.4. 
4,5.2.2 Method of determination 
Water uptakes by wafers were determined by the method of Mitchell et al 
(140) 
(1993a) as described in section 2.2.2.4. The same method was used also for 
determining the water taken up by polymers at 37°C except that the samples 
were held in the sample compartment of a Perkin Elmer DSC 7 differential 
scanning calorimeter at 37°C. After storage for 1,5,15 or 30 minutes, the 
pans and their contents were cooled to -30°C at 10°C min 1. Each sample was 
then heated up to 20°C at 5°C min' and the enthalpies of fusion of ice were 
determined. The quantities of water bound to the polymers were then 
calculated in the same manner as for the samples held at room temperature. 
4.5.3 Results and discussion 
4.5.3.1 Water uptake by discs at ambient temperature 
Figure 4.11 shows typical DSC scans obtained for the water uptake of discs 
containing HPMC K4M. The amount of water taken up increased over the 30 
minutes period. The data of percentages of water bound are presented in 
table 4.7. After 5 minutes of contact with water, approximately 32% uptake 
had occurred. The results confirm the report of Mitchell et al (1993a) that 
during the initial 5 minutes of contact over 30% of the uptake of water 
occurred using HPMC K15M. However, the first few minutes of hydration are 
the most important because this period corresponds to the time when the 
protective gel layer is formed around the matrix (Ford and Mitchell, 1995). 
Typical data obtained for the water uptake of discs containing NaCMC 
(Blanose) are presented in figure 4.12 and table 4.7. Approximately 39% of 
(141) 
Figure 4.11: The DSC scans showing the melting endotherms of water in 
contact with HPMC K4M discs following storage at 1,5,15 or 30 minutes at 
ambient temperature. 
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water taken up occurred after 5 minutes of contact indicating that NaCMC 
was probably able to absorb water faster than HPMC K4M. The results of 
Tukey's tests on the data from wafers containing NaCMC (Blanose), in 
comparison with HPMC wafers, suggest that there were significant 
(142) 
Figure 4.12: The DSC scans showing the melting endotherms of water in 
contact with NaCMC (Blanose) discs following storage at 1,5,15 or 30 
minutes at ambient temperature. 
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differences between the melting enthalpies after 5,15 and 30 minutes of 
contact with water (p<0.05). A comparison of figure 4.11 (hydration of HPMC) 
and figure 4.12 (hydration of NaCMC) indicates that the shapes of the DSC 
peaks for NaCMC and HPMC were different. This may be due to the 
(143) 
differences in the degree and strength of the interaction between water and 
these two polymers. 
Data for discs containing 1: 1 HPMC : NaCMC are presented in figure 4.13 
and table 4.7. Discs containing 1: 1 HPMC : NaCMC absorbed 34% water 
during the initial 5 minutes of contact with water which was intermediate to 
the HPMC and NaCMC discs. 
Tukey's tests were performed to compare the significances of the melting 
enthalpies from wafers containing HPMC K4M, NaCMC (Blanose) and their 
1: 1 mixture at each of the periods of time. The results of Tukey tests from 
wafers containing 1: 1 HPMC : NaCMC suggest that at p <0.05, there were 
significant differences only at 1 and 30 minutes with HPMC. There were no 
significant differences between the 1: 1 mixture and NaCMC, indicating that 
they absorbed water in a similar function. 
The mean values for the bound water for samples containing HPMC, NaCMC 
or their 1: 1 mixture at ambient are plotted in figure 4.14 as a function of 
time. The 1: 1 mixture had the lowest water uptake at the first minute of 
contact with water. After that, the water uptake increased and finally 
hydration of 1: 1 HPMC : NaCMC occurred in a manner intermediate to the 
pure HPMC and NaCMC. 
(144) 
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Figure 4.13: The DSC scans showing the melting endotherms of water in 
contact with discs containing 1: 1 HPMC K4M : NaCMC (Blanose) following 
storage at 1,5,15 or 30 minutes at ambient temperature. 
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4.5.3.2 Water uptake by discs at 37°C 
Table 4.7 shows data for discs containing HPMC K4M, NaCMC (Blanose) or 
1: 1 HPMC : NaCMC obtained also at 37°C. Increasing the temperature 
(146) 
Figure 4.14: The effect of time on the amount of water bound by 10 mg discs 
containing HPMC K4M (A), NaCMC Blanose (+) and 1: 1 HPMC : NaCMC 
(0) from an unbound 10 mg quantity of distilled water at ambient (results 
are the means ± SD of three determinations) 
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caused an increase in the water taken up by the polymers. Discs containing 
HPMC K4M, after 30 minutes contact with water at 37°C, absorbed 29% 
more water compared with similar discs at ambient. Similarly the discs 
containing NaCMC and the 1: 1 mixture absorbed 62% and 60% more water 
respectively than similar discs at ambient. The water uptakes at 37°C by 
discs containing the mixture of the two polymers were similar to NaCMC 
whereas, at ambient it was probably intermediate of the two polymers. 
The results of Tukey's tests between the melting enthalpies of discs 
containing HPMC K4M, NaCMC (Blanose) and their 1: 1 mixture at ambient 
and 37°C, suggest that at p<0.05 there were no significant differences 
between the polymers at 1,5,15 or 30 minutes of contact with water. 
4.6 CONCLUDING REMARKS 
The characterization of hydroxypropylmethylcellulose (HPMC) K4M and three 
viscosity grades of sodium carboxymethylcellulose (NaCMC) was investigated. 
The NaCMC gels had higher viscosities compared to that of HPMC K4M gels 
of similar concentration. In mixtures containing HPMC K4M and NaCMC 
(Blanose), the viscosities in the polymer range of 0.0-0.05% w/w were 
intermediate to those of the individual polymers whereas in the range of 0.1- 
0.5% w/w the viscosities of 1: 1 mixture were higher than predicted from those 
of the polymers alone. The viscosity increased with increase in the proportion 
of NaCMC. The viscosities indicate that the admixture of gels containing 
(148) 
HPMC and NaCMC could provide a synergistic increase in viscosity at higher 
concentrations. 
As the concentration of HPMC gels increased from 0.5 to 5% (w/w), the cloud 
points decreased by more than 8°C. In spite of gels containing NaCMC not 
showing a cloud point, gels containing the 1: 1 ratio of HPMC and NaCMC 
showed a decrease in cloud point compared with HPMC gels of equivalent 
concentration. The reason might be due to the ability of NaCMC to retain its 
associated water at higher temperatures. 
A simple relationship existed between the melting enthalpies of free water 
and the concentration of polymer in the gels of HPMC, NaCMC or their 1: 1 
mixture. As the concentration of the polymer in the gels increased the 
melting enthalpies decreased. Extrapolation to zero-enthalpy indicated that 
the compositions of the fully hydrated gels were 6.4 t 0.3,6.0 ± 0.4 or 5.6 ± 
0.3 mole water per 100 g of HPMC, NaCMC or their 1: 1 mixture respectively. 
This suggest that 1: 1 HPMC : NaCMC may have required less water for 
hydration than HPMC or NaCMC. 
The results of water uptake determination from discs containing HPMC, 
NaCMC or their 1: 1 mixture at ambient and at 37°C (table 4.7) showed that 
discs containing HPMC, after 30 minutes of contact with water at 37°C, 
absorbed 29% more water compared with similar discs at ambient. Discs 
containing NaCMC or their 1: 1 mixture at the similar condition absorbed 62% 
(149) 
or 60% more water respectively. Since the shapes of the DSC scans, as well 
as the effects of increasing the temperature from ambient to 37°C for the 
mixture was similar to NaCMC alone, it seems reasonable to suggest that 
when mixed with HPMC, in terms of absorption of water, NaCMC is the 
dominant component. 
(150) 
CHAPTER 5 INTERACTIONS BETWEEN PROPRANOLOL 
HYDROCHLORIDE AND 
HYDROXYPROPYLMETHYLCELLULOSE OR SODIUM 
CARB OXYMETHYLCELLULO SE 
5.1 INTRODUCTION 
The characteristics of HPMC, NaCMC and their mixtures were discussed in 
the previous chapter. Gels containing the 1: 1 mixture of HPMC : NaCMC had 
higher viscosities than gels containing the individual polymers. When the 
concentration of HPMC in gels increased their cloud points decreased 
whereas NaCMC gels did not display cloud points. Gels containing 1: 1 HPMC 
: NaCMC had lower cloud points than the corresponding HPMC gels. 
It is well known that the presence of a drug in a hydrophilic matrix could 
change the characteristics of the polymer which subsequently could change 
the drug release. Factors such as erosion of the matrix (Bonferoni et al, 
1994), interaction between the drug and polymer (Tucker, 1988; Lin and 
Perng, 1993) and water uptake also govern the release of drugs from matrices 
containing HPMC and NaCMC. The effects of propranolol hydrochloride on 
HPMC K15M gels have been investigated by Mitchell et al (1991b) but the 
effects of propranolol hydrochloride on HPMC K4M, NaCMC or their 
combinations have not been thoroughly investigated. Such information is vital 
to the understanding of drug release from matrices containing HPMC K4M, 
NaCMC or their mixtures. 
(151) 
5.1.1 Aims and objectives 
Since drugs alter the hydration of HPMC K15M (Ford and Mitchell, 1995), 
the aims of the studies presented in this chapter were to investigate the 
effects of propranolol hydrochloride (as a model drug) on the cloud point and 
water distribution of gels containing HPMC K4M, NaCMC (Blanose) or their 
mixtures. This was to gain further insight into the mechanisms of drug 
release from their matrices by investigating their erosion rates and the 
release of sodium ions. 
5.2 INTERACTION BETWEEN PROPRANOLOL HYDROCHLORIDE 
AND HYDROXYPROPYLMETHYLCELLULOSE K4M 
In section 4.4, it was shown that there was a balance between free and bound 
water in gels containing HPMC K4M. By adding drugs or any other 
substance, this balance might be changed. It was therefore necessary to 
determine the effect of propranolol hydrochloride on the characteristics of 
HPMC K4M gels. 
5.2.1 The effect of propranolol hydrochloride on the cloud points of 
hydroxypropylmethylcellulose K4M gels 
Touitou and Donbrow (1982) reported that drugs and uncharged molecules 
affected the cloud points of cellulose ethers and generally made HPMC more 
soluble. Mitchell et al (1991b) also showed that the addition of propranolol 
hydrochloride increased the amount of bulk water within HPMC K15M gels. 
(152) 
5.2.1.1 Experimental 
5.2.1.1.1 Materials 
Propranolol hydrochloride and HPMC K4M were used as described in sections 
2.1.5 and 2.1.1.1. 
5.2.1.1.2 Gel preparation 
Gels (20 g) were prepared to contain 1,2 or 3% w/w of HPMC K4M and 1 to 
5% w/w propranolol hydrochloride according to the methods described in 
section 2.2.1.1, except that after dispersing the required amount of HPMC 
K4M in approximately one third of the total volume distilled water (at 80°C) 
and before adding distilled water, an aqueous solution containing the 
required amount of propranolol hydrochloride was added. The gels were 
mixed in a mortar with a pestle, before cold distilled water was added to 
make up to the required weight. 
5.2.1.1.3 Cloud point determination 
The cloud point of gels were determined as described in section 2.2.1.3. 
5.2.1.2 Results and discussion 
Figure 5.1 demonstrates the effects of propranolol hydrochloride (1-5% w/w) 
on the cloud points of gels containing 1,2 or 3% w/w HPMC K4M. When 
propranolol hydrochloride was added to the HPMC gels, their cloud points 
increased and for higher propranolol concentrations (> 3% w/w) cloud points 
(153) 
were not observed below 75°C. The highest values for light transmission were 
observed for the gels containing 3% w/w HPMC K4M and 5% w/w of 
propranolol hydrochloride where the light transmission was in excess of 100% 
at 75°C. This fact suggests that the solubility of HPMC was increased and/or 
less water was required for hydration of the polymer. Similar results were 
observed by Mitchell et al (1991b) who showed that the cloud points of HPMC 
K15M gels were increased by the addition of propranolol hydrochloride. 
Mitchell et al (1991b) concluded that at high concentrations, propranolol 
hydrochloride enabled the HPMC K15M to hydrate to a greater extent than 
at lower concentrations. Hence, propranolol hydrochloride effectively salted-in 
the HPMC. 
5.2.2 The effect of propranolol hydrochloride on the distribution of 
water in gels containing hydroxypropylmethylcellulose K4M 
Since the cloud points of HPMC K4M gels were affected by the addition of 
propranolol hydrochloride, DSC was performed to find if the water 
distribution in HPMC gels was modified by propranolol hydrochloride. 
5.2.2.1 Experimental 
5.2.2.1.1 Materials 
Propranolol hydrochloride and HPMC K4M were used as described in sections 
2.1.5 and 2.1.1.1. 
(154) 
U 
boo 
0 
0 
0 
U2 
M9 
aý 
w 0 
4-3 
v 
aý 
aý 
ºcý 
aý 
Lý 
. -: 
rn cd 
a) 
r-, 
Cd 
E 
0 w 
rd 
.0 0 
a> c. 4 cat 
m 
ca 
W 
0 
0 
0 
cý ti 
0 c. 
a 
w 
0 
cý 
0 
0 
cd 
c) c) 
0 cý 
a> 
rd 
-4 
Q 
c=oTssTUZ U9. XL 
Wa 
LioTs®Tuseu@I 1% 
mum 
oQp 
m 
"M 
N 
tIOTwI3TUZ TIla. ZJi°o 
0 
so 
ti ý 
°. 
o 
P, e- 
-+-! 9 0 
S 
.r 
g 
O 
m 
CD L- y 
oi m 
asz. 
4 
0 
s 
. -. 
(155) 
5.2.2.1.2 Gel preparation 
Gels containing propranolol hydrochloride and HPMC K4M were made as 
described in section 5.2.1.1.2 to contain 5,10 or 15% w/w of propranolol 
hydrochloride and 5,10,15 or 20% w/w HPMC K4M. For comparison, 
aqueous solutions of 5,10,15 or 20% w/w propranolol hydrochloride were also 
prepared. To ensure homogeneity of propranolol hydrochloride solutions, the 
samples were first heated to dissolve the propranolol hydrochloride and then 
samples were transferred to sample pans before recrystallisation of the 
supersaturated solution occurred. 
5.2.2.1.3 Methodology 
The enthalpies of gels were determined as described in section 2.2.2.3. 
5.2.2.2 Results and discussion 
Typical DSC scans of aqueous solutions containing propranolol hydrochloride 
are shown in figure 5.2 and the resultant enthalpies are presented in table 
5.1. The values of the melting enthalpy decreased as the concentration of 
propranolol hydrochloride in the solutions increased. The data were used as 
basis for comparison of the melting enthalpies of the aqueous propranolol 
hydrochloride solutions with those of HPMC K4M gels containing similar 
concentrations of drug. Extrapolation of the data from plot in figure 5.2 to 
zero enthalpy by linear regression, indicates that the composition of the 
eutectic of water and propranolol hydrochloride was 57.8 ± 3.1% propranolol 
hydrochloride : 42.2% water. Mitchell et al (1991b) reported a similar value 
(156) 
Figure 5.2 Differential scanning calorimetry scans of solutions containing 5, 
10,15 or 20% w/w propranolol hydrochloride 
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Figures 5.3,5.4 and 5.5 show the DSC scans of gels containing propranolol 
hydrochloride (5,10 or 15% w/w) and different concentrations (5,10,15 or 
(157) 
20% w/w) of HPMC K4M. Table 5.1 gives the melting enthalpies determined. 
Figure 5.6 was obtained by plotting these enthalpies (table 5.1) against the 
HPMC K4M content of the gels. Acceptable linear relationships (r > 0.997) 
were observed between the free water detected and the concentration of 
HPMC K4M at each concentration of propranolol hydrochloride (figure 5.6). 
Data obtained from the extrapolation of the linear portion of the gels 
containing HPMC K4M and varying concentrations of propranolol 
hydrochloride (5,10 or 15% w/w), to zero enthalpy in figure 5.6, are presented 
in table 5.2 which indicates the minimum water content required to form 
fully hydrated gels. 
These data clearly show that with 10% propranolol hydrochloride and various 
concentrations of HPMC K4M, the zero enthalpy observed was higher than 
at gels containing 5% or 15% propranolol hydrochloride, or in other words 
less water was required to produce the gels. Similar results have been 
reported by Mitchell et al (1991b) using 10-40% propranolol hydrochloride 
and varying concentrations of HPMC K15M. They showed that the intercept 
to zero enthalpy for gels containing 10% propranolol hydrochloride and 
varying concentrations of HPMC K15M was 55.4% solid (10: 90 propranolol 
: HPMC K15M) : 44.6% water. Mitchell et al (1989) claimed that with 10% 
propranolol hydrochloride, less water was required to produce a fully 
hydrated gel. Mitchell et al (1991b) suggested that the decrease in zero 
enthalpy following the inclusion of propranolol hydrochloride might be due 
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Figure 5.3: Differential scanning calorimetry of gels containing 5-20% (w/w) 
HPMC K4M and 5% w/w of propranolol hydrochloride. 
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Figure 5.4: Differential scanning calorimetry of gels containing 5-20% (w/w) 
HPMC K4M and 10% w/w of propranolol hydrochloride. 
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Figure 5.5: Differential scanning calorimetry of gels containing 5-20% (w/w) 
HPMC K4M and 15% w/w of propranolol hydrochloride. 
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Figure 5.6: The effect of propranolol hydrochloride (0,5,10 or 15% w/w) on 
the melting enthalpies of free water produced from gels containing 0,5,10, 
15 or 20% w/w HPMC K4M. 
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Table 5.2: The effects of propranolol hydrochloride concentrations (% w/w) on 
the water required to fully hydrate HPMC K4M in gels containing 
propranolol hydrochloride and HPMC K4M. The ratio of water : HPMC at 
equilibrium hydration of the gels is also given. Results are the means ± SD 
of three determinations. 
Propranolol 
hydrochloride 
(% w/w) 
HPMC K4M 
content 
(% w/w) 
Water 
required 
(% w/w) 
Ratio of 
g water/100 g 
HPMC K4M 
0 46.6 ± 1.3 53.4 114.611.5 
5 48.1 ± 7.5 51.9 107.9± 8.1 
10 54.4 ± 6.7 45.6 83.8 ± 5.6 
15 47.5 ± 7.2 52.5 110.5±7.9 
to the precipitation of propranolol hydrochloride crystals. The mechanism of 
the effect of propranolol hydrochloride on HPMC matrices is unknown, 
however the implications of these studies are that drugs play an active role 
in controlling the structure of HPMC matrices during their hydration. 
5.3 INTERACTION BETWEEN PROPRANOLOL HYDROCHLORIDE 
AND SODIUM CARBOXYMETHYLCELLULOSE 
Although polymers are usually considered to be chemically inert, many of 
them interact with drug molecules resulting in physical or chemical 
(164) 
incompatibilities (Lin and Perng, 1993). Interactions between drug and 
excipient may influence the technological and biopharmaceutical properties 
of solid dosage forms (Lin and Perng, 1993). 
During the study it was found that there was an interaction between 
propranolol hydrochloride and NaCMC. Addition of aqueous solutions of 
propranolol hydrochloride to NaCMC gels, immediately produced a 
precipitate, suggesting an interaction. The interaction between NaCMC and 
various tranquilizers and hypotensive agents has previously been reported by 
Graham et al (1963). Graham et al (1963) reported that highly insoluble 
complexes were formed between NaCMC and promazine hydrochloride or 
chlorpromazine hydrochloride. 
In order to explain the release of propranolol hydrochloride from matrices 
containing NaCMC, it was necessary to characterize this interaction. 
Therefore, differential scanning calorimetry (DSC) and equilibrium dialysis 
were used to evaluated the nature of the interaction. 
5.3.1 Cloud points of propranolol hydrochloride and NaCMC 
Gels containing NaCMC did not display cloud points (section 4.3). Initially, 
the aim of this part of the study was to investigate the effect of propranolol 
hydrochloride on the gels containing NaCMC and 1: 1 mixtures of HPMC : 
NaCMC, but after addition of propranolol hydrochloride to NaCMC gels a 
precipitate was produced, which made it impossible to determine the cloud 
(165) 
point and water distribution of gels containing NaCMC or admixture of 
HPMC and NaCMC with propranolol hydrochloride. 
5.3.2 Differential scanning calorimetric (DSC) analysis 
To study the interaction between propranolol hydrochloride and NaCMC, 
physical mixtures of propranolol hydrochloride and NaCMC were made and 
tested. 
5.3.2.1 Experimental 
5.3.2.1.1 Materials 
Propranolol hydrochloride, sodium carboxymethylcellulose (Blanose) and 
glass-distilled water were used as described in section 2.1. 
5.3.2.1.2 Preparation of physical mixtures of propranolol hydrochloride and 
NaCMC 
Physical mixtures of propranolol hydrochloride (<125 pm) and NaCMC 
(Blanose) were prepared by mixing the required amounts of propranolol 
hydrochloride and NaCMC (total amount, 5 g) in a 30 mL jar and blending 
for 15 minutes using an electric mixer. Mixtures were prepared to contain 
1: 0,3: 1,1: 1 or 1: 3 propranolol hydrochloride : NaCMC (Blanose). Accurately 
weighed samples in the range of 4-6 mg were placed in aluminum DSC 
sample pans (6.35 mm diameter). 
(166) 
5.3.2.1.3 Preparation of precipitate of propranolol hydrochloride and NaCMC 
The methods of Ranga Rao et al (1988b) were initially used to prepare the 
precipitate formed between propranolol hydrochloride and NaCMC. These 
methods were mixing aqueous solutions of drug (pindolol hydrochloride, 
alperenolol hydrochloride or salicylic acid) with the aqueous dispersions of 
NaCMC or HPMC K4M at different ratios and drying at room temperature. 
However, when the precipitate dried, it was very hard and inhomogeneous. 
Therefore, the methods were slightly changed. Samples containing 4-6 mg of 
physical mixtures of propranolol hydrochloride : NaCMC were accurately 
weighed into empty sample pans (Perkin-Elmer, 6.35 mm diameter) and 
approximately 30 mg distilled water (using a micro syringe) was added into 
the pans. The samples were placed in an oven at 50°C for about one hour to 
allow the water to evaporate and to achieve their previous weight. In 
comparison samples containing only propranolol hydrochloride were similarly 
examined. 
5.3.2.1.4 DSC methodology 
An aluminum lid was placed on top of each sample discussed in sections 
5.3.2.1.2 or 5.3.2.1.3. The samples were kept unsealed. The samples were 
scanned from 120°C to 180°C at 3°C min 1 and the fusion enthalpies were 
determined. The enthalpies were determined in at least triplicate. 
5.3.2.2 Result and discussion 
Figure 5.7 shows typical DSC scans of physical mixtures containing 1: 0,3: 1, 
(167) 
1: 1 or 1: 3 propranolol hydrochloride : NaCMC (Blanose). The enthalpies of 
fusion associated with the propranolol hydrochloride in the mixtures are 
presented in table 5.3. 
Figure 5.7: DSC scans of samples containing physical mixtures of 1: 0,3: 1,1: 1 
or 1: 3 propranolol hydrochloride : NaCMC 
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The enthalpy of fusion of propranolol hydrochloride was 123.8 t 1.2 J g'' 
(table 5.3). Similar data were reported by Sanghavi and Shiravadekiar (1994) 
(168) 
who showed that propranolol hydrochloride had a melting enthalpy of 122.6 
J g'1. Neau et al (1993) reported a value 35.1 KJ/mol which was made up of 
118.66 J g' for the (-) enantiomer of propranolol hydrochloride and 124.75 
J g'1 for the (+) propranolol hydrochloride. 
Table 5.3: The melting enthalpies of propranolol hydrochloride obtained from 
physical mixtures and dried physical mixtures which had been exposed to 
water previously, at the ratios 1: 0,3: 1,1: 1 or 1: 3 propranolol hydrochloride 
: NaCMC (Blanose) (results are the means ± SD of four determinations) 
Ratio 
* 
Melting enthalpies (J/g propranolol HC1) 
PH .- NaCMC Physical mixture Dried samples 
1: 0 123.8± 1.2 117.2± 1.1 
3: 1 112.3±6.4 22.0 t4.0 
1: 1 108.6 ± 3.0 8.3 1 1.2 
1: 3 77.9±2.7 2.8±1.2 
PH is Propranolol hydrochloride 
The DSC data, given in table 5.3, reveal that the scans of propranolol 
hydrochloride when mixed with NaCMC in dry form, decreased indicating a 
weak interaction between the two ingredients. In contrast, the values of 
(169) 
enthalpy from samples which had been treated with water and dried, 
decreased compared to the equivalent physical mixture. These decreases 
suggest that an interaction occurred between propranolol hydrochloride and 
NaCMC. 
In thermal analysis, a sharp symmetric peak can indicate relative purity 
whereas broad curves suggest impurities or interaction. This fact is seen in 
figure 5.7 in which propranolol hydrochloride showed a sharp endothermic 
peak at about 159°C. As the concentration of NaCMC in the samples 
increased, the sharpness of the curves decreased and the melting peak 
slightly decreased (e. g., from 159°C for pure propranolol hydrochloride to 
155.9°C for the ratio 1: 3 propranolol hydrochloride : NaCMC mixture). The 
peaks for propranolol hydrochloride powder and recrystallised propranolol 
hydrochlorideand were similar. However, the peaks of propranolol 
hydrochloride in the presence of NaCMC were examined, following the 
addition of water, which were considerably reduced. These results indicate 
that the produced mass is different in its physicochemical properties from the 
physical mixture of propranolol hydrochloride and the polymer. 
Similar results were observed by Ranga Rao et al (1988b) using mixtures of 
pindolol hydrochloride with NaCMC or HPMC K4M. They reported that 
admixture of solutions of pindolol hydrochloride and NaCMC or HPMC and 
analysis of the resultant precipitate, significantly reduced the fusion enthalpy 
of pindolol hydrochloride whereas, there were small differences between pure 
(170) 
pindolol and its 1: 1 physical mixture with NaCMC. 
From table 5.3 it is seen that the melting enthalpy decreased as the 
proportion of NaCMC in the samples increased. Following the addition of 
water, the interaction between propranolol hydrochloride and NaCMC 
significantly increased, a possible reason being the formation of a complex 
between propranolol and CMC. To further investigate this interaction a 
dialysis method was used. 
5.3.3 Assessment of interaction between propranolol hydrochloride 
and NaCMC by equilibrium dialysis 
Dialysis tubing is capable of retaining polymer molecules with large 
molecular weight with allowing diffusion of smaller molecules such as drugs. 
If any interaction between drug and polymer occurs, a big molecule will be 
formed which can not pass through dialysis bag. This method was used to 
determine the degree of binding between propranolol hydrochloride and 
NaCMC to evaluate the propranolol-CMC complex formation. 
5.3.3.1 Experimental 
5.3.3.1.1 Materials 
Propranolol hydrochloride and NaCMC (Blanose) were used as described in 
section 2.1. 
(171) 
5.3.3.1.2 Dialysis tubing 
Dialysis visking tubing size 5-24/32 (Medicell International, U. K. ) was used. 
Prior to use, the dialysis tubes (15 cm in length) were soaked overnight in 
deionized water and then rinsed under running deionized water. 
5.3.3.1.3 Methodology 
The methods of Tucker et al (1988) for determination of binding between 
propranolol hydrochloride and NaCMC were used with slight modification. 
Tucker et al (1988) prepared samples (10 mL) by mixing stock solutions of 
propranolol hydrochloride and NaCMC to contain 10 to 50 mg propranolol 
hydrochloride and 20 to 50 mg NaCMC at different ratios. They placed the 
samples in an Amicon Reusable Micropartition System MPS-1 with YMT 
membrane, then after centrifuging the samples, determined the free 
propranolol hydrochloride. However, due to the high viscosity produced using 
NaCMC, transferring the samples to dialysis bags was difficult and the 
results poorly reproducible. Therefore the methods of Tucker et al (1988) were 
modified. 
After treatment of the dialysis tubes, one end of the tubes was tied by a knot 
and 0,25,50,100,200,300,400,500 or 600 mg of NaCMC powder was 
placed in the bottom of the bags. Five millilitre of an aqueous solution 
containing 2% (w/v) of propranolol hydrochloride (100 mg) was then placed 
in each dialysis bag. The bags were then tightly closed by knotting the open 
end, leaving enough space to allow increase in volume and placed in a 
(172) 
ground-glass stoppered Erlenmyer flask (125 mL). 95 mL distilled water was 
added to each Erlenmyer flask. The Erlenmyer flasks were then stoppered 
tightly and agitated in a thermostated shaking water bath at 37°C for 24 
hours. Thereafter, 1 mL samples were removed from the Erlenmyer flasks 
and diluted to 25 mL with distilled water and the amounts of free propranolol 
hydrochloride released through the dialysis bags were determined 
spectrophotometrically at 288 nm. The amount of propranolol hydrochloride 
bound to the NaCMC was then calculated by subtracting the equilibrium 
content of the free propranolol hydrochloride from the total concentration of 
propranolol (100 mg) used in the samples. The free propranolol hydrochloride 
was calculated by equation 5.1 which was produced from equation 2.1, 
discussed in section 2.2.3.1. 
C= (Y - 0.054)/ 18.11 Equation 5.1 
where: Y= absorbance of propranolol hydrochloride at 288 nm and C= 
concentration of propranolol (mg) in 1 mL of the sample. 
5.3.3.1.4 Validation 
Before conducting the experiments, the suitability of the dialysis bag for 
diffusion of propranolol hydrochloride was investigated by determining the 
free propranolol hydrochloride in the fluids on either side of the dialysis 
membrane. For this purpose, the following validation experiments were 
performed as shown in figure 5.8. 
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Figure 5.8: Diagram of dialysis tests in Erlenmyer flask at 37°C 
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Aliquots, 5 mL, of an aqueous solution containing 2% (w/v) of propranolol 
hydrochloride (=100 mg) were used in each test of A, B and C. The samples 
of propranolol hydrochloride were placed in a ground-glass stoppered 
Erlenmyer flask (125 mL) and then kept at 37°C in a shaking water bath. 
After 1 hour, 1 mL samples from the aqueous solution in the Erlenmyer 
flasks and from the inside of the dialysis bags were removed and diluted to 
25 mL with distilled water. Then the amount of propranolol hydrochloride 
was measured spectrophotometrically at 288 nm. 
Tests A and B were carried out to see if propranolol hydrochloride could be 
(174) 
absorbed by dialysis bag. Tests B and C were performed to understand if 
propranolol hydrochloride could pass through dialysis bag. However, it was 
observed that the concentrations of propranolol hydrochloride in all samples 
(i. e. in the fluids on either side of dialysis bag) were equal. Therefore, these 
tests showed that propranolol could pass freely through the membranes of 
dialysis bags in both directions and that it would reach an equilibrium within 
an hour. Also, calculation of the mass balance revealed that no propranolol 
was bound to the dialysis membrane at equilibrium. 
Another validation experiments was performed by placing samples containing 
100 mg propranolol hydrochloride (5 mL of 2% aqueous solution) and 100 mg 
NaCMC (Blanose) powder as described in section 5.3.3.1.3 in the dialysis bag. 
Determination of free propranolol at different periods of time (5,10,15 or 24 
hours) showed an initial decrease in free propranolol but no differences were 
observed between 15 and 24 hours, indicating that the binding of propranolol 
to the polymer had reached an equilibrium. Therefore, sampling for 
equilibrium dialysis studies was made at 24 hours. The data obtained are 
presented in table 5.4. The validation clearly showed that propranolol 
hydrochloride could pass through the dialysis bag in both directions. 
5.3.4 Results and discussion 
Figure 5.9 shows the effect of increasing NaCMC content on the binding with 
propranolol hydrochloride. As the NaCMC content in the dialysis bag 
increased, the free propranolol hydrochloride in the fluid outside the dialysis 
(175) 
Table 5.4: The effect of time on the binding of propranolol hydrochloride to 
NaCMC (Blanose) in dialysis bag (results are the means :t SD of three tests). 
% Propranolol hydrochloride 
Time (hour) 
Free Bound 
5 66.1 ± 1.7 33.9 
10 55.4± 0.7 44.6 
15 50.0 f 0.4 50.0 
24 50.0 ± 0.4 50.0 
bag decreased and subsequently the percentage of propranolol hydrochloride 
bound to NaCMC increased. Tucker et al (1988) using propranolol 
hydrochloride and NaCMC, reported that one propranolol cation would be 
bound to each carboxy anion of the sodium carboxymethylcellulose. Lee et al 
(1991) reported an interaction by using propranolol hydrochloride and 
methacrylic acid. They claimed that since the cationic propranolol 
hydrochloride reacts with the anionic polymer to form a sparingly soluble 
complex, the product could be used as matrix tablet for prolonged release of 
propranolol hydrochloride. 
However, by considering the approximate value of the polymer repeating unit 
(176) 
Figure 5.9: The effect of NaCMC (Blanose) concentration on its binding to 
propranolol hydrochloride (100 mg). Results are the means ± SD of three 
determinations. 
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0 100 200 800 400 500 000 700 
(PRU) of NaCMC which is 326.2 and the molecular weight of propranolol 
hydrochloride which is 295.8, it is possible to evaluate the interaction 
between propranolol hydrochloride and the average PRU of NaCMC. 
The structural formula of cellulose ethers is shown in figure 1.8 (section 
1.5.1) and the PRU of NaCMC is shown in figure 5.10. 
Figure 5.10: Typical polymer repeating unit of NaCMC. 
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C) 
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Figure 5.10 shows three sodium ions in each repeating unit of the polymer. 
However with a DS of 0.7, only 70% of these positions would be taken up. 
When propranolol hydrochloride is present in aqueous solution with NaCMC, 
each sodium in NaCMC can potentially be replaced by a propranolol moiety. 
Therefore each propranolol base can potentially occupy each of the sites and 
subsequently produce precipitates of an insoluble CMC : propranolol complex. 
This reaction can be expressed in the following equation: 
(178) 
[PC! ] + [NaCMC] [NaCI] [ PCMC] Equation 5.2 
where PCl is propranolol hydrochloride. 
It is obvious that the number of sites occupied depends on the amount of 
NaCMC and propranolol hydrochloride in the reaction and the DS of NaCMC. 
The molecule of propranolol hydrochloride is small compared to the molecule 
of NaCMC, but large compared to the sodium atom whose space it could 
occupy. It is unlikely that all three sites of sodium would be saturated with 
propranolol. The number of sites that require replacement before 
precipitation is unknown. It is therefore difficult to create a model to describe 
precisely the binding interaction between propranolol hydrochloride and 
NaCMC, but three interpretation were attempted. 
1) A dissociation constant for equation 5.2, may be expressed by the following: 
K=[ Na Cl ][ PCMC] 
[ PC1 ] [NaCMC] Equation 5.3 
It is possible to use equation 5.3, to calculate the dissociation constant K` for 
the tabulated NaCMC concentrations (table 5.5) using the following 
assumptions: 
(a) the molecular weight of NaCl is 58.5. 
(179) 
(b) the molecular weight of propranolol hydrochloride (PCi) is 295.8 
(c) the PRU of NaCMC is approximately 326.2. 
(d) from the above, the value of PCMC may be calculated as the PRU of 
NaCMC plus the molecular weight of propranolol hydrochloride (PCi) 
less the molecular weight of NaCl. Therefore the value obtained is 563.5. 
(e) The values of free propranolol (FP) and bound propranolol (BP) are 
measured after 24 hours and are shown graphically in figure 5.9. 
An example of the calculation for 25 mg of NaCMC is shown below : 
[ MW(NaC1) x(BP) ] x( 
PRU(PCMC) 
X(BP) ] 
[ Mw(PC1) MW(PC1) ) Equation 5.4 
[ (FP) ] x[NaCMC(mg) - 
PRU(NaCMC) 
x[ (BP) ] MW (PC1) 
[ (58.5) X(17)1X( 
(563.5) 
X(17)1 
[ (295.8) (295.8) I =0.21 Equation 5.5 
((83)]X[25- (326.2) x[ (17) (295.8) 
The values of dissolution constant from different amounts of NaCMC which 
were used in this study are presented in table 5.5. The values show an 
approximate five-fold range of values showing that the simple model 
predicted by equation 5.3 is inappropriate. 
2) By considering the degree of substitution of NaCMC (0.7) and the three 
sodium ions in each PRU of NaCMC, the interaction between NaCMC with 
propranolol hydrochloride should follow equation 5.6. 
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Table 5.5: The estimated values of dissociation constant from binding 
interaction between propranolol hydrochloride and NaCMC (Blanose) 
NaCMC (mg) Dissociation constant (K`) 
25 0.21 
50 0.15 
100 0.42 
200 0.42 
300 0.40 
400 0.35 
500 0.60 
600 0.69 
-CMC (Na)2, w-h -CMC (Na)1.4(P)0 7 F'' 
-CMC (Na)07 (P)1.4 -CMC (P)21 Equation 5.6 
Therefore it is possible to determine the theoretical values of the weight (mg) 
of propranolol hydrochloride bound to NaCMC for each of the three 
propranolol-CMC complexes. The values obtained are presented in table 5.6. 
As can be seen from table 5.6, for 25 mg NaCMC, 17 mg propranolol was 
bound indicating that more than one site previously occupied by sodium was 
occupied. However, for 50 mg or more NaCMC not even one sodium site 
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completely is occupied in each PRU of NaCMC. This result is in contrast to 
the finding of Tucker et al (1988) who reported that one propranolol cation 
would be bound to each carboxy anion of the NaCMC. 
Table 5.6: The theoretical values of mg propranolol hydrochloride bound to 
NaCMC, assuming different degrees of binding, as well as the assumed in 
equation 5.6 and actual values. 
NaCMC (mg) mg propranolol hydrochloride bound to NaCMC 
Degrees of substitution (NaCMC: P) 
Actual 1: 0.7 1: 1.4 1: 2.1 
25 17.0 15.9 31.7 47.6 
50 25.4 31.7 63.4 95.2 
100 50.0 63.5 127.0 190.4 
200 67.4 126.9 253.9 380.9 
300 75.2 190.4 380.8 571.3 
400 78.8 253.9 507.8 761.7 
500 87.9 317.4 634.8 952.1 
600 91.0 380.9 761.7 1142.6 
3- A Langmuir equation is expressed by equation 5.7, 
r_ K[PH] Equation 5.7 1+K[ PH] 
(182) 
in which r is number of moles of propranolol bound per mole of total PRU of 
NaCMC and K is an association constant. The data obtained are presented 
in table 5.7. The data are plotted in figure 5.11, following rearrangement of 
equation 5.7 to give equation 5.8. 
1_1+ Equation 5.8 
r K[PH] 
According to Martin et al (1983) such a plot as shown in figure 5.11 should 
be a straight line. Clearly, there is considerable curvature and this confirms, 
along with tables 5.5 and 5.6 that more than one binding site for proprnaolol 
hydrochloride on NaCMC exist. 
Table 5.7: The values of r (number of moles of drug bound per amount of used 
NaCMC as PRU of NaCMC) as well as free propranolol hydrochloride 
NaCMC (mg) r= x/m Free PH 
25 0.750 83.0 
50 0.560 74.6 
100 0.550 50.0 
200 0.370 32.6 
300 0.276 24.8 
400 0.217 21.2 
500 0.194 12.1 
600 0.167 9.0 
(183) 
Figure 5.11: A Langmuir-type plot showing the binding of propranolol 
hydrochloride to NaCMC 
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5.4 EROSION OF MATRICES CONTAINING HPMC, NACMC OR 
THEIR MIXTURES 
The erosion of a polymer can be defined as the conversion of an initially 
water-insoluble material to a water-soluble material and does not necessarily 
signify a major chemical degradation (Heller, 1987b). Drug release from a 
hydrophilic matrix is the result of several mass transport phenomena. During 
the initial contact of the matrix with the dissolution media, the drug present 
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0.00 0A2 0.04 0.06 0A1 0.10 0.12 
1 
[PH) 
at or near to the surface will dissolve and surface pores fill with the media; 
the drug consequently is released by dissolution and diffusion through the 
pores (Gurny et al, 1982). Eventually, drug release from a swollen hydrophilic 
matrix occurs by diffusion through the gel layer countercurrently to the 
incoming dissolution fluid and by erosion of the swollen matrix (Hussain et 
al, 1994). Ranga Rao et al (1989) showed that the drug release profiles can 
be modified by optimizing the erosion rate of the matrix and also reported 
that certain other factors, e. g., interaction between the drug and the 
polymer(s), might govern the release of the drugs. Bettini et al (1994), using 
different viscosity grades of HPMC, reported that matrices made with lower 
viscosity grade of HPMC were more erodible. However, in spite of the large 
quantity of literature written on the erosion of HPMC matrices, there are 
relatively few reports on the erosion of matrices containing NaCMC 
(Bonferoni et al, 1992). 
5.4.1 Experimental 
5.4.1.1 Materials 
Propranolol hydrochloride (<125 pin), HPMC K4M, NaCMC (Blanose) and 
lactose (<105 um) were used as described in section 2.1. 
5.4.1.2 Tablet Preparation 
Flat-faced tablets, 12.7 mm diameter, containing 300 mg HPMC, NaCMC, 
their 1: 1 mixture, 1: 1: 1 HPMC : NaCMC : propranolol hydrochloride or 1: 1: 1 
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HPMC : NaCMC : lactose were directly compressed as described in section 
2.2.4 at 182 MNm'2. 
5.4.1.3 Erosion measurement 
The methods of Bonferoni et al (1992), were used to determine the erosion of 
matrices. The USP XXII (Apparatus 1) was used, rotating at 100 rpm, in 500 
mL distilled water at 37°C. Tablets were placed in the baskets of dissolution 
apparatus and were withdrawn at 0.5,1,2,3,5,10 or 15 hours and dried to 
constant weight in an oven at 60°C. The percent erosion was calculated from 
the weight loss of the matrices. Results were determined in triplicate. 
5.4.1.4 Dissolution methodology 
Dissolution was measured as described in section 2.2.5 using the means of 6 
matrices to calculate drug release. 
5.4.2 Results and Discussion 
Figure 5.12 shows the polymer erosion, expressed as a function of time. The 
slopes from erosion of matrices (erosion rates) in figure 5.12, based on time, 
were obtained to be 2.5,10.1 and 5.9% per hour for HPMC K4M, NaCMC 
(Blanose) and their 1: 1 mixture respectively. Therefore the synergism in 
viscosity between HPMC and NaCMC (section 4.2.3.2) did not lead to an 
increased resistance to erosion. The rapid erosion of NaCMC matrices may 
be due to the higher solubility of NaCMC compared with HPMC. Hussain et 
al (1994), using hydroxyethylcellulose (HEC) and NaCMC reported that the 
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Figure 5.12: Erosion of matrices containing 300 mg HPMC K4M, NaCMC 
(Blanose), 1: 1 HPMC : NaCMC, 1: 1: 1 HPMC : NaCMC : propranolol 
hydrochloride and 1: 1: 1 HPMC : NaCMC : lactose. Results are the means t 
SD of three determinations. 
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presence of the ionized carboxylic acid groups in NaCMC was responsible for 
the rapid dissolution of the NaCMC matrices. Addition of propranolol 
hydrochloride to the matrices, reduced the erosion. This fact might be due to 
the formation of a complex between propranolol hydrochloride and NaCMC 
which is less water soluble than pure NaCMC. Propranolol hydrochloride was 
replaced by the water soluble lactose and did not interact with NaCMC. 
Replacement of propranolol hydrochloride by lactose, produced more erosion 
of the matrices (figure 5.12). This clearly proved the importance of the 
interaction between the drug and NaCMC. The fast erosion of the HPMC : 
NaCMC : lactose matrices might have been due to the high solubility of 
lactose which facilitated water penetration into the matrices and 
subsequently caused disintegration of the matrices (see also section 7.5.2.2. ). 
Figure 5.13 shows the release of propranolol hydrochloride from matrices 
containing 1: 1: 1 HPMC K4M : NaCMC (Blanose) : propranolol hydrochloride 
versus time. The data for propranolol hydrochloride release and also polymer 
loss and total weight loss of matrices were fitted to equation 1.2 (Q=K2(t-1)°), 
section 1.4.1). The value of release exponent (n) for propranolol hydrochloride 
release was 0.89, indicating near zero order release of these matrices (Ford 
et al, 1991). The values of n for polymer loss and total matrix loss which were 
obtained by subtracting the data for propranolol hydrochloride dissolution 
were 0.63 and 0.72 respectively. These data indicate that the release 
mechanisms of each process (release of propranolol hydrochloride, polymer 
loss and total polymer loss) are different and that admixture of HPMC and 
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Figure 5.13: Release of propranolol hydrochloride and weight loss (polymer 
or total loss) from matrices containing 1: 1: 1 HPMC : NaCMC : propranolol 
hydrochloride. 
250 
'd 
CD 
d 
O 
200 
160 
to 100 
9 
so 
0 
Time (hour) 
(189) 
02488 10 12 14 16 
NaCMC could lead to higher value of the release exponent. 
5.5 RELEASE OF SODIUM IONS FROM MATRICES CONTAINING 
SODIUM CARBOXYMETHYLCELLULOSE 
The amount of sodium in NaCMC (Blanose) is considerable (7% w/w 
according to the manufacturer's information). The aim of the present study 
was to determine the mechanism of release of sodium ions from NaCMC, 
HPMC and their 1: 1 mixture and the relationship between it (the mechanism 
of sodium release) and the erosion of its matrices, since sodium ions should 
be preferentially released ifpropranolol hydrochloride complexes with sodium 
carboxymethylcellulose. Additionally the effects of replacement of lactose 
instead of propranolol hydrochloride on the release of sodium ions was 
investigated. 
5.5.1 Experimental 
5.5.1.1 Materials 
Sodium carboxymethylcellulose (Blanose), HPMC K4M, propranolol 
hydrochloride (<125 µm) and lactose (<105 }im) were used as described in 
section 2.1. Sodium standard solution (1000 mgl'i) manufactured by BDH 
(U. K. ) (lot No. 7926280P) was used as reference for, the determination of 
sodium ions by flame photometry. 
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5.5.1.2 Preparation of matrix tablets 
Flat-faced tablets, 12.7 mm diameter, were directly compressed at 182 MNm'Z 
as described in section 2.2.4. Matrices contained 285 mg NaCMC and 160 mg 
propranolol hydrochloride or lactose. Matrices containing 285 mg NaCMC or 
1: 1 HPMC : NaCMC free of drug were also made. 
5.5.1.3 Calibration of flame photometry 
Aqueous solutions containing 0.125,0.25,0.5,0.75,1,1.5 and 2 mg sodium 
ion in 100 mL deionized water were made using the sodium standard 
solution. The sodium content was determined by Flame photometry (Evans 
Electroselenium, England). The flame photometer was initially calibrated 
using deionized water to give a reading of zero and a solution containing 2 
mg sodium ion in 100 mL to give a reading of 100 respectively. Then 
absorbances of different standard concentrations of sodium ion ( 0.125 to 1.5 
mg/100 mL) were determined. The data obtained are presented in figure 5.14. 
The best fit equation for the plot of the sodium absorbance versus 
concentration, is given by equation 5.9, 
Y= 5.96 C+ 48.54 Equation 5.9 
where, Y is the absorbance and C is the concentration of sodium ion (mg/100 
mL). This equation was used for calibration of sodium ion in the samples 
containing NaCMC or NaCMC : propranolol hydrochloride. 
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Figure 5.14: Calibration curve absorbance due to sodium ions versus 
concentration (mg sodium ion /100 mL) in deionized water. 
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5.5.1.4 Determination of sodium content of NaCMC (Bianose) 
To determine the sodium content of NaCMC, 285 mg NaCMC (Blanose) was 
dissolved and made up to 1000 mL of deionized water and left overnight to 
completely dispersed. The sodium content of these solutions were determined 
by flame photometry as described in section 5.5.1.3. 
5.5.1.5 Dissolution methodology 
Dissolution was measured as described in section 2.2.5. Quantities of 5 mL 
samples of media at intervals of 1,2,3,5,7,10 and 15 hours were 
withdrawn. Sodium release was determined by placing the samples in the 
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flame photometer. The values obtained were compared with sodium content 
from gels containing 285 mg NaCMC (Blanose). The mean of at least three 
determinations was used for each time for each matrix. 
5.5.2 Results and discussion 
Figure 5.15 shows that the release of sodium ion from various matrices. The 
sodium content of NaCMC (Blanose) was 5.5% w/w of the dry polymer, 
compared to the manufacturer's value of 7%. The value of 5.5% was assumed 
as 100% sodium content for dissolution data, varied according to the NaCMC 
content of the matrices. The release of sodium ions was accelerated by the 
presence of both lactose and propranolol hydrochloride. Propranolol 
hydrochloride would react with NaCMC to form the propranolol-CMC 
complex with liberation of sodium ions. Therefore, for matrices containing 
NaCMC, the less soluble form of CMC, at its complex with propranolol 
hydrochloride, would control release. In order to compare the erosion of 
matrices containing NaCMC : propranolol hydrochloride and NaCMC : 
lactose, lactose was chosen because it is a soluble excipient and does not 
interact with NaCMC. Lactose increased the release of sodium, and hence the 
dissolution of the polymer could be explained by an increase in porosity 
caused by dissolution of lactose. HPMC reduced the release of sodium (figure 
5.15). 
5.6 CONCLUDING REMARKS 
Cloud point data indicated that the amount of water required for the 
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Figure 5.15: Percentage release of sodium ions from matrices containing 285 
mg NaCMC (Blanose), 285 mg 1: 1 HPMC : NaCMC, 285 mg NaCMC : 160 
mg propranolol hydrochloride or 285 mg NaCMC : 160 mg lactose. Results 
are the means :t SD of three determinations. 
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hydration of HPMC K4M gels decreased in the presence of propranolol 
hydrochloride (section 5.2.1.2). DSC showed that propranolol hydrochloride 
altered the balance between bound water and propranolol hydrochloride in 
HPMC gels. 
A weak interaction was observed in physical mixtures between NaCMC 
(Blanose) and propranolol hydrochloride by DSC. Following the prior addition 
of distilled water to the physical mixtures, the fusion enthalpies of the 
propranolol hydrochloride content significantly decreased indicating a 
stronger interaction (section 5.3.2.2). A binding study of this interaction by 
dialysis showed that as the NaCMC admixture with propranolol 
hydrochloride increased, the amount of propranolol bound to NaCMC 
increased. 
Matrices consisting solely of NaCMC eroded more quickly than similar HPMC 
matrices. The addition of propranolol hydrochloride to the matrices 
containing NaCMC, reduced the erosion rates, due to the insoluble complex 
formed between NaCMC and propranolol hydrochloride. Since lactose is a 
soluble excipient and does not interact with NaCMC, it was chosen to 
compare the erosion of matrices containing NaCMC : propranolol 
hydrochloride and NaCMC : lactose. Replacement by lactose of the 
propranolol hydrochloride caused an increase in the rate of erosion. This 
clearly proved the importance of the interaction between the propranolol 
hydrochloride and NaCMC, to the stability of matrices. 
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The results of sodium release showed that matrices containing NaCMC and 
propranolol hydrochloride or NaCMC and lactose had a rapid release of 
sodium ions compared to matrices containing NaCMC alone. From the results 
of interaction between propranolol hydrochloride and NaCMC, it could be 
suggested that the formation of propranolol - CMC complex, which is 
insoluble, might be the reason for the rapid release of sodium ion. The reason 
for fast release of sodium ion from matrices containing NaCMC : lactose could 
be explained by an increase in porosity caused by dissolution of lactose. 
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CHAPTER 6 THE INFLUENCE OF DISSOLUTION MEDIUM 
ON THE RELEASE OF PROPR NOLOL HYDROCHLORIDE FROM 
MATRICES CONTAINING HYDROXYPROPYLMETHYLCELLULOSE 
AND SODIUM CARBOXYMETHYLCELLULOSE 
6.1 INTRODUCTION 
Oral dosage forms are conveyed to the stomach via the esophagus, then to 
the duodenum, jejunum, ileum and finally to large intestine (Hui et al, 
1987; Skelly 1988). Via their journey, controlled-release dosage forms would 
encounter a spectrum of pH ranging from 7 in the mouth, 1 to 4 in the 
stomach and 5 to 7 in the small intestine gradually increasing up to 8 in 
the distal section of the intestinal tract (Hui et al, 1987; Sutinen et al, 
1993). Conceivably, since most of drugs are either weak acids or weak 
bases, their release from sustained release formulations is pH dependent 
(Hui et al, 1987). Therefore, pH becomes a major variable that must be 
considered in both the design and the evaluation process of controlled 
dosage forms. In addition, since controlled-release dosage forms may be 
swallowed in the extremes of the presence of food or under fasting 
conditions, dramatic pH changes as well as the solubilizing influence of both 
bile and highly buffered pancreatic secretions, should be considered. 
Obviously these variables will greatly influence the dissolution rate of 
controlled-release dosage forms and present a much more complex situation 
than that observed with conventional preparations (Skelly, 1988). However, 
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it is imperative that a controlled release formulation should have a uniform 
release pattern at the different sites of the gastrointestinal tract over the 
period of dosing. This would assure a low variability of release during its 
transit along the gastrointestinal tract and a low sensitivity to the effects 
of food. 
It is well known that the behaviour of the gel layer that is formed around 
hydrophilic matrices after water intake is of major importance to the drug 
release profile (Ford and Mitchell, 1995). It is also known that the 
behaviour of gel layer is sensitive to interchain interactions and 
entanglements and to the influence of the medium on swelling or shrinking 
of the polymer coil (Bonferoni et al, 1995). Therefore, the release of a drug 
probably would depend on the composition of the surrounding medium. 
However, since the biopharmaceutical evaluation of a drug for potential use 
in controlled release drug delivery requires knowledge of the release and 
solubility of the drug at different pHs (Ritschall, 1989), the solubility and 
release of propranolol hydrochloride in different media were investigated. 
Since in section 3.2.3 it was found that the matrices containing 285 mg 1: 1 
HPMC : NaCMC (Blanose) gave the lowest release rate (1.3 t 0.1 %min ') 
of propranolol hydrochloride and a high release exponent value (0.81) (table 
3.6), this study focused mainly on the release of drug from matrices 
containing 1: 1 HPMC : NaCMC. 
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6.1.1 Aims and objectives 
The main aim of the studies described in this chapter was to investigate the 
release of propranolol hydrochloride from matrices containing 1: 1 HPMC : 
NaCMC in different media. To undertake this study, the release of 
propranolol hydrochloride from matrices containing 285 mg HPMC K4M, 
NaCMC (Blanose) or 1: 1 their mixture was investigated firstly in 0.1 M 
hydrochloric acid. Then the release of propranolol hydrochloride from 
matrices containing 1: 1 HPMC and different viscosity grades of NaCMC at 
various media was investigated, in order to find out the effect of viscosity 
grade of NaCMC on the release of propranolol hydrochloride into various 
media. Additionally the solubilities of propranolol hydrochloride in the 
various media were determined. 
6.2 RELEASE OF PROPRANOLOL HYDROCHLORIDE FROM 
MATRICES CONTAINING HYDROXYPROPYLMETHYLCELLULOSE. 
SODIUM CARBOXYMETHYLCELLULOSE OR THEIR 1: 1 MIXTURE IN 
0.1 M HYDROCHLORIC ACID 
Since all oral dosage forms first pass from the stomach, it is important to 
investigate the release of drugs into 0.1 M hydrochloric acid. In the case of 
HPMC matrices, Alderman (1984) stated that HPMC provided a matrix 
component which is stable over a pH range of 3 to 11. In the case of 
NaCMC, due to its ionic characteristics, the pH of the media effects the 
behaviour of its matrices (Bonferoni et al, 1992). However, the release of 
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drug from matrices containing 1: 1 HPMC : NaCMC has not been thoroughly 
investigated. 
6.2.1 Experimental 
6.2.1.1 Materials 
Propranolol hydrochloride (<125 pm), HPMC K4M, NaCMC (Blanose) and 
magnesium stearate as described in section 2.1, were used in this part of 
the study. 
6.2.1.2 Tablet preparation 
Tablets were prepared as described in section 2.2.4, containing 160 mg 
propranolol hydrochloride (<125 }im), 0.75% magnesium stearate as 
lubricant and 285 mg HPMC, NaCMC (Blanose) or their 1: 1 mixture at 182 
MNm 2. 
6.2.1.3 Dissolution methodology 
Dissolution was performed as described in section 2.2.5, except that 0.1 M 
hydrochloric acid maintained at 37°C were used as media. The UV 
absorbance for a solution containing 0.1 mg/mL propranolol hydrochloride 
into 0.1 M hydrochloric acid was determined at 288 nm (1.822 ± 0.01, n, 3) 
and its E 1%, 1 cm value was 182.2. 
6.2.1.4 Analyses of pronranolol hydrochloride 
The data corresponding to 5-60% drug release were fitted into equation 1.2 
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(Q=K2(t-1)°) that is described in section 1.4.1. Release rates were calculated 
from the data in the range of 5-60% drug release. 
6.2.2 Results and discussion 
Figures 6.1,6.2 and 6.3 show the drug release profiles from matrices 
containing 285 mg HPMC K4M, NaCMC (Blanose) or 1: 1 HPMC : NaCMC 
(Blanose) into distilled water and 0.1 M hydrochloric acid respectively. 
Matrices containing HPMC K4M (figure 6.1) did not show a major 
difference between the release in the two media, whereas matrices 
containing NaCMC (figure 6.2) and matrices containing 1: 1 HPMC : 
NaCMC (figure 6.3) showed differences in the two media. Table 6.1 shows 
the release rates and values of K,, n and 1 based on equation 1.2 in 0.1 M 
hydrochloric acid. 
Data in table 6.1 indicate that the exponent value for HPMC matrices (0.65) 
is close to those of 1: 1 HPMC : NaCMC (0.59) whereas, the exponent value 
for matrices containing NaCMC was higher (0.82). A comparison between 
the release rates of propranolol hydrochloride from similar matrices 
containing HPMC, NaCMC or 1: 1 mixture in distilled water (table 3.1) and 
in 0.1 M hydrochloric acid (table 6.1) showed that the release rates from 
HPMC matrices were similar in both media, whereas the release rates of 
matrices containing NaCMC changed. More than 70% of drug released from 
matrices containing NaCMC (Blanose) during 2 hours and all drug released 
within 3 hours. The fast release of propranolol hydrochloride into 0.1 M 
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Figure 6.1: The release of propranolol hydrochloride from matrices containing 
160 mg propranolol hydrochloride and 285 mg HPMC K4M into distilled 
water (") and 0.1 M hydrochloric acid ("). Results are the means t SD of six 
determinations. 
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Figure 6.2: The release of propranolol hydrochloride from matrices containing 
160 mg propranolol hydrochloride and 285 mg NaCMC (Blanose) into distilled 
water (") and 0.1 M hydrochloric acid (a). Results are the means t SD of six 
determinations. 
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Figure 6.3: The release of propranolol hydrochloride from matrices containing 
160 mg propranolol hydrochloride and 285 mg 1: 1 HPMC K4M : NaCMC 
(Blanose) into distilled water (A) and 0.1 M hydrochloric acid (u). Results are 
the means ± SD of six determinations. 
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Table 6.1: Release rates (%min "2) and K2, n and 1 based on equation 1.2, 
calculated in the range of 5- 60% propranolol hydrochloride release from 
matrices containing 285 mg HPMC K4M, NaCMC (Blanose) or their 1: 1 
mixture into 0.1 M hydrochloric acid 
Polymers in Release rate Equation 1.2 
0.1 M HCl (%mirf "2) 
n 1 
HPMC K4M 2.9 ± 0.1 1.11 0.65 -0.03 
NaCMC (Blanose) 8.8 ± 0.7 1.83 0.82 3.6 
1: 1 HPMC: NaCMC 3.2 ± 0.1 1.85 0.59 2.0 
hydrochloric acid from NaCMC matrices is probably due to the insolubility 
of NaCMC in 0.1 M hydrochloric acid (Bonferoni et al, 1992). Bonferoni et 
al (1992) used salbutamol sulphate and reported that at pH values below 
the pKa of NaCMC (which is 4.3), the polymer reverted to its non-ionized 
form which is less water soluble and less capable of interacting with drug. 
Therefore, the solubility of the NaCMC is much lower in 0.1 M hydrochloric 
acid than in distilled water. Subsequently matrices containing NaCMC in 
hydrochloric acid could not make the protective gel layer that is essential 
to produce controlled drug release. Another reason for the higher release 
rate of propranolol hydrochloride in 0.1 M hydrochloric acid might be due 
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to the interaction between propranolol hydrochloride and NaCMC in 
distilled water (section 5.3). This interaction could not occur in 0.1 M 
hydrochloric acid due to the insolubility of NaCMC. 
As discussed in section 3.2.3, the lowest release rates were obtained from 
matrices containing 1: 1 HPMC ; NaCMC in distilled water. The increase in 
release rates from matrices containing 1: 1 HPMC : NaCMC into 0.1 M 
hydrochloric acid (table 6.1) compared with distilled water (table 3.1), would 
be again due to the insolubility of NaCMC. 
6.3 EFFECT OF WIDER pH RANGE ON THE RELEASE OF 
PROPRANOLOL HYDROCHLORIDE FROM MATRICES CONTAINING 
1: 1 HPMC : NaCMC (BLANOSE 
In spite of the efforts directed at the use of HPMC and NaCMC or their 
mixtures, little attention has been paid to the performance of these tablets 
when subjected to changes in pH. As was observed in section 6.2, the drug 
release was different in water and 0.1 M hydrochloric acid and also several 
investigators have reported that the pH and ionic strength of a dissolution 
media may modify the release of drug substances from HPMC matrices 
(Ford et al, 1985c; Pagay, 1988; Mitchell et al, 1990b). Therefore the release 
of propranolol hydrochloride from matrices containing 1: 1 HPMC : NaCMC 
was investigated at a wider range of pH. 
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6.3.1 Methodology 
Tablets were prepared as described in section 2.2.4, containing 160 mg 
propranolol hydrochloride <125 tim, 0.75% magnesium stearate as lubricant 
and 57,95 or 285 mg of 1: 1 HPMC K4M : NaCMC (Blanose) at 182 MNm'. 
6.3.1.1 Dissolution methodology 
Dissolution was measured as described in section 2.2.5 using various media 
maintained at 37°C. The media were 0.1 M hydrochloric acid, phosphate 
buffer solutions pH 6.8 or pH 7.4 and borate buffer solution pH 9.4. The 
formulae of the different buffer solutions are given in appendix 1. The UV 
absorbances for solutions containing 0.1 mg/mL propranolol hydrochloride 
in phosphate buffer solution pH 6.8, phosphate buffer solution pH 7.4 or 
borate buffer solution pH 9.4 were determined at 288 nm and were 1.885 
0.01,1.891 ± 0.01 or 1.926 ± 0.01 respectively. The corresponding E 1%, 
1 cm values were 188.5,189.1 or 192.6 respectively. 
Dissolution tests were also carried out by changing the pH of the medium. 
Dissolution was initially performed in 750 mL of 0.1 M hydrochloric acid for 
two hours and then, by adding 250 mL of 0.2 M trisodium phosphate 
solution, the pH was adjusted to 6.8. This method is described in (USP 23 
/ NF 18,1995) as the delayed-release method. To simplify referring to this 
method, it is called changed pH and shown by letter (C) in figures 6.4,6.5 
and 6.11 and tables 6.3 and 6.4. 
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6.3.1.2 Determination of propranolol hydrochloride solubility 
The solubility of propranolol hydrochloride was determined as described in 
section 2.2.3 except that it was determined in 0.1 M hydrochloric acid, 
phosphate buffer solutions pH 6.8 and pH 7.4 and borate buffer solution pH 
9.4 (see appendix 1) as described in section 6.3.1.1. 
6.3.2 Results and discussion 
6.3.2.1 Solubility of propranolol hydrochloride 
The solubilities of propranolol hydrochloride in different media at 37°C, are 
shown in table 6.2. Shivanand and Sprockel (1993) reported a value of 115 
24 mg/mL for propranolol hydrochloride in distilled water at 37°C. Lee et 
al (1991) reported that the solubilities of propranolol hydrochloride in 0.1 
M hydrochloric acid, distilled water and phosphate buffer solution pH 7.4 
at 25°C were 56.53,155.72 and 140.37 mg/mL respectively. Comparing the 
reported data by Lee et al (1991) with the obtained data in table 6.2, the 
solubility of propranolol hydrochloride in distilled water and phosphate 
buffer pH 7.4 were similar but the solubility in 0.1 M hydrochloric acid was 
different. The lowest solubility of propranolol hydrochloride was in borate 
buffer pH 9.4 and was a consequence of the pKa of propranolol 
hydrochloride (Mitchell et al, 1990b; Sutinen et al, 1993). Sutinen et al 
(1993) determined the solubility of propranolol hydrochloride at 4 different 
pHs (1.6,4.6,7.3 and 9.4) and 2 different ionic strengths and reported that 
the solubility of propranolol hydrochloride at pH 9.4 was lower (0.5 mg/mL) 
(208) 
than at the other values of pH. 
Table 6.2. Solubilities of propranolol hydrochloride (mg/mL) in distilled 
water, 0.1 M hydrochloric acid, phosphate buffer pH 6.8 or 7.4 and borate 
buffer pH 9.4 at 37°C (results are the means t SD of three determinations) 
Media 
Solubility 
(mg(mL) ± SD 
0.1 M Hydrochloric acid 134.5 t 5.4 
Phosphate buffer pH 6.8 143.3 ± 6.4 
Phosphate buffer pH 7.4 137.3 t 2.1 
Borate buffer pH 9.4 57.4 ± 1.2 
Distilled water 159.8 t 1.3 
6.3.2.2 Influence of PH on the release of propranolol hydrochloride from 
matrices containing 1: 1 HPMC : NaCMC (Blanose) 
Figures 6.4,6.5 and 6.6 give the release profiles of propranolol 
hydrochloride from matrices containing 1: 1 HPMC : NaCMC (Blanose) and 
285,95 and 57 mg total polymer respectively. Matrices containing 57 mg 
total polymer were not examined by the pH change method, because all the 
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drug was released within 2 hours. The dissolution rates and values of K2, 
n and 1 obtained using equation 1.2, are presented in table 6.3. 
In spite of the solubility of propranolol hydrochloride being higher in 
distilled water than at the other pHs (table 6.2), its release rates from 
matrices containing 285 mg polymer into distilled water was slower than 
into the other media except at pH 9.4. The reason might be the interaction 
between propranolol hydrochloride and NaCMC which was discussed in 
sections 3.2.3 and 5.3.3. The release rates from matrices containing 285,95 
and 57 mg 1: 1 HPMC K4M : NaCMC (Blanose) into 0.1 M hydrochloric acid 
were fast, which would be attributed to the insolubility of NaCMC in 0.1 M 
hydrochloric acid (section 6.2). 
The effect of the pH change method on the drug release is clearly seen in 
figure 6.4. After two hours in 0.1 M hydrochloric acid, when the medium 
was adjusted to pH 6.8, a decrease in release rate was observed. The values 
of the release exponent based on equation 1.2 from matrices containing 285 
mg 1: 1 HPMC : NaCMC were 0.65 between 5-30% (first 2 hours) drug 
release and 0.32 between 30-60% drug release which indicate that two 
mechanisms were apparent in the two portions of the profile. This fact 
indicates that mixed diffusion and erosion of matrices containing NaCMC 
occured in acidic medium and that diffusion probably predominated at the 
high pH. The decreased release rate observed in phosphate buffer solution 
pH 6.8 or phosphate buffer solution pH 7.4 could be attributed to the 
(210) 
Figure 6.4: The effect of pH on the dissolution of propranolol hydrochloride 
from matrices containing 285 mg 1: 1 HPMC K4M : NaCMC (Blanose). 
Results are the means t SD of six determinations. 
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Figure 6.5: The effect of pH on the dissolution of propranolol hydrochloride 
from matrices containing 95 mg 1: 1 HPMC K4M : NaCMC (Blanose). Results 
are the means ± SD of six determinations. 
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Figure 6.6: The effect of pH on the dissolution of propranolol hydrochloride 
from matrices containing 57 mg 1: 1 HPMC K4M : NaCMC (Blanose). Results 
are the means ± SD of six determinations. 
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Table 6.3: Estimated values of T60% (hour), release rates (% min"'), K2, n 
and 1 based on equation 1.2 from matrices containing 1: 1 HPMC : NaCMC 
(Blanose) into different pH. 
Matrices contai 
Media T6o% 
(hour) 
Distilled water 18.1 ± 1.1 
0.1MHC1 4.7±0.2 
pH 6.8(c) I 6.3 ± 0.5 
pH 6.8 12.4 ± 1.0 
pH 7.4 14.9 ± 0.840% 
pH 9.4 27.6 ± 0.525% 
Matrices containing 
Distilled water 1.9 * 0.1 
0.1 M HCl 1.7t 0.1 
pH 6.8 (c)` 1 1.7 ± 0.1 
pH 6.8 2.4 t 0.4 
pH 7.4 2.5±0.2 
pH 9.4 13.710.936% 
Matrices containing 
Distilled water 0.6 t 0.1 
0.1 M HC1 0.1: t 0.1 
pH6.8 0.410.0 
pH 7.4 0.4 ± 0.1 
pH 9.4 2.1 ± 0.3 
285 mg 1: 1 HPMC : Na CMC 
Release rate 
(mini ) 
KZ n 
1.3 t 0.1 0.14 0.81 
3.2±0.1 1.85 0.59 
3.0: i-. 0.22' 1.29 0.65 
_ 
2.1 ± 0.1' 7.68 0.32 
2.1 ± 0.1 0.44 0.71 
1.7 ± 0.1 0.47 0.68 
1.1 ± 0.125% 0.03 1.00 
95 mg 1: 1 HPMC : NaCMC 
5.1 ± 0.1 2.75 0.61 
5.5 ± 0.1 3.66 0.56 
5.0 t 0.22h 2.94 0.60 
5.6 0.3R 
4.3 ± 0.3 3.89 0.50 
4.1 t 0.2 4.46 0.48 
1.4±0.1 5.56 0.29 
57 mg 1: 1 HPMC : NaCMC 
9.7 ± 0.1 6.70 0.57 
6.9±0.2 8.97 0.43 
11.0 ± 0.3 13.60 0.41 
11.0±0.5 17.90 0.33 
3.0 t 0.4 No responsc 
1 
-6.4 
2.0 
-0.2 
49.9 
5.0 
5.7 
-11.5 
-0.4 
-0.3 
-1.6 
-1.8 
-4.8 
-17.3 
0.2 
-0.7 
0.5 
2.7 
'Changing pH method (see section 6.3.1.1). 2h data from 5% drug release up 
to first 2 hours in 0.1 M hydrochloric acid, 'data for 2 hours up to 60% 
release. °o%, 25% and "' indicate maximum release. 
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reduction in propranolol solubility (Clarke and Cahoon, 1987). 
The release rates were slower at pH 9.4 than at the other pHs. Table 6.3 
indicates that as the pH of medium increased from 1 to 9.4, the release rate 
from matrices containing 285 mg polymer decreased from 3.2 t 0.1 to 1.1 
0.1 %min "2. The decrease in release rates at pH 9.4 could be explained 
on the basis of the reduced solubility of the drug at this pH. The pKa of 
propranolol hydrochloride is 9.5 (Clark's Isolation and Identification of 
Drugs, 1986) and the solubility will decrease near a pH of 9.5. Thus, the 
drug release would be reduced. When the matrices were removed at the end 
of the test a white precipitate had been formed on the outer gel layer 
presumably of propranolol base. The reason for lower total release of drug 
(about 25% after 14 hours) might be due to formation of this base (i. e., 
lower solubility of propranolol) and also that it might not allow propranolol 
hydrochloride to diffuse from the matrix. In similar studies, Ford et al 
(1985c) showed that the release of promethazine hydrochloride from HPMC 
matrices was highest at pH 1 but decreased as the pH increased to 9. They 
attributed this to a reduction in the solubility of the drug. The solubility of 
propranolol hydrochloride in borate buffer pH 9.4 was 57.4 t 1.2 mg/mL, 
compared with 159.8 ± 1.3 mg/mL for distilled water (table 6.2) and this 
reduction alone could account for the reduction in release. 
Figures 6.5 and 6.6 indicate that, as the polymer content decreased, the 
differences observed between the release profiles in different media 
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decreased. In matrices containing 95 mg (figure 6.5) or 57 mg (figure 6.6), 
the amount of polymer was insufficient to protect the matrix. Therefore, the 
release rates of propranolol hydrochloride would depend on its solubility at 
the pH of medium. It was discussed in section 5.3.3 that, as the amount of 
NaCMC in the dialysis bags containing constant amount of propranolol 
increased, the quantity of bound propranolol to NaCMC increased. 
Therefore a decrease in the polymer content, leaves more propranolol to be 
free, or in other words, the interaction between the drug and the polymer 
would decrease. The release rates from matrices containing 95 mg 1: 1 
HPMC K4M: NaCMC into pH change method were 5.0 ± 0.2 min" for first 
2 hours (5% to 53% drug release) when the media was 0.1 M hydrochloric 
acid and 5.6 ± 0.3 mini' between 53-60% drug release (into phosphate 
buffer pH 6.8). Due to lack of enough points (only 2 points) between 53% 
and 60% release, estimating the release exponent from matrices containing 
95 mg in pH change method was impossible and therefore the data are 
missing in table 6.3. The increase in release rates of these matrices may 
also be due to the same reason, so the value of 5.6 * 0.3 min '"s for the rest 
of release is an estimate. It was observed that as the polymer content 
decreased from 285 to 57 mg, the release exponent in the same media 
decreased. The mechanism of release from values of release exponent less 
than 0.45 is unknown. The values less than 0.45 which were obtained from 
matrices containing 95 or 57 mg polymer content might be due to the initial 
burst drug release. 
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6.4 EFFECT OF PH ON THE RELEASE RATE OF PROPRANOLOL 
HYDROCHLORIDE FROM MATRICES CONTAINING 1: 1 HPMC AND 
DIFFERENT VISCOSITY GRADES OF NaCMC 
In section 3.2.3.2, the release of propranolol hydrochloride from matrices 
containing 57,95,140 and 285 mg polymer content in the ratio 1: 1 of 
HPMC : NaCMC Blanose, HPMC : NaCMC P 800 and HPMC : NaCMC P 
350 in distilled water was determined. The results obtained showed that the 
viscosity grade of NaCMC affected the drug release (see figure 3.15) 
whereas the viscosity grade of HPMC was generally considered unimportant 
(Ford et al, 1985a). In this section, the release of propranolol hydrochloride 
from matrices containing 57,95 or 285 mg of 1: 1 HPMC : NaCMC (Blanose, 
NaCMC P 800 or NaCMC P 350) in different media is described. 
6.4.1 Methodology 
Tablets were prepared as described in section 2.2.4 containing 160 mg 
propranolol hydrochloride <125 pm, 0.75% magnesium stearate as lubricant 
and 57,95 or 285 mg 1: 1 HPMC K4M: NaCMC (Blanose, NaCMC P 800 or 
NaCMC P 350). Dissolution was performed as in section 6.3.1.1. 
6.4.2 Results and discussion 
Figures 6.7 - 6.11 show the release profiles of propranolol hydrochloride 
from matrices containing 285 mg total polymer in ratio 1: 1 of HPMC : 
NaCMC (Blanose), HPMC : NaCMC P 800 or HPMC : NaCMC P 350 into 
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0.1 M hydrochloric acid, phosphate buffer pH 6.8, phosphate buffer pH 7.4, 
borate buffer solution pH 9.4 and the pH change method respectively. The 
release rates and exponent values from these matrices are presented in 
table 6.4. Matrices containing 285 mg 1: 1 HPMC : NaCMC (Blanose, P 800 
or P 350) at pH 7.4 or 9.4 after 14 hours, had a maximum of 40% or 25% 
drug release from the total drug in the matrix respectively, therefore data 
between 5% to the end of dissolution testing were fitted into the equation 
1.2. 
There were no major differences in the release of propranolol hydrochloride 
from the matrices at 0.1 M hydrochloric acid (figure 6.7 and table 6.4) 
whereas, as was shown in figure 3.15 and table 3.6, the release rates were 
different from these matrices into distilled water and depended on the 
viscosity grade of NaCMC. The viscosity grades of NaCMC therefore had 
little effect on the release of propranolol hydrochloride into 0.1 M 
hydrochloric acid. 
As the pH increased the differences between the release rates from matrices 
increased (table 6.4), indicating that the viscosity grades of NaCMC 
increasingly influence the release of propranolol hydrochloride. The rank 
order was observed to be NaCMC (Blanose) < NaCMC P 800 < NaCMC P 
350. Figures 6.7 to 6.10 indicate that the total release of propranolol 
hydrochloride decreased as the pH of media increased. 
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Figure 6.7: The release of propranolol hydrochloride from matrices containing 
285 mg 1: 1 HPMC K4M : NaCMC (Blanose), 1: 1 HPMC : NaCMC P 350 or 
1: 1 HPMC : NaCMC P 350 into 0.1 M hydrochloric acid. Results are the 
means ± SD of six determinations. 
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Figure 6.8: The release of propranolol hydrochloride from matrices containing 
285 mg 1: 1 HPMC K4M : NaCMC (Blanose), 1: 1 HPMC : NaCMC P 350 or 
1: 1 HPMC : NaCMC P 350 into phosphate buffer solution pH 6.8. Results are 
the means ± SD of six determinations. 
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Figure 6.9: The release of propranolol hydrochloride from matrices containing 
285 mg 1: 1 HPMC K4M : NaCMC (Blanose), 1: 1 HPMC : NaCMC P 350 or 
1: 1 HPMC : NaCMC P 350 into phosphate buffer solution pH 7.4. Results are 
the means ± SD of six determinations. 
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Figure 6.10: The release of propranolol hydrochloride from matrices 
containing 285 mg 1: 1 HPMC K4M: NaCMC (Blanose), 1: 1 HPMC : NaCMC 
P 350 or 1: 1 HPMC : NaCMC P 350 into borate buffer solution pH 9.4. 
Results are the means ± SD of six determinations. 
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Figure 6.11: The release of propranolol hydrochloride from matrices 
containing 285 mg 1: 1 HPMC K4M: NaCMC (Blanose), 1: 1 HPMC : NaCMC 
P 350 or 1: 1 HPMC : NaCMC P 350 into changing pH media (C). Results are 
the means ± SD of six determinations. 
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Mitchell et al (1991a) examined the effect of electrolytes on the dissolution 
of propranolol hydrochloride from matrices containing HPMC K15 and 
reported that since ions, such as phosphate ions have a great affinity for 
water, caused reduction in the cloud point of HPMC. However, Mitchell et 
al (1991a) stated that any reduction in hydration of polymer, such as 
increasing the concentration of salt in the dissolution media or increasing 
the temperature of the dissolution media, will start to prevent gelation and 
therefore may cause failure in sustained release. 
Figure 6.11 shows the release profiles from matrices containing 285 mg 
total polymer by the pH change method. No difference in propranolol 
hydrochloride, release between the three NaCMCs, in the first two hours 
when the media was 0.1 M hydrochloric acid, was observed. When the pH 
was adjusted to 6.8, differences became apparent due to their viscosity 
grades. 
The release from matrices containing 95 mg polymer into different media 
had release exponents less than 0.60 (table 6.4) and as the pH of media 
increased from 1 to 9.4, the value of release exponent decreased. Matrices 
containing 57 mg into all media tested gave a release exponent of less than 
0.48. As mentioned before (section 6.3.2.2), the values less than 0.45 might 
be due to initial burst of drug release. 
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6.5 CONCLUDING REMARKS 
The pH of media affected the drug release from NaCMC matrices whereas 
the release of propranolol hydrochloride from HPMC matrices were 
relatively insensitive to pH (table 6.1). The release of propranolol 
hydrochloride in 0.1 M hydrochloric acid was faster than in distilled water 
but its solubility in 0.1 M hydrochloric acid was lower than distilled water. 
Replacing NaCMC (Blanose) by two other viscosity grades of NaCMC, 
namely NaCMC (P 800) and NaCMC (P 350) showed no significant 
difference in release rate of propranolol hydrochloride into 0.1 M 
hydrochloric acid. This fact probably indicates that because of insolubility 
of NaCMC at 0.1 M hydrochloric acid, the interaction between NaCMC and 
propranolol hydrochloride is very low. The release rates decreased as the pH 
increased from that of 0.1 M hydrochloric acid to pH 9.4. As the pH 
increased the difference between release of drug from matrices with 
different viscosity grades of NaCMC was more obvious. The most significant 
difference between three viscosity grades of NaCMC admixture with HPMC 
was observed in distilled water (table 6.4) which might have been due to the 
maximum interaction between propranolol and NaCMC. The reason for the 
maximum interaction between propranolol hydrochloride and NaCMC in 
distilled water, probably is the fact that NaCMC is less soluble at 0.1 M 
hydrochloric acid and propranolol hydrochloride is less soluble at high pHs, 
therefore they must have their most ability to interact into distilled water. 
This interaction is weak at other pHs, due to reduction in the solubility of 
propranolol hydrochloride (table 6.2) or insolubility of NaCMC (in 0.1 M HCI). 
(226) 
CHAPTER 7 DRUG RELEASE FROM MATRICES CONTAINING 
ETHYLCELLULOSE 
7.1 INTRODUCTION 
Ethylcellulose (EC) is an inert, hydrophobic polymer and has properties such 
as lack of toxicity, stability during storage (Dubernet et al, 1990) and good 
compersibility (Upadrashta et al, 1993) which make it suitable for sustained 
release matrices. Ethylcellulose is used to control the dissolution rate of 
drugs from sustained-release products in, for example, matrix tablets (Stamm 
and Tritsch, 1986; Upadrashta et al, 1993), film-coated tablets (Porter, 1989; 
Narisawa et al, 1994) and microencapsulated dosage forms (Deasy et al, 
1980). It has also been used as a matrix in the preparation of both water- 
soluble and sparingly water-soluble drugs using the solid dispersion 
technique (Shaikh et al, 1987a, b). 
Gurny et al (1982) reported that when porous hydrophobic polymeric drug- 
delivery systems are placed in contact with an appropriate dissolution 
medium (usually water), the release of the drug to the medium must be 
preceded by drug dissolution in the water-filled pores and by diffusion 
through the water-filled channels. They reported that the geometry and 
structure of the pore network were important to this drug release process. 
Gurny et al (1982) proposed a model for drug diffusion through porous 
systems. In their model (figure 7.1), they denoted Ca as the initial drug 
loading in the sample, C. as the drug saturation concentration at the pore 
(227) 
wall-dissolution medium interface where dissolution occurs and c, as the 
surface concentration of the drug at the slab dissolution medium interface. 
In figure 7.1, it is assumed that the water entering the pores does not 
interact with the polymer or otherwise make it swell (contrary to hydrophilic 
polymers). Consequently Gurny et al (1982) claimed that the porosity was the 
major factor effective on drug release. This fact was in close agreement with 
the report by Higuchi (1963) that showed, in the matrix type delivery system, 
that the porosity and degree of tortuosity in the capillaries influenced the 
drug release rate. 
Figure 7.1: Simplified diagram of drug release from porous polymers (after 
Gurny et al, 1982) 
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7.1.1 Aims and objectives 
The purpose of this study was to investigate the possible application of 
ethylcellulose, as a potential carrier for the preparation of prolonged release 
formulations using propranolol hydrochloride again as a model drug. The 
effects of drug : polymer ratio, viscosity grades and compaction pressure on 
drug release and also the replacement of ethylcellulose by hydrophilic 
polymers such as HPMC or NaCMC were investigated. Additionally, the 
water uptake of ethylcellulose on its own or admixture with HPMC, was 
investigated in an attempt to quantify the dissolution processes. 
7.2 EFFECT OF PROPRANOLOL HYDROCHLORIDE 
ETHYLCELLULOSE 7 cP RATIO ON DRUG RELEASE 
The effect of polymer concentration within a matrix is a direct consequence 
of Higuchi's equation (Higuchi, 1963). Several workers (Shaikh et al, 1987a; 
Doelker, 1989; Van Bommel et al, 1990; Bonny and Leuenberger, 1991) 
reported that the greater the concentration of the polymer within a matrix, 
the slower the release of a drug. In this section the effect of ethylcellulose 
content on the release of propranolol hydrochloride is described. 
7.2.1 Experimental 
7.2.1.1 Materials 
Propranolol hydrochloride (<125 pm), ethylcellulose 7 cP (<125 pm) and 
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magnesium stearate were used in this part of the study and are described in 
section 2.1. 
7.2.1.2 Matrix preparation 
Tablets containing 160 mg propranolol hydrochloride, 95,140 or 285 mg 
ethylcellulose 7 cP (<125 pm) and 0.75% magnesium stearate and were made 
as described in section 2.2.4. The compaction pressure used was 181.1 MNm 2. 
7.2.1.3 Dissolution methodology 
Dissolution was carried out at 37°C as described in section 2.2.5. 
7.2.1.4 Anal ses of drug release 
The data between 5 to 80% release were fitted to equations 1.2 (Q=K2 (t"1)°) 
and 1.3 (Q=K3tm + C) which were discussed in section 1.4.1. 
7.2.2 Results and discussion 
Figure 7.2 shows the effect of drug : ethylcellulose ratio on the release of 
propranolol hydrochloride. The release kinetics from matrices composed of the 
varying amount of ethylcellulose are shown in table 7.1. As the polymer 
fraction increased, the release rate of the drug decreased (value of K3 in table 
7.1) whereas the release exponents remained almost unchanged. The value 
of n below 0.5 indicates that the diffusion release mechanism predominated 
(Ritger and Peppas, 1987). It is clearly seen that the polymer content, 
(230) 
Figure 7.2: The effect of ethylcellulose 7 cP content on the release of 
propranolol hydrochloride from matrices containing 160 mg propranolol 
hydrochloride and 95,140 or 285 mg ethylcellulose 7 cP. Results are the 
means ± SD of six determinations 
100 
90 
80 
Id 70 
0 
,! 60 
U 
x ao 
0 
r. 0 ä 40 
a 0 
N a' so 
9 
20 
10 
0 
06 10 16 20 26 80 
1/2 
Square root of time (min ) 
(231) 
r.. 0 
bn 
0 
co 
r-q 
ba 
w 
d 
IS 
ti 
.4 10 
H 
P-4 
ti 
C 
0 
I 
Q) 
b 
b 
0 
0 
CD CO bý 
, d C3 u? o m U 
co 
L m N O 
7-4 ö 6 Ö Ö g4 
. t1 +1 +1 
00 00 CfD 
N 
`o a 
C c 
cq 
am 
'd , 0 0 0 0 
ä 
d' tom- M 
A 
U 1 00 
tl r+ +I +1 +1 
°° co r-+ 
°° m c 
ü 
° `n' + 111 o o C9 
V 
. -4 
r-i 
0 
ri 
a 
0 
C4 
r4 
uJ 
0 
ra 
CD (1) 
"d 
W c. 
m 
cd 
cý a 
aý 
U 
b 
cý 
q 
w 
(232) 
between 95 and 285 mg did not affect the release mechanism. Negative 
values of C indicate a burst release of drug and high positive values imply a 
delay to release. The data in table 7.1 indicate that matrices containing 95 
mg ethylcellulose 7 cP had a burst release while matrices containing 285 mg 
polymer did not. 
7.3 EFFECT OF PARTICLE SIZE AND VISCOSITY GRADES OF 
ETHYLCELLULOSE ON DRUG RELEASE 
Ritger and Peppas (1987) and Mitchell et al (1993d) reported that smaller 
particle sizes of hydrophilic polymers such as HPMC, generally gave slower 
release profiles than with large particles sizes. Although hydrophobic 
polymers such as ethylcellulose do not swell on contact with moisture, the 
effect of their particle size on drug release has not been studied in depth. 
Because the matrices containing 95 mg or 140 mg ethylcellulose 7 cP did not 
show the desired sustenance of release (section 7.2), matrices containing 285 
mg were more thoroughly investigated. 
7.3.1 Experimental 
7.3.1.1 Materials 
The materials used in this part of study, and described in section 2.1, were 
propranolol hydrochloride (<125 pm), ethylcellulose 7 cP, ethylcellulose 10 cP 
and magnesium stearate. 
(233) 
7.3.1.2 Matrix preparation 
For the purpose of achieving different particle size ranges of ethylcellulose 7 
cP and ethylcellulose 10 cP, both grades were sieved to produce the <125 pm, 
150-250 pm, 250-355 }un and 355-425 }un fractions. All tablets in this study 
were manufactured as described in section 2.2.4 and contained 160 mg 
propranolol hydrochloride, 0.75% magnesium stearate as lubricant and 285 
mg ethylcellulose 10 cP or ethylcellulose 7 cP. The compaction pressure used 
was 181.1 MNm"2. 
7.3.1.3 Dissolution methodology 
Dissolution was carried out at 37°C, as described in section 2.2.5. 
7.3.1.4 Analyses of drug release 
The same methods as described in section 7.2.1.4 for analyses of drug release 
were used. 
7.3.2 Results and discussion 
The release profiles of propranolol hydrochloride from matrices containing 
285 mg ethylcellulose 10 cP (figure 7.3) or ethylcellulose 7 cP (figure 7.4) of 
different particle sizes were generally linear for up to more than 80% drug 
release when plotted as a function of the square root of time. The release 
data, analyzed using equations 1.2 and 1.3, are shown in tables 7.2 and 7.3. 
The matrix tablets which consisted of <125 pm ethylcellulose showed the 
slowest drug release. As the particle size increased the release rate increased 
(234) 
(values of K3 in tables 7.2 and 7.3). This may be due to the fact that 
penetration of water into the matrices was facilitated when the coarser 
particle size fractions were used. The times for 50% release of the drug to be 
released (Tso%) are also shown in tables 7.2 and 7.3. It is seen that as the 
particle size of both grades of ethylcellulose increased, the values of 1 (lag 
time) and C decreased, indicating a burst release of drug with the coarser 
particle sizes. 
Although both ethylcellulose 10 cP and ethylcellulose 7 cP showed similar 
behaviour, matrices containing ethylcellulose 7 cP showed marginally slower 
release rates than matrices containing ethylcellulose 10 cP at equivalent 
particle size. The lowest release rate of 4.53 ± 0.03% mirf m was obtained 
from matrices containing 285 mg ethylcellulose 7 cP compared with 4.84 ± 
0.07% min' from matrices containing ethylcellulose 10 cP. Similar results 
have been reported by Upadrashta et al (1993) who, using ethylcellulose 10, 
20,45 and 100 cP, reported that a controlled release rate is achieved with 
lower viscosity grades of ethylcellulose. 
The matrices containing <125 pm ethylcellulose 7 cP remained intact during 
testing, whereas matrices consisting of coarser particles slowly disintegrated. 
As the particle size of each ethylcellulose increased, the release exponent 
(values of n) increased and the highest value, n=0.88, was obtained for 
ethylcellulose 10 cP with the 425-355 pm fraction. The data indicate that, 
since the values of n were dependent on the particle size, as the particle size 
(235) 
Figure 7.3: The effect of particle size of ethylcellulose 10 cP on the release of 
propranolol hydrochloride from matrices containing 160 mg propranolol 
hydrochloride and 285 mg ethylcellulose 10 cP. Results are the means t SD 
of six determinations. 
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Figure 7.4: The effect of particle size of ethylcellulose 7 cP on the release of 
propranolol hydrochloride from matrices containing 160 mg propranolol 
hydrochloride and 285 mg ethylcellulose 7 cP. Results are the means ± SD of 
six determinations. 
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of ethylcellulose decreased the release became progressively controlled by 
diffusion. Although the value of n for coarse particle size of ethylcellulose 10 
cP is the desired for near zero order release, the negative value of C indicates 
a burst release of drug before control of release is accomplished. 
7.4 EFFECT OF COMPACTION PRESSURE ON DRUG RELEASE 
It is well known that compaction pressure does not effect drug release rates 
from matrices containing hydrophilic polymers (Ford et al, 1985a; Conte et 
al 1993). However, ethylcellulose is thought to deform plastically when 
subjected to compression (Rekhi and Jambhekar, 1995) and consequently the 
drug release may be a function of the compaction pressure used to produce 
the matrices. Therefore, matrix tablets containing 285 mg ethylcellulose 7 cP 
<125 pm size were chosen for investigation of the effects of compaction 
pressure on drug release. The reasons for choosing this viscosity grade and 
particle size of ethylcellulose were that: 
a- matrices containing 95 mg or 140 mg of ethylcellulose 7 cP gave a release 
faster than from matrices containing 285 mg (section 7.2), 
b- matrices containing 285 mg ethylcellulose <125 pm size showed a 
sustained release of propranolol hydrochloride for more than 7 hours (section 
7.3), 
(240) 
c- the release rate from matrices containing ethylcellulose 7 cP was slightly 
lower than from matrices containing ethylcellulose 10 cP (values of K3 in 
tables 7.2 and 7.3), 
7.4.1 Experimental 
7.4.1.1 Materials 
Propranolol hydrochloride (<125 pm), ethylcellulose 7 cP (<125 pm) and 
magnesium stearate, used in this part of the study, are described in section 
2.1. 
7.4.1.2 Matrix preparation 
Tablets in this study were manufactured as described in section 2.2.4 and 
contained 160 mg propranolol hydrochloride (<125 µm), 0.75% magnesium 
stearate as lubricant and 285 mg ethylcellulose 7 cP (<125 dun). Tablets were 
compressed at pressures ranging from 7.8 to 393.7 MNm Z. Tablets up to 
213.4 MNm 2 pressure (7.9,39.4,78.7,118.1 or 213.4 MNm 2) were made on 
a Manesty F3 single punch machine. In order to avoid damage to the press, 
tablets made at higher pressures (315.0 or 393.7 MNm 2) were compressed 
using a compaction simulator (ESH testing Ltd., Brierly Hill, U. K. ). 
7.4.1.3 Porosity determination 
The porosities of the matrices were calculated using equation 7.1 (Narisawa 
et al, 1994). 
(241) 
(1 - PT / Pt) x 100 Equation 7.1 
Where: e= porosity of matrix, Pr the apparent density of the compact at any 
given pressure (g/cm3), Pt= the true density of powder (g/cm3). 
Pt was determined using an Air Comparison Pycnometer (Model 930, 
Beckman Instruments Ltd. U. K. ). The mean of three determinations for each 
batch was used for the true density of powder. The dimensions of the tablets 
were measured using a screw-gauge micrometer (Moore and Wright, 
Sheffield) and used to calculate the tablet volume in order to determine Pr for 
each tablet. The mean of six determinations was used to determine the 
porosity of matrices at each compaction pressure. 
7.4.1.4 Dissolution methodology 
Dissolution was carried out at 37°C as described in section 2.2.5. 
7.4.2 Results and discussion 
Figure 7.5 shows the effect of compaction pressure on drug release from 
matrices containing 285 mg ethylcellulose 7 cP. The data obtained are 
presented in table 7.4. The release from matrices compressed at 7.8 MNm 2 
was very rapid. The dissolution profile from matrices made at 39.4 MNni 2 
was biphasic. The rates were 5.62% ± 0.28 min'" for up to 30% release and 
subsequently 11.07% ± 0.41 min up to 80% release. The release rates of 
matrices compressed at forces between 78.7 and 393.7 MNm'2 were relatively 
(242) 
unaffected by pressure. 
As the compaction pressures initially increased, the porosities of matrices 
decreased and subsequently the release rates (value of K3 in table 7.4) 
decreased. The porosity of matrices made at pressures between 78.7 and 
393.7 MNm 2 were similar and the values of release exponent (n) at this 
range of compaction pressures were also similar (between 0.43 to 0.46), 
whereas at 39.4 MNrri 2 pressure the porosity and the value of n were high. 
Therefore it could be suggested that the porosity of matrices affected the drug 
release mechanism. Stamm and Tritsch (1986), using ethylcellulose 20 cP, 
reported that matrices made with low crushing strengths had high porosity 
and gave quick release of metoclopramide hydrochloride whereas the release 
profiles of this drug were similar, but lower from matrices made to higher 
crushing strengths. Higuchi (1963) showed that in the matrix type of delivery 
system, the porosity and degree of tortuosity in the capillaries influenced 
drug release rate and reported that the amount of drug per unit of matrix 
volume decreased with time as dissolution occurred. Similarly, Desai et al 
(1966) reported that the release data from elastic matrices such as polyvinyl 
chloride were found to be independent of the compression force which was 
attributed to a constancy of porosity within the matrix. 
The release kinetics and Tso%s are also shown in table 7.4. The T60xs were 
similar for matrices compressed at 78.7 - 393 MNm 2. The values of n suggest 
that drug release became predominantly diffusional controlled as the 
(243) 
Figure 7.5: The effect of compaction pressure (MNm 2) on the release of 
propranolol hydrochloride from matrices containing 160 mg propranolol 
hydrochloride and 285 mg ethylcellulose 7 cP. Results are the means ± SD 
of six determinations. 
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compaction pressure increased. In table 7.4 it may be observed that an 
increase in compaction pressure caused increase in the values of C or 1. 
Therefore the burst release seen at low compaction pressures was suppressed 
at higher compaction pressures. 
7.5 EFFECT OF REPLACEMENT OF ETHYLCELLULOSE BY 
HYDROXYPROPYLMETHYLCELLULOSE OR SODIUM 
CARBOXYMETHYLCELLULOSE ON DRUG RELEASE 
In swelling systems, the release of a solute (e. g. drug, dye) is controlled by 
one or more of the following processes namely, the transport of the solvent 
into the polymer matrix, swelling of the associated polymers, diffusion of the 
solute through the swollen polymer and erosion of the swollen polymer 
(Ranga Rao and Padmalatha Devi, 1988). Since ethylcellulose is a 
hydrophobic polymer and can not swell in a manner similar to HPMC or 
NaCMC, it was considered that admixture of HPMC or NaCMC with 
ethylcellulose could change the permeability of the matrix (Porter, 1989) and 
consequently modify the release rate or, in the case of NaCMC, additionally 
interact with propranolol hydrochloride. 
7.5.1 Experimental 
7.5.1.1 Materials 
Propranolol hydrochloride (<125 pm), ethylcellulose 7 cP (<125 pin), HPMC 
(246) 
K4M, NaCMC (Blanose) and magnesium stearate, described in section 2.1, 
were used in this part of study. 
7.5.1.2 Matrix preparation 
Tablets were compressed to contain 160 mg propranolol hydrochloride (<125 
}im), 285 mg of total polymers in ratios 1: 3,1: 1 or 3: 1 of HPMC K4M : 
ethylcellulose 7 cP (<125 pm) or NaCMC (Blanose) : ethylcellulose 7 cP (<125 
pm) and 0.75% magnesium stearate and were compressed at 181.1 MNm 2 as 
described in section 2.2.4. 
7.5.1.3 Dissolution methodology 
Dissolution was carried out at 37°C as described in section 2.2.5. 
7.5.2 Results and discussion 
7.5.2.1 Replacement of HPMC by ethylcellulose 
Drug release profiles of tablets prepared from different ratios of HPMC K4M 
: ethylcellulose 7 cP are shown in Figure 7.6 and the data obtained using 
equations 1.2 and 1.3 are presented in table 7.5. As the proportion of 
ethylcellulose in the matrix increased the value of T 0% decreased and 
subsequently the release rate increased from 2.7% t 0.2 min ' (HPMC K4M 
alone) to 4.8% ± 0.1 miri' (ethylcellulose 7 cP alone). It was surprising that 
the values of n did not change when the matrices consisted of an admixture 
of the two polymers or HPMC alone. This fact confirmed the finding of Ford 
(247) 
Figure 7.6: The effect of HPMC K4M : ethylcellulose 7 cP ratio on 
propranolol hydrochloride release from matrices containing 160 mg 
propranolol hydrochloride and 285 mg total polymer. Results are the means 
SD of six determination. 
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et al (1987) who investigated the effect of replacement HPMC by diluents and 
reported that replacement of portions of HPMC within the matrices by 
diluents increased the release rates of promethazine hydrochloride, 
irrespective of whether the diluents were water soluble or water insoluble. 
The exponent value from matrix tablets containing ethylcellulose (0.44) 
indicates that the matrix exhibits mainly diffusional release mechanisms, 
whereas the exponent values from matrices containing various ratios of 
HPMC K4M : ethylcellulose (0.59 - 0.62) indicates a coupling of diffusion 
(case 1) and polymer relaxation phenomena (case II). This fact indicates that 
the presence of HPMC encouraged erosion in the matrices. 
Visually, the matrices containing ethylcellulose remained intact during the 
test and matrices containing HPMC alone swelled. When the matrix tablets 
consisted of 1: 3 HPMC : ethylcellulose, they disintegrated slowly. This 
phenomenon could be due to the fact that when the proportion of 
ethylcellulose in the matrix is high, the hydrophilic particles in the matrix 
were separated from each other and formation of a protective gel layer 
around the matrix did not occur. As the proportion of HPMC in the matrix 
increased, the matrix remaining at the end of dissolution became larger. 
7.5.2.2 Replacement of NaCMC by ethylcellulose 
Figure 7.7 shows the data for NaCMC - ethylcellulose matrices. The data 
obtained by using equations 1.2 and 1.3 (between 5- 60% drug release) are 
(250) 
presented in table 7.5. Since the release data from matrices containing 
NaCMC alone or ratio 3: 1 NaCMC : ethylcellulose did not fit to equation 1.2, 
it is omitted in table 7.5. As the ethylcellulose portion in the matrices 
consisting of NaCMC : ethylcellulose increased, the T50% decreased and the 
release rates (K3 in table 7.5) increased. When the proportion of ethylcellulose 
in the matrix tablets was 75% (i. e., 1: 3 NaCMC : ethylcellulose) a burst 
release was observed and more than 45% drug released during the initial 6 
minutes of dissolution test. This phenomenon could be explained in the 
following way: when the proportion of NaCMC in the matrix was low and 
therefore its particles were separated by non-hydrophilic ethylcellulose 
particles, the formation of a protective layer by NaCMC (which occurs 
following water absorption at higher proportions of NaCMC) did not occur 
effectively. Consequently the drug was released rapidly. The interaction 
between propranolol hydrochloride and NaCMC which discussed in section 
5.3.3 is another reason that caused the slow release from matrices, whereas 
propranolol hydrochloride could not interact with ethylcellulose. 
Matrices containing 3: 1 NaCMC : ethylcellulose (25% ethylcellulose content) 
gave a release exponent value of 1.45 (table 7.5). This value indicates super 
case-II transport. The reason for this value might be the high swelling nature 
of the polymer at this ratio (Ranga Rao et al, 1988a; Bain et al, 1991). 
Addition of ethylcellulose into NaCMC matrices possibly would increase the 
porosity of the matrix tablets and the matrices swell very fast in contact with 
water, because the penetration of water into matrices is facilitated. 
(251) 
Figure 7.7: The effect of NaCMC (Blanose) : ethylcellulose 7 cP ratio on 
propranolol hydrochloride release from matrices containing 160 mg 
propranolol hydrochloride and 285 mg total polymer. Results are the means 
SD of six determinations. 
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7.6 WATER UPTAKE OF ETHYLCELLULOSE. 
HYDROXYPROPYLMETHYLCELLULOSE AND THEIR MIXTURES 
Knowledge of the water uptake by the polymer is necessary to understand the 
dissolution process. The purpose of this study was to investigate the process 
of hydration of ethylcellulose 7 cP on its own or in admixture with HPMC, in 
order to evaluate the release mechanism of propranolol hydrochloride from 
these matrices. 
7.6.1 Experimental 
7.6.1.1 Materials 
Ethylcellulose 7 cP (<125 pm) and HPMC K4M, as described in section 2.1, 
were used. 
7.6.1.2 Preparation of wafers 
Wafers were made using approximately 10 mg of ethylcellulose (<125 pm), 
HPMC K4M or their 1: 1 mixture as described in section 2.2.2.4. 
7.6.1.3 Evaporation of water from wafers containing HPMC or ethvlcellulose 
Wafers containing ethylcellulose, after 30 minutes of contact with water 
(before the scan) were reweighed. The results showed 32 ± 1.8% w/w 
reduction in their weight indicating evaporation of water. Similar tests were 
carried out for HPMC and NaCMC wafers. The results showed a 1.6 ± 0.1% 
(253) 
w/w loss due to water evaporation. The reason for this difference might be the 
ability of HPMC or NaCMC to absorb water and therefore prevent the water 
from evaporating. 
7.6.1.4 Method of determination 
Water uptake by wafers was initially determined by the methods described 
in section 2.2.2.4. As discussed before, water evaporation occurred and 
therefore the sample pans containing ethylcellulose were measured after 
storage prior to analysis. The amounts of water remaining in the pans were 
re-determined such that water uptake could be calculated accurately. 
7.6.2 Results and discussion 
Figure 7.8 shows typical DSC scans of water taken up by wafers containing 
ethylcellulose 7 cP (<125 )im). The data of percent water bound are presented 
in table 7.6. The amount of water apparently taken up increased over the 
period of 30 minutes. After 5 minutes of contact with water, 7.4% of uptake 
had occurred. Typical data for water taken up by wafers containing 1: 1 
HPMC K4M : ethylcellulose are presented in figure 7.9 and table 7.6. 
Approximately 39% of uptake occurred after 5 minutes of contact of the 
wafers with water. 
The results of Tukey's test from wafers containing ethylcellulose 7 cP suggest 
that at (p<0.05), there was no significant difference between the enthalpies 
of pure water and the enthalpies of discs containing ethylcellulose after 
(254) 
Figure 7.8: DSC scans showing the melting endotherms of free water in 
contact with ethylcellulose 7 cP discs following storage at 1,5,15 or 30 
minutes at ambient temperature. 
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1 minute of contact with water indicating weak ability of ethylcellulose to 
absorb water. There were significant differences between the percentage of 
bound water from discs containing ethylcellulose at 1,5 and 15 minutes of 
contact with water. However, no significant increase in bound water was 
observed after 15 minutes indicating saturation of ethylcellulose. There were 
significant differences between the melting enthalpies of discs containing 
(255) 
Figure 7.9: The DSC scans showing the melting endotherms of free water in 
contact with discs containing 1: 1 HPMC K4M : ethylcellulose 7 cP following 
storage at 1,5,15 or 30 minutes at ambient temperature. 
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HPMC and ethylcellulose at all periods of time of contact with water. 
The data in table 7.6 indicate that discs containing 1: 1 HPMC : ethylcellulose 
absorbed water similar to HPMC K4M at 1 minute whereas, they absorbed 
water more than HPMC at 5 minutes (p<0.05, Tukey's test). The water 
uptake from discs containing the 1: 1 mixture was more than anticipated. 
(256) 
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The expected amount of water taken up by these discs after 5 minutes of 
contact with water, was 19.8% (mean of values in table 7.6) while the actual 
water uptake observed was about 39%. This suggests that water penetrated 
these wafers more easily than predicted from the data for the individual 
polymers. The ethylcellulose particles presumably facilitated water uptake by 
decreasing the apparent tortuosity of the matrix. However, Tukey's tests 
showed significant differences between HPMC and the 1: 1 mixture at 15 or 
30 minutes of contact with water (p<0.05). 
Table 7.6: Effect of time on the percent of water bound by 10 mg discs 
containing HPMC K4M, ethylcellulose 7 cP or their 1: 1 mixture (results are 
the means ± SD of three tests). 
Time (min) HPMC K4M EC 7 cP 1: 1 HPMC : EC 
0 0 0 0 
1 27.5 ± 2.3 3.4 ± 0.6 26.0±1.3 
5 32.2 ± 1.2 7.4 ± 1.6 39.1±0.2 
15 56.6 ± 0.4 12.5 ± 1.7 39.9 ± 1.2 
30 63.6 ± 1.4 13.6 ± 1.7 51.2±1.3 
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Furthermore, the endotherms in the DSC of water in contact with 
ethylcellulose were sharp and there was no broadening in their scans (figure 
7.8) whereas, the endotherms from wafers containing 1: 1 HPMC : 
ethylcellulose were broad (figure 7.9) which indicates an interaction between 
water and the polymer. However, the results of water bound to ethylcellulose 
were similar to those findings of Joshi and Wilson (1993) who reported that 
moles of non-freezing water per polymer repeat unit for ethylcellulose EC E4 
were 1.6 ± 0.3 mole water, whereas the moles of non-freezing water per 
polymer repeat unit for HPMC E5 were 6.2 ± 1.3, indicating a high difference 
in the water absorbing capacity of HPMC compared to ethylcellulose. 
7.7 CONCLUDING REMARKS 
The results confirm that the release rate of propranolol hydrochloride from 
matrices containing ethylcellulose can be modified using smaller particle sizes 
and a lower viscosity grade of ethylcellulose. The smaller particle size and the 
lowest viscosity grade of ethylcellulose gave the slowest release rate. 
Compaction pressure up to 39.4 MNm 2 affected the release rates whereas 
from 78.7 to 393.7 MNm 2 did not affect release rate. This was attributed to 
the high porosity of the matrices at low compaction pressure. In the matrices 
containing HPMC K4M : ethylcellulose, as the proportion of ethylcellulose 
increased the release rates gradually increased. Similar behaviour was seen 
for matrices containing NaCMC : ethylcellulose except when the portion of 
ethylcellulose was 75% where the burst release of propranolol hydrochloride 
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occurred. The admixture of HPMC and ethylcellulose had the ability of 
absorbing more water. Water bound to ethylcellulose was very low whereas 
the water bound to mixture of ethylcellulose and HPMC was high at initial 
stages of uptake. This fact can be attributed to the ease of penetration of 
water to the wafers containing 1: 1 HPMC : ethylcellulose, because addition 
of ethylcellulose to HPMC would increase the porosity of wafers which 
enables them to absorb more water. 
(259) 
CHAPTER 8 THE RELEASE OF PROPRANOLOL 
HYDROCHLORIDE FROM MATRICES CONTAINING 
HYDROXYPROPYLMETHYLCELLULOSE AND ß-CYCLODEXTRIN 
8.1 INTRODUCTION 
Cyclodextrins (CDs) are cyclic oligosaccharides having a(1-4) linked glucose 
units, which are formed by the enzymatic degradation of amylose. They are 
well documented for their ability to form inclusion complexes with a wide 
variety of "guest" molecules (Szetjli, 1982). Cyclodextrins can be produced by 
the relatively simple technology of fermentation of starch. The most common 
cyclodextrins are a, ß and y cyclodextrins, consisting of 6,7 and 8 glucose 
units respectively. All of the CDs are water-soluble, crystalline and non- 
hygroscopic (Szetjli, 1982). Since all of the free hydroxyl groups are on the 
outer surface of the ring, the internal cavity of the doughnut-shaped molecule 
is slightly apolar and the outer surface of a CD molecule is hydrophilic 
(Szetjli, 1991). Figure 8.1 shows the chemical structure of 13-cyclodextrin (left) 
and its side view or doughnut-shaped molecule (right) (Uekama and Otagiri, 
1987). Among the three groups of CDs and a wide variety of their derivatives, 
ß-cyclodextrin is more important than the others because a-CDs can be used 
only for small molecules or for the complexation of slim side chains (Szetjli, 
1991) and y-CDs are, at present, too expensive for any practical purposes and 
could be used to advantage only with large molecules such as macrolides or 
steroids (Szetjli, 1991). However, ß-cyclodextrin, due to its medium diameter 
(260) 
cavity, is suitable for many drugs (Le Bas and Rysanek, 1987). 
Figure 8.1: Chemical structure of ß-cyclodextrin (left) and its side view (right) 
(after Uekama and Otagiri, 1987) 
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Cyclodextrin (CD) and its derivatives can be used for drugs either for 
complexation or as auxiliary additives (carriers, diluents, solubilizers or 
tablet ingredients) (Szetjli, 1982; Roy, 1994). ß-cyclodextrin (ß-CD) and its 
derivatives also have been used in pharmaceutical formulations to enhance 
the solubility (Uekama et a1,1990), dissolution rate (Uekama et al, 1983), 
membrane permeability (Uekama et al, 1983), taste masking (Roy, 1994) or 
modification of dissolution behaviour of water-insoluble drugs such as 
naftazone (Giunchedi et al, 1994), through the formation of inclusion 
complexes with the drugs. However, there are few reports on the use of ß- 
cyclodextrins as excipients for soluble drugs (Duddu et al, 1993). 
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Armstrong et al (1986) reported that propranolol hydrochloride molecules 
could make an inclusion complex with ß-cyclodextrin. Duddu et al (1993) 
using propranolol hydrochloride and ß-cyclodextrin, confirmed the findings of 
Armstrong et al (1986). However, it could be assumed that a complex formed 
by ß-cyclodextrin and propranolol hydrochloride which has a molecular weight 
and size bigger than each of its agents, would modify drug release from 
matrices. This assumption was based on findings of Korsmeyer et al (1983a) 
who observed that the release of three drugs, differing widely in their 
molecular weights, namely potassium chloride (mol. wt. 74.55), 
phenylpropanolamine hydrochloride (mol. wt. 187.67) and bovine serum 
albumin (mol. wt. 69000), through poly(vinyl alcohol) matrices. Their results 
revealed that as the molecular size of the solute increased, the release rate 
deceased. This part of the study set out to investigate the release of 
propranolol hydrochloride - ß-cyclodextrin complex from HPMC K4M 
matrices. 
8.1.1 Aims and objectives 
The main aim was to investigate the release of propranolol hydrochloride 
from propranolol - ß-cyclodextrin complex or from the admixture of 13- 
cyclodextrin and HPMC K4M. Additionally, the water uptake of wafers 
containing ß-cyclodextrin, lactose, 1: 1 HPMC : 13-cyclodextrin and 1: 1 HPMC 
: lactose were studied in an attempt to illucidate the mechanisms of drug 
release. 
(262) 
8.2 PREPARATION AND CHARACTERIZATION OF 13-CYCLODEXTRIN 
COMPLEX 
The propranolol hydrochloride - ß-cyclodextrin complex was examined by DSC 
by comparing its scans with those of the pure materials and their physical 
mixture. 
8.2.1 Experimental 
8.2.1.1 Materials 
ß-cyclodextrin (<105 inn) and propranolol hydrochloride were used as 
described in section 2.1. 
8.2.1.2 Preparation of physical mixture of propranolol hydrochloride and ß- 
cyclodextrin 
1: 1 molar ratio of propranolol hydrochloride (1.183 g) and ß-cyclodextrin 
(4.540 g) were mixed in a glass jar using a tumbler mixer for 10 minutes. 
8.2.1.3 Preparation of propranolol-cyclodextrin complex 
The method used for the preparation of the complex was similar to that used 
by Duddu et al (1993). The molar ratio of propranolol hydrochloride (2.958 g) 
and ß-cyclodextrin (11.350 g) were dissolved in distilled water (60 mL and 
300 mL respectively). The aqueous solution of ß-cyclodextrin was heated to 
70 °C to produce a clear solution. Then both aqueous solutions of propranolol 
hydrochloride and ß-cyclodextrin were mixed in a 500 mL baker. The solution 
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was kept overnight in five petri dishes in an oven at 50°C to evaporate the 
water. 
8.2.1.4 Methodology 
Samples (5 mg) containing propranolol hydrochloride, physical 1: 1 molar 
mixture of propranolol hydrochloride and ß-cyclodextrin (section 8.2.1.2) and 
the complex of propranolol-ß-cyclodextrin (section 8.2.1.3) were accurately 
weighed and placed into aluminum pans (Perkin Elmer, 6.35 mm diameter). 
Aluminum lids were used to cover the sample without sealing. The samples 
were heated from 40°C to 300°C at 10°C/min. The heats of fusion of 
propranolol hydrochloride in the samples were measured, calculated on the 
basis of the propranolol hydrochloride to be in the samples. 
8.2.2 Results and discussion 
Figure 8.2 shows the DSC scans of propranolol hydrochloride, ß-cyclodextrin, 
physical mixture of 1: 1 molar propranolol hydrochloride and ß-cyclodextrin 
and the complex. The peak of pure propranolol hydrochloride was at 164°C 
(enthalpy of 123.8 ± 1.2 J/g). A similar peak was observed for the physical 
mixture indicating that there was no interaction between propranolol 
hydrochloride and 13-cyclodextrin in solid forms (enthalpy of 116.6t 4.8). The 
propranolol hydrochloride and ß-cyclodextrin complex showed the complete 
disappearance of the endothermic peak at about 164°C. These results clearly 
indicate that there is a difference between the physical mixture and the 
propranolol hydrochloride - ß-cyclodextrin complex. Similar results were 
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Figure 8.2: DSC scans of propranolol hydrochloride, ß-cyclodextrin, physical 
mixture of 1: 1 molar propranolol hydrochloride and ß-cyclodextrin and the 
complex of propranolol-ß-cyclodextrin following heating from 40°C to 300°C 
at 10°C/min. 
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reported by Duddu et al (1993) who used the 1: 1 molar ratio of propranolol 
hydrochloride and ß-cyclodextrin in different solid forms (freeze-dried 
inclusion complex, freeze-dried ß-cyclodextrin, freeze-dried d-propranolol and 
physical mixture of propranolol and ß-cyclodextrin). They claimed that the 
formation of an inclusion complex by freeze-drying was suggested by the 
absence of the melting endotherm of racemic propranolol hydrochloride at 
165°C in the DSC curve of the inclusion complex. The 13-cyclodextrin and its 
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physical mixture with propranolol hydrochloride had peaks around 100 °C 
which probably were related to water in the samples. 
8.3 RELEASE OF PROPRANOLOL HYDROCHLORIDE FROM 
MATRICES CONTAINING ß-CYCLODEXTRIN COMPLEX 
As mentioned before, in order to produce a bigger molecule of propranolol 
hydrochloride, that was thought to be able to reduce the drug release, a 
complex of propranolol - ß-cyclodextrin was made. The release of drug from 
propranolol ß-cyclodextrin complex was compared to release of drug from 
matrices containing physical mixture of propranolol and 13-cyclodextrin. 
8.3.1 Experimental 
8.3.1.1 Materials 
Propranolol hydrochloride (<125 pm), unseived ß-cyclodextrin and its <105 
pm fraction and magnesium stearate were used as described in section 2.1. 
8.3.1.2 Tablet preparation 
Tablets were prepared containing 80 mg propranolol hydrochloride, 307 mg 
ß-cyclodextrin (unsieved and <125 }pm fraction in size) and 0.75% magnesium 
stearate as described in section 2.2.4. This ratio corresponded to the 1: 1 
molar ratio of propranolol hydrochloride : ß-cyclodextrin. Similarly tablets 
containing 387 mg of the complex of propranolol and 13-cyclodextrin (<105 pm) 
which contained 80 mg propranolol hydrochloride were also made. All tablets 
(266) 
were compressed at 182 MNm 2. 
8.3.1.3 Dissolution methodology 
Dissolution was carried out at 37°C as described in section 2.2.5. 
8.3.2 Results and discussion 
The release of propranolol hydrochloride from tablets containing the 1: 1 
molar ratio of unsieved ß-cyclodextrin and propranolol hydrochloride was very 
fast and all drug was released within 15 minutes of the start of the test. 
Therefore ß-cyclodextrin of particle size < 105 pm fraction was examined. The 
release remained fast but was slower than the unsieved fraction. A T50% of 
14.0 ± 1.0 minutes was obtained. Release of propranolol hydrochloride from 
tablets containing 387 mg of the complex, which contained 80 mg propranolol 
hydrochloride and 307 mg ß-cyclodextrin, was examined and a T50% of 8±1.2 
minutes was obtained which indicated a faster release than from the physical 
mixture. Duddu et al (1993) using discs (10 mm diameter) containing 250 mg 
of the complex with a similar formulation reported that the release was very 
fast and that the discs dissolved completely within 30 minutes. 
8.4 RELEASE OF PROPRANOLOL HYDROCHLORIDE FROM 
MATRICES CONTAINING ß-CYCLODEXTRIN AND 
HYDROXYPROPYLMETHYLCELLULOSE K4M 
The release of propranolol hydrochloride from HPMC matrices containing ß- 
cyclodextrin was investigated. For comparison, similar formulations 
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containing lactose instead of ß-cyclodextrin were made to see if the 
complexation of ß-cyclodextrin with propranolol hydrochloride had any affect 
on drug release. 
8.4.1 Methodology 
Propranolol hydrochloride (<125 um), ß-cyclodextrin (<105 pm), lactose (<105 
pm) and magnesium stearate were used as described in section 2.1. Matrix 
tablets were prepared containing 80 mg propranolol hydrochloride, 160 mg 
HPMC K4M and 0,76.7,153.5 or 307.0 mg ß-cyclodextrin or lactose and 
0.75% magnesium stearate as described in section 2.2.4 which were 
compressed at 182 MNm 2. These ratios corresponded to the 0,0.25,0.5 or 1 
molar ratios of propranolol hydrochloride : ß-cyclodextrin respectively. 
Additionally matrices containing 160 mg HPMC K4M and 387 mg of the 
complex, were similarly made. Dissolution was carried out at 37°C as 
described in section 2.2.5 and equation 1.2 (Q=K2(t-1)°) was used in the 
evaluation of the release mechanisms. 
8,4.2 Results and discussion 
Figure 8.3 shows the release profiles from matrices containing 80 mg 
propranolol hydrochloride, 160 mg HPMC K4M and 307 mg ß-cyclodextrin or 
lactose. Figure 8.3 also demonstrates the release of propranolol hydrochloride 
from matrices containing the complex of propranolol hydrochloride and ß- 
cyclodextrin in admixture with 160 mg HPMC K4M. The data obtained using 
equation 1.2 are presented in table 8.1. 
(268) 
Figure 8.3: Release profiles from matrices containing 80 mg propranolol 
hydrochloride, 160 mg HPMC K4M and 307 mg 13-cyclodextrin or lactose 
and matrices containing 160 mg HPMC K4M with 387 mg complex of 
propranolol - ß-cyclodextrin. Results are the means t SD of six 
determinations. 
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Table 8.1: Estimated values of K2(% mini °), n, 1, T60% (hour) and release rates 
(% min9 from matrices containing 80 mg propranolol hydrochloride, 160 mg 
HPMC K4M and 0,76.7,153.5 and 307 mg ß-cyclodextrin or lactose (between 
5-60% released) based on equation 1.2. Results are the means ± SD of six 
determinations 
Content (mg) K2 n1 T60% (hour) Release 
rate 
HPMC: ß-CD 
160: 0 2.67 0.60 3.40 2.38±0.22 5.0110.1 
160: 76.7 2.31 0.61 2.65 2.58±0.23 4.70±0.1 
160: 153.5 2.34 0.60 2.90 2.83±0.16 4.52±0.1 
160: 307.0 2.05 0.61 2.60 3.47±0.30 4.04±0.2 
HPMC: Lactose 
160: 76.7 2.57 0.61 0.15 2.1110.10 4.9410.1 
160: 153.5 2.56 0.60 3.84 2.5210.30 4.81±0.2 
160: 307.0 2.15 0.60 5.61 3.26±0.12 4.17±0.1 
ß-CD-propranolol complex` - 0.1310.02 - 
HPMC: ß-CD-PH** 2.21 0.62 3.99 2.6310.28 4.73±0.1 
* =387.0 mg ß-cyclodextrin-propranolol complex, ** =387.0 mg complex + 160 
mg HPMC K4M. 
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Data in table 8.1 indicate that as the ß-cyclodextrin or lactose in the matrices 
increased the release rates decreased. Matrices containing the molar ratio of 
ß-cyclodextrin and propranolol hydrochloride gave the slowest release rate 
(4.04% mm-) compared with matrices containing HPMC K4M alone (5.01% 
min '2). The values of release exponents were between 0.60 - 0.62, suggesting 
that the release of propranolol hydrochloride is controlled by both diffusion 
of the drug through the hydrated matrix and the erosion of the matrix itself 
(Peppas and Sahlin, 1989). It is seen that in spite of high difference in ß- 
cyclodextrin content in the matrices (table 8.1) the value of n did not change 
dramatically. This result was similar to findings of Ford et al (1987) who 
investigated the effect of adding soluble or insoluble excipients in HPMC 
matrices and reported that despite the vast differing solubility between used 
materials the release exponent did not change. Drug release from matrices 
containing the complex was faster than from the other matrices at the same 
composition, indicating that propranolol in the complex was more freely able 
to dissolve. This was contrary to what had been expected and the reason is 
unknown and needs more thorough investigation. However, one possible 
explanation is that the size of the complex particles used in this study (<105 
µm) was small. The particle size of the propranolol hydrochloride in the 
complex would be considerably smaller than the size of propranolol 
hydrochloride in the physical mixture. This could consequently result in 
faster drug release than expected. 
For further investigation of the release of drug from these matrices, the 
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solubilities of propranolol hydrochloride in aqueous ß-cyclodextrin solutions 
and the water uptake of discs composed of ß-cyclodextrin, lactose, 1: 1 HPMC 
: ß-cyclodextrin or 1: 1 HPMC : lactose were determined. 
8.5 PHASE-SOLUBILITY STUDIES 
The method of Higuchi and Connors (1965) was used to determine the 
solubility of propranolol hydrochloride in different molar ratios of aqueous 1- 
cyclodextrin solutions. 
8.5.1 Experimental 
8.5.1.1 Materials 
Propranolol hydrochloride and ß-cyclodextrin as described in section 2.1 were 
used. 
8.5.1.2 Methodology 
Excess amounts of propranolol hydrochloride (2 g) were weighed into 20 mL 
test tubes, to which were added 5 mL of distilled water containing various 
concentrations of ß-cyclodextrin (0.001-0.016 M). The tubes were shaken at 
37°C ± 0.5°C in a water bath (Companstat 882942, England). After 48 hours, 
the supernatant was filtered through a Whatman No. 1 filter. One mL of the 
sample was adequately diluted with distilled water and analyzed 
spectrophotometrically at 288 nm. The amount of dissolved propranolol was 
calculated from equation 2.1 (section 2.2.3.1). Determinations were carried 
(272) 
out in triplicate. 
8.5.2 Results and discussion 
The phase solubility diagram obtained for propranolol hydrochloride with ß- 
cyclodextrin is shown in figure 8.4. The solubility of propranolol hydrochloride 
decreased as the ß-cyclodextrin concentration increased. 
Figure 8,4: The effect of ß-cyclodextrin concentration on the solubility of 
propranolol hydrochloride (results are the means t SD of three 
determinations) 
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A number of investigators have reported that ß-cyclodextrin enhances the 
solubility of poorly soluble drugs such as benzodiazepines (Uekama et al, 
1983) and piretanide (Uekama et al, 1990). The decrease observed in the 
solubility of propranolol hydrochloride with increasing ß-cyclodextrin content 
might be due to an interaction between them. Armstrong et al (1986) reported 
that since the molecule of propranolol hydrochloride is almost completely 
included in the cavity of 13-cyclodextrin, the solubility of the complex of 
propranolol and 13-cyclodextrin would be influenced more by the interaction 
of the water molecules with ß-cyclodextrin than by their interaction with the 
drug. Since the solubility of propranolol is more than that of ß-cyclodextrin 
(Szetjli, 1982), this result confirmed the theory of Armstrong et al (1986) that 
the solubility of soluble drugs depends on the solubility of 13-cyclodextrin. The 
solubility of propranolol hydrochloride is almost 2.5 times more than that of 
ß-cyclodextrin. 
8.6 WATER UPTAKE BY WAFERS CONTAINING ß-CYCLODEXTRIN. 
LACTOSE OR 1: 1 HYDROXYPROPYLMETHYLCELLULOSE : ß- 
CYCLODEXTRIN OR LACTOSE 
Since the water uptakes of polymers or excipients could affect drug release, 
DSC was used to evaluate and determine the uptake of water into matrices 
containing ß-cyclodextrin alone or its admixture with HPMC in the ratio 1: 1. 
For comparison, the water uptakes of lactose and 1: 1 HPMC : lactose were 
also determined. 
(274) 
8.6.1 Experimental 
8.6.1.1 Materials 
ß-cyclodextrin (<105 pm), HPMC K4M and lactose (<105 pm) were used as 
described in section 2.1. 
8.6.1.2 Preparation of wafers 
Wafers containing approximately 10 mg of 13-cyclodextrin, 1: 1 ß-cyclodextrin 
: HPMC, lactose, or 1: 1 lactose : HPMC were made and tested as described 
in section 2.2.2.4. 
8.6.1.3 Methodology 
The water uptake was determined according to the methods described in 
section 2.2.2.4. 
8.6.2 Results and discussion 
Figure 8.5 shows the mean values (mg) for the bound water from discs 
containing 10 mg HPMC K4M, ß-cyclodextrin, lactose, 1: 1 HPMC : ß- 
cyclodextrin and 1: 1 HPMC : lactose at ambient as a function of time. These 
results show that the water uptake by HPMC was faster than with the other 
samples. Mixtures of 1: 1 HPMC : ß-cyclodextrin or 1: 1 HPMC : lactose 
hydrated in a manner intermediate to the individual materials. An initial 
rapid water uptake occurred in the ß-cyclodextrin-HPMC wafers that slowed 
down after 5 minutes. Similar behaviour was obtained from discs containing 
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HPMC and ethylcellulose (section 7.6). As mentioned before, the increase in 
water uptake might be due to the ease of penetration of water to these 
wafers. Replacement of lactose instead of A-cyclodextrin slowed down the 
water uptake by the wafers. This was probably due to the greater solubility 
of lactose compared to ß-cyclodextrin which prevents water from being 
absorbed by the HPMC. 
Tukey's test on the data from wafers containing HPMC K4M, ß-cyclodextrin, 
lactose, 1: 1 HPMC : ß-cyclodextrin and 1: 1 HPMC : lactose was carried out. 
There were generally significant differences between the melting enthalpies 
after 1,5,15 or 30 minutes of contact with water (p<0.05) with the exceptions 
that, no significant differences were observed at 1 and 5 minutes between 
HPMC and 1: 1 HPMC : ß-cyclodextrin and there were also no significant 
differences at 1,15 or 30 minutes between ß-cyclodextrin and lactose. 
The water uptake from wafers containing 1: 1 mixture of HPMC: ß-cyclodextrin 
was greater than predicted from the uptake of the individual polymers. This 
was similar to that of HPMC : ethylcellulose wafers which was discussed in 
section 7.6.2. The 1: 1 HPMC : lactose showed different behaviour to the 1: 1 
HPMC : ß-cyclodextrin wafers. The water uptake from wafers containing 1: 1 
HPMC lactose was less than predicted. This difference might be due to the 
different characteristics of the two ingredients. Since ß-cyclodextrin is less 
soluble than lactose, when it is mixed with HPMC, there would be less 
competition to absorb water. In a mixture of HPMC and lactose, the lactose 
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Figure 8.5: The effect of time on the amount of water bound by 10 mg discs 
containing HPMC K4M (a), ß-cyclodextrin (0), lactose (x), 1: 1 HPMC : ß- 
cyclodextrin (i), 1: 1 HPMC : lactose (A) from an unbound 10 mg quantity 
of distilled water at ambient. Results are the means t SD of three 
determinations. 
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retards the uptake of water by HPMC due to its own high solubility, 
presumably increases the tortuosity of the hydrating gel. 
8.7 CONCLUDING REMARKS 
Although the drug release from HPMC matrices containing the physical 
mixture of propranolol hydrochloride and ß-cyclodextrin was fast, it was 
slower than from those matrices containing the complex at the same 
conditions. The dissolution profiles of these matrices decreased as the ß- 
cyclodextrin increased. This fact is attributed to increase in surface area of 
the matrices which was caused by increasing the amount of ß-cyclodextrin in 
the matrices. Replacement of lactose instead of ß-cyclodextrin at the same 
content showed slightly faster release than matrices containing ß- 
cyclodextrin. The solubility of propranolol hydrochloride decreased in the 
presence of ß-cyclodextrin. When they were mixed with HPMC, their water 
uptakes were dependent on their solubilities. 13-Cyclodextrin facilitated the 
penetration of water into the discs containing 1: 1 HPMC : 13-cyclodextrin. 
This was similar to the water uptake of discs containing 1: 1 HPMC 
ethylcellulose. 
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CHAPTER 9 GENERAL DISCUSSION 
9.1 INTRODUCTION 
During the last two decades, cellulose ethers have become popular as the 
basis for use as controlled-release dosage forms. Their ease of compression, 
non-toxic nature, their ability to accommodate a large percentage of drug 
and the negligible influence of processing variables on the release from their 
matrices are some of the reasons for their popularity (Doelker, 1987). 
Hydroxypropylmethylcellulose (HPMC) and sodium carboxymethylcellulose 
(NaCMC) are the most popular cellulose ethers and were selected for this 
study. Three different viscosity grades of NaCMC namely NaCMC 
(Blanose), NaCMC (P 800) and NaCMC (P 350) were investigated as well 
as ethylcellulose, which is a hydrophobic polymer, and 13-cyclodextrin as 
adjuncts to provide sustained release of propranolol hydrochloride from oral 
matrix systems. 
Propranolol hydrochloride, a non-selective ß-blocker antihypertensive drug, 
has a short elimination half life of three hours and an extensive saturable 
first-pass hepatic metabolism, which make it a suitable candidate to be 
delivered at a controlled rate (Martindale, The Extra Pharmacopoeia, 1993). 
Matrix delivery systems are finding increasing application in the areas of 
controlled-release of pharmaceutical due to their potential use as simple 
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inexpensive devices capable of releasing a drug at a controlled rate. One 
disadvantage of matrix system is that it can not produce zero-order drug 
release (Baveja et al, 1987; Grass and Robinson, 1990). The release profiles 
of freely soluble drugs from hydrophilic matrix systems normally follow a 
square root of time relationship, i. e., the release rate decreases with time 
(Ranga Rao and Padmalatha Devi, 1988). This fact has been proven by 
many researchers (Ford et al, 1985b; Baveja et al, 1988a; Mitchell et al, 
1993a; Perez-Marcos et al, 1994) who showed that the release of propranolol 
hydrochloride from matrices containing HPMC was dependent on the 
square root of time and did not produce zero-order release. Since zero-order 
release of a drug is the most appropriate release pattern (Baveja, 1987; 
Silber et al, 1988), attempts were made to formulate propranolol 
hydrochloride to give a zero-order release by using combinations of 
polymers. The main aim was to find out under which circumstances and to 
what extent varying the ratio of polymers could be of assistance in 
controlling drug release and providing a zero-order release. 
9.2 RELEASE MECHANISMS OF PROPRANOLOL HYDROCHLORIDE 
FROM MATRICES CONTAINING ONE POLYMER 
9.2.1 HPMC K4M matrices 
Initially propranolol hydrochloride (160 mg) was formulated into matrices 
containing 57,71,95,140 or 285 mg HPMC K4M. The release rates 
decreased as the polymer content increased. This finding is similar to the 
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findings of Ford et al (1985b), Ranga Rao et al (1990) and Mitchell et al 
(1993a). Matrices containing only HPMC K4M provided a sustained release 
of propranolol hydrochloride which was dependent on the square root of 
time where the correlation coefficients were > 0.997 for the release data. 
This confirmed the reports of Ford et al (1985a, b) and Baveja et al (1988a) 
who claimed that drug release from HPMC matrices followed square root 
of time relationships. 
Two mathematical models were used to calculate release exponents (n) 
from matrices containing HPMC K4M. Equation 1.2 (Q=K2(t-1)°) produced 
by Ford et al (1991) gave lower sum of squares of errors compared with the 
simple equation 1.1 (Q=Kt°) produced by Korsmeyer et al (1983a). Thus 
equation 1.2, which included a lag time, best described the release of 
propranolol hydrochloride from matrices containing HPMC K4M. The 
results confirmed the findings of Ford et al (1991) who stated that a lag 
time must be used when determining release exponents. 
The values of release exponent (n) from matrices containing different 
amounts of HPMC K4M were in the range of 0.59 and 0.69, indicating that 
the release of propranolol hydrochloride was controlled by diffusion and 
erosion of the matrix. Ford et al (1987) and Ranga Rao et al (1990) reported 
similar values of n of 0.64 and 0.63 for propranolol hydrochloride release 
from matrices containing HPMC K15M and HPMC K4M matrices, 
respectively. 
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It is generally thought that HPMC matrices are physico-chemically inert. - 
However, cloud point determination showed that an interaction took place 
between HPMC and propranolol hydrochloride. It was observed that adding 
propranolol hydrochloride to HPMC gels caused an increase in the cloud 
point, which suggests that the solubility of HPMC was increased and/or less 
water was required for its hydration. Mitchell et al (1993a) demonstrated 
that factors such as the cloud point of the HPMC K15M may influence the 
performance and properties of the gel layer around the matrix and 
subsequently modify the drug release. Therefore, increase in solubility of 
HPMC by adding propranolol hydrochloride would cause faster formation 
of a gel layer, which is necessary for achieving controlled release. These 
results were in agreement with reports of Rassing (1985) and Rassing and 
Davis (1986) who reported that water penetration into HPMC matrices was 
faster if drugs or detergents were present. 
Using differential scanning calorimetry (DSC), it was observed that 100 g 
HPMC K4M required 6.4 ± 0.3 moles of water for full hydration (12.3 t 0.5 
moles water per PRU). This result was different from those results obtained 
by Ford and Mitchell (1995) and Joshi and Wilson (1993). The reason for 
the difference between the results from water distribution test in this study 
and those obtained by Ford and Mitchell (1995) (8.5 moles water per PRU) 
and Joshi and Wilson (1993) (6.2: t 1.3 moles water per PRU) could be due 
to different polymer types and the concentration of the gels previously 
examined (section 4.4). However, DSC clearly showed that when propranolol 
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hydrochloride was added to HPMC K4M gels, the water required for full 
hydration of polymer decreased. This was in agreement with the several 
findings of Ford and Mitchell (1995). 
It is well known that the most important factor in drug release is the water 
uptake of the polymers which relates to the rate at which the gel layer 
forms around the matrix (Ford and Mitchell, 1995). DSC was used to 
determine the water uptake of HPMC at ambient and at 37°C. It was 
observed that HPMC wafers after 30 minutes contact with water at 37°C, 
absorbed 29% more water than at ambient. 
In conclusion, dissolution of propranolol hydrochloride from HPMC matrices 
is controlled or characterized by: 
* both diffusion and erosion mechanisms (0.59 <n<0.69), 
* the increased solubility of HPMC caused by the addition of 
propranolol hydrochloride. 
9.2.2 NaCMC matrices 
The release data obtained from the different viscosity grades of NaCMC, 
indicated that NaCMC behaved differently to HPMC. As the polymer 
content increased, the release kinetics of the drug became more dependent 
on time rather than the square root of time. Since most of formulations in 
this study were dependent on the square root of time, the release rates for 
NaCMC matrices were calculated based on square root of time. 
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Matrices containing 57 or 71 mg NaCMC disintegrated during the 
dissolution testing whereas matrices containing HPMC of similar content 
did not. This fact could be due to the higher solubility of NaCMC compared 
with HPMC (Klug, 1971; Doelker, 1987). However, the strong interaction 
between propranolol hydrochloride and NaCMC might be the main reason 
for the disintegration of matrices with low polymer content. In section 5.3.3 
it was shown that as the NaCMC content decreased, the ability of 
propranolol hydrochloride to occupy the sites occupied by sodium atoms in 
the PRU of NaCMC increased. Therefore, in matrices with low polymer 
content, the whole polymer in the matrix could bind to the propranolol and, 
due to the insolubility of the produced mass, the matrix disintegrated. 
The effects of the viscosity grade of polymers on drug release from 
compressed delivery systems have been studied by various researchers 
(Huber and Christenson, 1968; Lapidus and Lordi, 1968; Alderman, 1984; 
Ford et al, 1985a, b; Baveja et al, 1988a; Wan et al, 1991; Colombo et al, 
1992 and Cheong et al, 1995). The viscosity of a polymer solution is an 
indication of its molecular weight. Alderman (1984) claimed that increasing 
the molecular weight of a polymer in matrix formulations increases the gel 
layer formed at the surface of the matrix and therefore made it more 
resistant to erosion. However, as the viscosity. of NaCMC increased (the 
rank order of viscosity was NaCMC Blanose> NaCMC P 800> NaCMC P 
350) the release rate, into water, from matrices containing 285 mg polymer 
decreased from 5.2% min "2(for NaCMC P 350) to 3.1 % min' '"a (for NaCMC 
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Blanose). Therefore, it could be concluded that the viscosity grades of 
NaCMC affected the drug release. This behaviour was found to be in 
contrast to HPMC matrices, e. g., Ford et al (1985a) examined HPMC K100, 
HPMC K4M, HPMC K15M and HPMC K100M and reported that HPMC 
K100 (low viscosity grade) gave the highest release rate of propranolol 
hydrochloride whereas the other three grades, which had higher viscosities, 
behaved similarly. Bonferoni et al (1992) also confirmed the finding of Ford 
et al (1985a) about matrices containing HPMC and meanwhile claimed that 
the viscosity of NaCMC affected drug release. 
It was observed that the initial burst of drug release, which was seen in the 
case of HPMC matrices (figure 3.11), was suppressed by using NaCMC of 
equivalent content. This finding was similar to that of Padmalatha Devi et 
al (1989) who showed that tablets containing NaCMC, with or without 
HPMC, lacked an initial burst release of drug. This fact probably is due to 
the ability of NaCMC to interact with propranolol hydrochloride and 
produce an insoluble complex. 
The release data from matrices containing NaCMC were fitted into equation 
1.1 (Q=Kt°). As the polymer content increased the value of release exponent 
increased. Matrices with low polymer content (57,71 and 95 mg), due to 
their fast release, did not generate enough release data to allow estimation 
of the release mechanisms. Matrices containing 285 mg NaCMC (Blanose, 
P 800 and P 350) gave near zero order release (1.18 >n>1.05) and the 
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viscosity of polymer did not appear to affect the value of n. When the 
polymer content decreased from 285 mg (i. e., 140 or 95 mg) the effect of 
viscosity grade of NaCMC on the value of n was clearly observed. Although 
the values of the release exponents from matrices containing 285 mg 
NaCMC alone were in a range indicating near zero-order release into water, 
fast release of drug from these matrices into 0.1 M hydrochloric acid 
indicated that the matrices containing NaCMC alone were unsuitable. 
Using differential scanning calorimetry (DSC), it was shown that 100 g 
NaCMC (Blanose) required a minimum 6.0 ± 0.4 moles water per 100 g of 
polymer for full hydration. It seems that NaCMC probably requires less 
water for hydration than HPMC. 
When propranolol hydrochloride was added to NaCMC gels, a precipitate 
was produced, indicating an interaction between them and possibly the 
formation of a complex. The formation of the complex was confirmed by 
DSC and dialysis. DSC showed a weak interaction between propranolol 
hydrochloride and NaCMC in their physical mixture and strong interaction 
following addition of water to the physical mixture. 
A study on the erosion of the matrices confirmed that those containing 
NaCMC showed a faster erosion compared to HPMC matrices. This was in 
agreement with the findings of Bonferoni et al (1992). When propranolol 
hydrochloride was added to the matrices containing NaCMC, it provided a 
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reduction in erosion which was probably due to the insolubility of the 
complex formed between NaCMC and propranolol hydrochloride. The 
importance of this interaction between propranolol hydrochloride and 
NaCMC was proved by replacing propranolol hydrochloride by lactose, 
which is soluble and does not interact with NaCMC. This resulted in an 
increase in the rate of erosion of the matrices. 
To confirm the role of erosion in matrices, the release of sodium ions from 
matrices containing NaCMC and also various matrices (1: 1 HPMC : 
NaCMC, NaCMC : propranolol hydrochloride, NaCMC : lactose) was 
determined. The addition of propranolol hydrochloride or lactose to NaCMC 
caused an increase in the release of sodium ions. The probable reasons for 
the increases in sodium release by both propranolol and lactose are 
different. Propranolol hydrochloride, due to the formation of its complex 
with NaCMC, would facilitate the release of sodium ion whereas, the 
addition of lactose, due to its solubility, increased the porosity of matrices. 
The increased porosity eased the penetration of water and subsequently 
increased the erosion of matrices containing lactose and NaCMC. 
In conclusion, dissolution of propranolol hydrochloride from NaCMC 
matrices is controlled or characterized by: 
* formation of a complex between NaCMC and propranolol 
hydrochloride, 
*a wide range of release exponents (0.33 <n<1.18), 
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* the viscosity grade of NaCMC, 
*a reduction in erosion of matrices. 
9.2.3 Ethylcellulose matrices 
Matrices containing ethylcellulose had different characteristics to matrices 
composed of HPMC or NaCMC. As the polymer content increased from 95 
to 285 mg the release exponent (0.49 >n>0.44) remained almost 
unchanged, indicating that the polymer content did not affect the 
mechanisms of drug release from ethylcellulose matrices. This was in 
contrast to matrices containing of HPMC or NaCMC. The release 
mechanism from matrices containing ethylcellulose was via diffusion. 
Similar results from matrices containing propranolol hydrochloride 
ethylcellulose 14 cP in the ratios of 10: 90,30: 70 and 50: 50% w/w were 
reported by Sangavi and Shiravandekar (1994). The smaller particle size 
and the lowest viscosity grade of ethylcellulose gave the slowest release 
rate. This was in agreement with the findings of Upadrashta et al (1993). 
Compaction pressure up to 39.4 MNni 2 affected the release rates whereas 
from 78.7 to 393.7 MNm 2 did not. This was attributed to the high porosity 
of the matrices at low compaction pressure which facilitated the penetration 
of water into the matrices. 
Water uptake by ethylcellulose discs were very low (13.6%) compared to 
HPMC discs (63.6%) after 30 minutes of contact with water (table 7.6). Good 
(1981) stated that polymers which do not absorb significant amounts of 
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solvent are thought to release their enclosed drug via a pure diffusion 
mechanism involving a thin diffusion layer near the polymeric surface. The 
data perhaps supports the role of diffusion in ethylcellulose matrices. 
In conclusion: 
* the release mechanism was by diffusion ( 0.49 >n>0.44), 
* the polymer content did not affect the release mechanism, 
* the small particle size and the lowest viscosity grado of 
ethylcellulose gave the slowest release rate of propranolol 
hydrochloride. 
* compaction pressure did not affect the release rate, 
* the water uptake by ethylcellulose was very low. 
9.3 RELEASE MECHANISMS OF PROPRANOLOL HYDROCHLORIDE 
FROM MATRICES CONTAINING TWO POLYMERS 
9.3.1. Matrices containing HPMC : NaCMC 
One interesting characteristic of gels containing admixtures of HPMC and 
NaCMC is undoubtedly the synergistic increase in the viscosity of their gels. 
Baveja & Ranga Rao (1986) were the first to suggest the use of these 
properties, by combining both anionic (NaCMC) and non-ionic (FHPMC) 
cellulose ethers in matrix tablets, to produce a zero order release of soluble 
drugs. 
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A zero-order release of propranolol hydrochloride was generally not 
produced by matrices containing only NaCMC or HPMC. Therefore 
propranolol hydrochloride was used in matrices at different ratios of HPMC 
and NaCMC. Near zero-order release was only achieved within a narrow 
range of HPMC : NaCMC ratios. 
As mentioned before, the release exponent from matrices containing 
different amounts of HPMC K4M was in the range of 0.59 and 0.69 
whereas, the release mechanism from matrices containing NaCMC or its 
mixture with HPMC was very complicated and dependent on the polymer 
content. Similar observations were reported by Ranga Rao et al (1990). 
Bonferoni et al (1992), using salbutamol sulphate incorporated in mixtures 
of three viscosity grades of HPMC (HPMC K4M, HPMC K15M and HPMC 
K100M) and two viscosity grades of NaCMC (Blanose 7LFD and Blanose 
7HFD), similarly reported complex release mechanisms from matrices 
composed of admixtures of HPMC and NaCMC. 
The gels containing the various grades of NaCMC, had higher viscosities 
compared to those of HPMC K4M gels of similar concentrations. No 
relationship existed between the release rates from matrices containing 
HPMC and NaCMC of similar content. In mixtures containing HPMC and 
NaCMC, the viscosities of gels in the range of 0.0 - 0.05% w/w were 
intermediate between those of the two individual polymers, indicating that 
at low polymer content there was probably little interaction between the 
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polymer molecules. For gels containing 0.1 - 0.5% w/w polymer, the 
viscosities increased with increase in the proportion of NaCMC (Blanose) 
and were higher than produced from gels of HPMC or NaCMC alone. The 
increase in viscosities from gels containing admixtures of the two polymers, 
clearly showed that a synergistic increase in viscosity occurred above a 
critical concentration. 
The cloud points in gels containing 1: 1 HPMC : NaCMC was lower than 
from HPMC gels of similar concentration while gels containing NaCMC did 
not show any cloud points below 75°C. The decrease in cloud point was 
attributed to an interaction between the carboxyl groups of NaCMC and the 
hydroxyl groups of HPMC which provided a competition for the distribution 
of water in the gels. 
In conclusion, the most important factors affecting dissolution of propranolol. 
hydrochloride from matrices containing both HPMC and NaCMC were: 
* the increase in viscosity of gels containing HPMC and NaCMC due 
to the interaction between them, 
* the insoluble complex formed by the interaction between NaCMC 
and propranolol hydrochloride, 
* the HPMC : NaCMC used in the matrix, 
* the viscosity grade of NaCMC. 
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9.3.2 Matrices containing HPMC : ethylcellulose 
In the matrices containing HPMC K4M : ethylcellulose, as the proportion 
of ethylcellulose increased the release rates gradually increased. The values 
of the exponent n from matrices containing HPMC : ethylcellulose in the 
ratios of 1: 0,3: 1,1: 1 and 1: 3 appeared not to vary from the range of 0.59. 
0.61, indicating that both diffusion of the drug and the erosion of the 
matrix, contributed to the release of propranolol hydrochloride. 
The water bound to discs containing 1: 1 HPMC : ethylcellulose at initial 
stages of contact with water was high, possibly due to the increase in 
permeability of wafers containing 1: 1 HPMC : ethylcellulose caused by 
ethylcellulose. However, after 15 minutes of contact with water, wafers 
containing HPMC absorbed more water than their 1: 1 mixture. 
In conclusion, 
* the ratio of 1: 3,1: 1 or 3: 1 ethylcellulose : HPMC did not change 
the release mechanism (0.59 <n>0.61), 
* addition of ethylcellulose to HPMC caused an increase in 
permeability of the matrices, 
* wafers containing 1: 1 HPMC : ethylcellulose absorbed water more 
than predicated. 
9.3.3 Matrices containing NaCMC : ethylcellulose 
In contrast to matrices containing HPMC : ethylcellulose, major differences 
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in drug release were observed on changing the NaCMC : ethylcelluloso 
ratio. At the ratio of 3: 1 NaCMC : ethylcellulose, a value of 1.45 for the 
release exponent was obtained, indicating super case II transport. Some 
studies postulated that such high values are due to the high swelling nature 
of a polymer (Ranga Rao et al, 1988a; Bain et al, 1991). This swelling 
nature is caused by the addition of ethylcellulose to NaCMC, while 
ethylcellulose alone did not swell. Addition of ethylcellulose into NaCMC 
matrices possibly would increase the porosity of the matrix tablets and the 
matrices would swell quickly on contact with water, because the penetration 
of water into matrices was facilitated. 
Since the data obtained from matrices containing NaCMC alone and the 1: 3 
NaCMC : ethylcellulose ratio did not fit into equation 1.2 (see section 3.2.2), 
equation 1.3 (Q=Kt+C) was used for comparison of release rates from 
matrices. It was observed that as the proportion of ethylcellulose increased 
upto 75% of the polymer content, the release rates increased. 
In conclusion 
* addition of ethylcellulose to NaCMC, increased the permeability of 
its matrices and subsequently the matrices swelled rapidly, 
* replacement of NaCMC by ethylcellulose in the matrices, decreased 
the interaction between propranolol hydrochloride and NaCMC and 
subsequently increased the release rate of drug. 
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9.4 MATRICES CONTAINING HPMC : ß-CYCLODEXTRIN 
It was hoped that the formation of a complex of propranolol hydrochloride 
and ß-cyclodextrin, due to the increase in molecular weight and size of the 
complex compared with propranolol hydrochloride, would reduce the release 
of propranolol hydrochloride from HPMC matrices. Drug release from 
tablets containing the physical mixture of ß-cyclodextrin and propranolol 
hydrochloride was fast, but was slower than from tablets containing the 
complex of 13-cyclodextrin and propranolol hydrochloride (section 8.3). 
The dissolution rates of propranolol hydrochloride (80 mg) incorporated in 
matrices containing 160 mg HPMC K4M and 0,0.25,0.5 and 1 molar ratios 
of ß-cyclodextrin, decreased as the ß-cyclodextrin content increased. This 
was attributed to the increase in the surface area of the matrices. 
Replacement of ß-cyclodextrin by lactose in matrices led to slightly faster 
release rates than equivalent 13-cyclodextrin content. This fact probably is 
due to the increase in the porosity of the matrices containing HPMC and 
lactose. 
The values of release exponents from all matrices containing HPMC K4M 
and ß-cyclodextrin or lactose, were between 0.60 - 0.62, suggesting that the 
release of propranolol hydrochloride is controlled by both diffusion of the 
drug through the hydrated matrix and the erosion of the matrix itself 
(Peppas and Sahlin, 1989). This result was similar to findings of Ford et al 
(1987) who investigated the effect of adding soluble or insoluble excipients 
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in HPMC matrices and reported that despite the vast differing solubility 
between used materials, the release exponent did not change. Drug release 
from matrices containing HPMC K4M and the complex of propranolol-ß- 
cyclodextrin was slightly faster than from samples containing HPMC K4M 
and the equivalent physical mixture of propranolol hydrochloride and 13- 
cyclodextrin, indicating that drug release from the physical mixture and the 
complex were also similar. This was contrary to the assumption that a big 
molecule of complex would reduce drug release. 
Water uptake determination by wafers containing 13-cyclodextrin, lactose, 
1: 1 HPMC K4M : ß-cyclodextrin or 1: 1 HPMC : lactose, showed that lactose 
and 13-cyclodextrin had the lowest water uptake due to their high 
solubilities. When they were mixed with HPMC, ß-cyclodextrin caused 
HPMC to absorb more water while lactose prevented it from absorbing 
water. 
In conclusion, 
* the incorporation of ß-cyclodextrin or lactose into the matrices 
decreased the release rates of propranolol hydrochloride, 
* admixture of 13-cyclodextrin with HPMC increased the 
amount of water taken up initially while the admixture of 
lactose with HPMC caused less water than expected to be 
taken up. 
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9.5 EFFECT OF pH ON DRUG RELEASE 
Since a tablet is first introduced into the acidic medium of stomach, the 
influence of pH on drug release must not be ignored. Therefore, the release 
of propranolol hydrochloride from matrices containing HPMC : NaCMC in 
different media was investigated. The release rates of propranolol 
hydrochloride from matrices containing 285 mg HPMC showed slight 
increases when dissolution media was changed from distilled water to 0.1 
M hydrochloric acid, whereas a significant increase in release rates from 
matrices containing solely NaCMC were observed. This fact was attributed 
to the insolubility of NaCMC at acidic media. As mentioned before, drug 
release from matrices containing NaCMC in 0.1 M hydrochloric acid was 
very fast and more than 70% of drug released within 2 hours and all drug 
released during 3 hours. However the data suggested that matrices 
containing NaCMC alone are not suitable for soluble drugs. A similar 
statement was made by Ranga Rao et al (1988a) who claimed that NaCMC 
alone is not an ideal polymer to prepare sustained release matrix 
formulations. 
Only slight differences in the release rates of propranolol hydrochloride 
from matrices containing different viscosity grades of NaCMC admixture 
with HPMC was observed into 0.1 M hydrochloric acid. This fact indicates 
that the interaction between propranolol hydrochloride and NaCMC, due to 
the insolubility of NaCMC at 0.1 M hydrochloric acid, could not occur. These 
matrices (1: 1 HPMC : NaCMC) showed a significant difference in release 
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rates into distilled water, indicating that the synergistic increase in 
viscosity of gels containing HPMC and NaCMC only occurred in distilled 
water. 
As the pH increased, the difference between release of drug from matrices 
with different viscosity grades of NaCMC was more obvious. The reason for 
this difference might be due to the solubility of propranolol hydrochloride 
which has a pKa of 9.5 (Clark's Isolation and Identification of Drugs, 1986). 
Therefore, the solubility of propranolol hydrochloride will decrease as the 
pH of medium increases. Thus, the drug release would be reduced. Similarly 
the NaCMC would become ionized and the differences in viscosity grade 
could be reflected in changes in dissolution rate. 
In conclusion, 
* the interaction between propranolol hydrochloride and 
NaCMC was at its minimum into 0.1 M hydrochloric acid, 
* the solubility of propranolol hydrochloride was at its minimum into 
borate buffer solution pH 9.4, 
* the interaction between propranolol hydrochloride and NaCMC was 
at its maximum into distilled water or at higher pHs. 
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CHAPTER 10 CONCLUSIONS AND RECOMMENDATIONS FOR 
FURTHER WORK 
10.1 CONCLUSIONS 
Hydroxypropylmethylcellulose and sodium carboxymethylcellulose as 
hydrophilic polymers, ethylcellulose as a hydrophobic polymer and 13- 
cyclodextrin as an adjunct were used in the preparation of matrix tablets 
to examine sustained release ofpropranolol hydrochloride, as a model water 
soluble drug. 
Zero-order release of propranolol hydrochloride was obtained from matrices 
containing 285 mg polymer at the 3: 1 ratio of NaCMC (Blanose) : HPMC 
K4M. The reason for this might be related to factors such as the interaction 
between propranolol hydrochloride and NaCMC and the synergistic increase 
in the viscosity of gels containing admixtures of HPMC and NaCMC. 
Viscosity determination took place in a concentration range which would be 
found when matrices had completely dissolved into 1000 mL dissolution 
media. A synergistic increase in viscosity of gels containing HPMC and 
NaCMC occurred above a certain concentration. Addition of propranolol 
hydrochloride to HPMC caused an interaction which increased the cloud 
point and salted-in HPMC. Addition of propranolol hydrochloride to 
NaCMC, produced a precipitate which made matrices more resistant to 
(298) 
erosion. 
Although it is generally thought that HPMC or NaCMC are inert and free 
from problems, this study showed interactions occurred between HPMC or 
NaCMC and propranolol hydrochloride. NaCMC matrices alone were not 
suitable for producing a sustained release of propranolol hydrochloride, 
because when at low pHs, failure to provide controlled release was 
apparent. 
Differential scanning calorimetry was used to determine of water uptake by 
the polymers. The water uptake of wafers containing HPMC, NaCMC and 
their 1: 1 mixture was high, whereas the water uptake of ethylcellulose was 
very low. The effect of addition of ethylcellulose, ß-cyclodextrin and lactose 
on water uptake from wafers containing HPMC was investigated. Both 
ethylcellulose and ß-cyclodextrin caused HPMC to absorb more water while 
lactose prevented it from absorbing water. 
10.2 RECOMMENDATIONS FOR FURTHER WORK 
1. Since the addition of propranolol hydrochloride to NaCMC produced a 
complex, further investigation of this complex is recommended. Possibly a 
particular ratio of NaCMC : propranolol hydrochloride will produce a solid 
which may be appropriate for the sustained release of propranolol 
hydrochloride. 
(299) 
2. In this study only matrices made by direct compression were 
investigated. Wet granulation, producing the complex of propranolol-CMC 
prior to dissolution, might lead a desirable formulation, therefore 
preparation of matrices using wet granulation from HPMC, NaCMC and 
propranolol hydrochloride for future studies is recommended. 
3. Hydrophobic cyclodextrin derivatives such as ethylated ß-cyclodextrin 
are reported to be useful as slow-release carriers for water-soluble drugs 
such as diltiazem hydrochloride (Horiuchi et al, 1990) and isosorbide 
dinitrate (Hirayama et al, 1988). Therefore the release of propranolol 
hydrochloride from ethylated ß-cyclodextrin should be investigated prior to 
possible inclusion into HPMC matrices. 
4. The extension of this study to other drugs which are not hydrochloride 
salts and do not react with NaCMC should be investigated. 
5. Non-ionizable drugs could allow a thorough investigation of the influence 
of blends containing NaCMC and HPMC in matrix tablets. 
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APPENDIX 1 
BUFFER SOLUTIONS FORMULAE 
The following buffers were prepared for the dissolution tests determined in 
this thesis. 
Composition of different buffer solutions used in this study are as follows: 
I- Buffer phosphate pH 6.8 
0.1 M hydrochloric acid 750 mL 
0.2 M tribasic sodium phosphate 250 mL 
0.2 M tribasic sodium phosphate (Na3Po4) was prepared by dissolving 32.79 
g tribasic sodium phosphate in 1 litre distilled water. 
2- Buffer phosphate pH 7.4 
0.2 M monobasic potassium phosphate solution 250 mL 
0.1 M sodium hydroxide 
Water to 
195.5 mL 
1000 mL. 
0.1 M sodium hydroxide was prepared by dissolving 4g sodium hydroxide in 
1 litre distilled water. 0.2 M monobasic potassium phosphate solution 
(KH2Po4) was prepared by dissolving 27.22 g monobasic potassium phosphate 
in 1 litre distilled water. 
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3- Borate buffer pH 9.4 
0.2 M Boric acid and potassium chloride 250 mL 
0.1 M sodium hydroxide 
Water to 
160.5 mL 
1000 mL 
0.2 M Boric acid and potassium chloride were prepared by dissolving 12.37 
g boric acid (H3BO3) and 14.91 g potassium chloride (KCI) separately in 
distilled water, mixed and then diluted with distilled water to 1000 mL. 
The pHs of all buffers were determined by pH meter and adjusted to the 
desired pH, by using 2M hydrochloric acid or 2M sodium hydroxide. 
REFERENCES 
Aggeryd, I., Olin, A. Talanta, 32 (1985) 645-649. 
Aizawa, M., Suzuki, S. Bull. Chem. Soc. Japan 44 (1971) 2967-2971. 
Aizawa, M., Mizuguchi, J., Suzuki, S., Hayashi, S., Suzuki, T., Mitomo, N., 
Toyama, H. Bull. Chem. Soc. Japan 45 (1972) 3031- 3034. 
Alderman, D. A. Int. J. Pharm. Tech. Prod. Mfr. 5 (1984) 1-9. 
Alfery, T. J. Coll. Sci. 2 (1947) 99-114. 
Aoki, S., Ohwaki, T., Uesugi, K., Tatsuishi, K., Ozawa, H., Kayano, M. Int. 
J. Pharm. 85 (1992a) 29-38 
Aoki, S., Uesugi, K, Tatasuishi, K, Ozawa, H., Kayano, M. Int. J. Pharm. 85 
(1992b) 65-73. 
Armstrong, D. W., Ward, T. J., Armstrong, R. D., Beesley, T. E. Science 232 
(1986) 1132-1135. 
Arwidsson, H., Nicklasson, M. Int. J. Pharm. 56 (1989) 187-193. 
Arwidsson, H., Nicklasson, M. Int. J. Pharm. 58 (1990) 73-77. 
Bain, J. C., Tan, S. B., Ganderton, D., Solomon, M. C. Drug Dev. Ind. Pharm. 
17 (1991) 215-232. 
Baker, R. W., Lonsdale, H. K., controlled release: Mechanisms and Rates. in 
Controlled Release of Biologically Active Agents. Ed. Tanquary, A. C., Lacey, 
R. E., Plenum Press, New york, (1974) 15-71. 
Baker, R. W., Introduction, Chapter 1, in Controlled Release of Biologically 
Active Agents. Ed. J. Willey and Sons, New York, (1987a) 1-21. 
Baker, R. W., Materials used in controlled release devices. Chapter 6, in 
Controlled Release of Biologically Active Agents, Ed. J. Willey and Sons. Now 
York (1987b) 156-190. 
Bamba, M., Puisieux, F., Marty, J. P., Carstensen, J. T. Int. J. Pharm. 2 (1979) 
307-315. 
Batdorf, J. B., Rossman, J. M. Sodium carboxymethylcellulose, Chapter 31, in 
" Industrial gums" Polysaccharides and their derivatives. 2°d edition, Ed. 
Whistler, R. L. Academic Press, Inc., New York (1973) 695-727. 
Baveja, S. K., Ranga Rao, K. V., Padmalatha Devi, K. Int. J. Pharm. 27 (1985) 
157-162. 
Baveja, S. K., Ranga Rao, K. V. Int. J. Pharm. 31 (1986) 169-174. 
Baveja, S. K., Ranga Rao, K. V., Padmalatha Devi, K. Int. J. Pharm. 39 (1987) 
39-45. 
Baveja, S. K., Ranga Rao, K. V. Singh, A., Gombar, V. K. Int. J. Pharm. 41 
(1988a) 55-62. 
Baveja, S. K., Ranga Rao, K. V., Padmalatha Devi, K. Int. J. Pharm. 47 
(1988b) 133-139. 
Baveja, S. K., Hassan, A. U., Singh, A. Indian J. Pharm. Sci. Nov. -Dec. (1989) 
248-251. 
Bettini, R., Colombo, P., Massimo, G., Catellani, P. L., Vitali, T. Eur. J. 
Pharm. Sei. 2 (1994) 213-219. 
Bonferoni, M. C., Caramella, C., Sangalli, M. E., Conte, U., Hernandez, R. M., 
Pedraz, J. L. J. Control. Rel. 18 (1992) 205-212. 
Bonferoni, M. C., Rossi, S., Tamayo, M., Pedraz, J. L., Dominguez-Gil, A., 
Caramella, C. J. Control. Rel. 26 (1993) 119-127. 
Bonferoni, M. C., Rossi, S., Tamayo, M., Pedraz, J. L., Dominguez-Gil, A., 
Caramella, C. J. Control. Rel. 30 (1994) 175-182. 
Bonferoni, M. C., Rossi, S., Ferrari, F., Bertoni, M., Caramella, C. Int. J. 
Pharm. 117 (1995) 41-48. 
(xxxi) 
Bonny, J. D., Leuenberger, H. Pharm. Acta Hely. 66 (1991) 160-164. 
Borodkin, S. Tucker, F. E. J. Pharm. Sci. 64 (1975) 1289-1294. 
British Pharmacopoeia. Office of the British Pharmacopoeia Commission, 
London, Vol II, (1993) 554-555. 
British Standard 188. Determination of the viscosity of liquids. British 
standards, Institute, London, 1957. 
Brawn, L., Langer, R. Ann. Rev. Med., 39 (1988) 221-229. 
Bruno, A., Bernardo, P., Boylan, J. Carboxymethylcellulose Sodium, in 
Handbook of Pharmaceutical Excipients, Ed. Pharmaceutical Society of Great 
Britain, London, (1986) 45-48. 
Capan, Y. Drug Dev. Ind. Pharm. 15 (1989) 927-956. 
Catellani, P., Vaona, G., Plazzi, P., Colombo, P. Acta Pharm. Technol. 34 
(1988) 38-41. 
Chandrasekaran, S. K., Wright, R. M., Yuen, M. J. Controlled Release: Status 
and Future prospects. Chapter 1, in Controlled Release Delivery System, Ed. 
Rosenam, T. J., Mansdorf, S. Z., Marcel Dekker, (1983) 1-25. 
Cheong, L. W. S. Heng, P. W. S. Wong, L. F. Pharm. Res. 9 (1992) 1510-1514. 
Cheong, L. W. S. Heng, P. W. S., Wong, L. F. Int. J. Pharm. (1995) 159-168. 
Chien, Y. W., Concepts and system design for rate-controlled drug delivery, 
Chapter 1, in Novel drug delivery systems, Second edition, Revised and 
expanded, Ed. Chein, Y. W. Marcel Dekker, New York, (1992) 1-42, 
Clark's isolation and identification of drugs, 2nd edition. Ed. Moffatt, A. C., 
The Pharmaceutical Society of Great Britain, London, (1986) 936-937. 
Clarke, F. H., Cahoon, N. M. J. Pharm. 5ci. 76 (1987) 611-619. 
Colombo, P., Conte, U., Caramella, C., Gazzaniga, A., LaManna, A. J. Contro. 
Rel., 1 (1985) 283-289. 
(xxxii) 
Colombo, P., Gazzaniga, A., Caramella, C., Conte, U., La Manna, A. Acta 
Pharm. Technol. 33 (1987) 15-20 
Colombo, P., Catellani, P. L., Peppas, N. A., Maggi, L., Conte, U. Int. J. Pharm. 
88 (1992) 99-109. 
Conte, U., Maggi, L., Colombo, P., La Manna, A. J. Control. Rel. 26 (1993) 39- 
47. 
Dahl, T. C., Calderwood, T., Bormeth, A., Trimble, K. J. Control. Rel. 14 
(1990) 1-10. 
Daly, P. B., Davis, S. S., Kennerley, J. W. Int. J. Pharm. 18 (1984) 201-205. 
Danckwerts, M. P. Int. J. Pharm. 112 (1994) 37-45. 
Deasi, S. J., Singh, P., Simonelli, A. P., Higuchi, W. I. J. Pharm. Sei. 11(1966) 
1224-1229. 
Deasy, P. B., Brophy, M. R., Ecanow, B., Joy, M. M. J. Pharm. Pharmacol. 32 
(1980) 15-20. 
Doelker, E., Water-swollen cellulose derivatives in pharmacy, Chapter 5, In 
Hydrogels in Medicine and Pharmacy, Vol. II. Polymers. Ed. 
Peppas, N. A., 
CRC Press, Florida, (1987) 115-161. 
Donbrow, M., Friedman, M. J. Pharm. Sei. 64 (1975) 76-80. 
Dow chemical co. Handbook of Methocell Cellulose Ether Products, 1974. 
Dubernet, C., Rouland, J. C. Benoit, J. P. Int. J. Pharm. 64 (1990) 99-107. 
Duddu, S. P., Vakilynejad, M., Jamali, F., Grant, D. J. W. Pharm. Res. 10 
(1993) 1648-1653. 
Fagan, P. G., Harrison, P. J., Shankland, N. J. Pharm. Pharmacol. 41 (1989) 
25P. 
Feely, L. C., Davis, S. S. Int. J. Pharm. 44 (1988) 131-139. 
(xxxiii) 
Fielden, K. E., Newton, J. M., O'brien, P., Rowe, R. C. J. Pharm. Pharmacol. 40 
(1988) 674-678. 
Ford, J. L., Rubinstein, M. H., Hogan, J. E. Int. J. Pharm. 24 (1985a) 327-338. 
Ford, J. L., Rubinstein, M. H., Hogan, J. E. Int. J. Pharm. 24 (1985b) 339-350. 
Ford, J. L., Rubinstein, M. H., Changela, A., Hogan, J. E. J. Pharm. Pharmacol. 
37 (1985c) 115P. 
Ford, J. L., Rubinstein, M. H., Hogan, J. E. J. Pharm. Pharmacol. 37 (1985d) 
33P. 
Ford, J. L., Rubinstein, M. H., Mc Caul, F., Hogan, J. E., Edgar, P. J. Int. J. 
Pharm. 40 (1987) 223-234. 
Ford, J. L., Timmins, P. Pharmaceutical thermal analysis: techniques and 
applications. Published: Ellis Horwood, Chichester, England, (1989) 
Ford, J. L., Mitchell, K., Rowe, P., Armstrong, D. J., Elliott, P. N. C., Rostron, 
C. and Hogan, J. E. Int. J. Pharm. 71 (1991) 95-104. 
Ford, J. L., Mitchell, K., Sawh, D., Ramdour, S., Armstrong, D. J., Elliott, 
P. N. C., Rostron, C., Hogan, J. E. Int. J. Pharm. 71 (1991a) 213-221. 
Ford, J. L. Mitchell, K. Thermochimica Acta 248 (1995) 329-345 
Gautam, J., Schott, H. J. Pharm. Sci. 83 (1994) 316-321. 
Gedde, U. W. Drug Dev. Ind. Pharm. 16 (1990) 2465-2486. 
Gehrike, S. H., Lee, P. I., Hydrogels for drug delivery systems. Chapter 8 in 
Specialized Drug Delivery Systems, Ed. P. Tyle, (1989) 333-392. 
Giunchedi, P. Maggi, L., LaManna, A., Conte, U. J. Pharm. Pharmacol. 46 
(1994) 476-480. 
Good, W. R. Diffusion of water soluble drugs from initially dry hydrogels. In 
Polymeric delivery systems edited by R. J. Kostelnik Vol. 5 (1981) 139-156. 
(xxxiv) 
Graham, H. D., Baker, Y. M., Njoku-obi, A. N. J. Pharm. Sci. 52 (1963)192-195. 
Grass, G. M. Robinson, J. R. Sustained and controlled release drug delivey 
systems. Chapter 16 in Modern Pharmaceutics 2nd edition, edited by Banker, 
G. S. Marcel Dekker, New York, (1990) 635-671. 
Grerninger, G. K., Krumel, K. L. Alkyl and hydroxyalkylalkylcellulose. Chapter 
3, in handbook of water soluble gums and resins, Ed. Davidson, R. L. 
Academic Press, San Diego, (1980) 1-25. 
Grosse, L. S. T. P. Pharma 6 (1990) 83-86. 
Gurny, R., Doelker, E., Peppas, N. A. Biomaterials, 3 (1982) 27-32. 
Haldankar, G. S., Spencer, H. G. J. Appl. Polym. Sci., 37 (1989) 3137-3146. 
Harland, R. S., Gazzaniga, A., Sangalli, M. E., Colombo, P., Peppas, N. A., 
Pharm. Res. 5 (1988) 488-494. 
Hashim, H., Li Wan Po, A. Int. J. Pharm. 35 (1987) 201-209. 
Heller, J., Fundamentals of polymer science, Chapter 3, in Controlled Drug 
Delivery, Fundamental and Applications, 2°d edition, Revised expansion, Ed. 
Robinson J. R., Lee, V. H. L. Marcel Dekker, Inc. New York (1987a) 139-177. 
Heller, J., Use of polymers in controlled release of active agents. Chapter 4, 
in Controlled Drug Delivery, Fundamental and Applications, 2°d edition, 
Revised expansion, Ed. Robinson J. R., Lee, V. H. L. Marcel Dekker, Inc. New 
York (1987b) 179-212. 
Hernandez, J. I., Ghaly, E. S., Malave, A., Marti, A. Drug Dev. Ind. Pharm. 20 
(1994) 1253-1265. 
Higuchi, T. J. Pharm. Sei. 50 (1961) 874-875. 
Higuchi, T. J. Pharm. Sci. 52 (1963) 1145-1149. 
Higuchi, T., Connors, K. A., Phase-solubility techniques. Adv. Anal. Chem. 
Instrum. Ed. Reilley, C. N., Interscience Publishers, 4 (1965) 117-212. 
(xxxv) 
Higuchi, W. I., Ho, N. F. H., Merkle, H. P. Drug Dev. Ind. Pharm. 9 (1983) 1227- 
1239. 
Hirayama, F., Hirashima, N., Abe, K., Uekama, K., Jjitsu, T., Ueno, M. J. 
Pharm. Sci. 77 (1988) 233-236. 
Hogan, J. E. Drug Dev. Ind. Pharm. 15 (1989) 975-999. 
Horiuchi, Y., Hirayama, F., Uekama, K. J. Pharm. Sei. 79 (1990) 128-132. 
Huber, H. E., Christenson, G. L. J. Pharm. Sei. 57 (1968) 164-166. 
Huggins, M. L. J. Am. Chem. Soc. 764 (1942) 2716-2718. 
Hui, H. W., Rubinson, J. R., Lee, V. H., Design and Fabrication of Oral 
Controlled Release Drug Delivery Systems. Chapter 9, in Controlled Drug 
Delivery, Fundamental and Applications, 2°d edition, Revised expansion, Ed. 
Robinson J. R., Lee, V. H. L. Marcel Dekker, Inc. New York, (1987) 373-432. 
Hussain, A. S., Johnson, R. D., Shivanand, P., Zoglio, M. A. Drug Dev. Ind. 
Pharm. 20 (1994) 2645-2657. 
Johnson, J. L., Holinej, J., Williams, M. D. Int. J. Pharm. 90 (1993) 151-159. 
Joshi, H. N., Wilson, T. D. Proc. Int. Symp. Control. Rel. Bioact. Mater., 19 
(1992) 262-263. 
Joshi, H. N., Wilson, T. D. J. Pharm. Sci. 82 (1993) 1033-1038. 
Kim, S. W., Cardinal, J. R., Wisniewski, S., Zentner, G. M., Solute permeation 
through hydrogel membranes. Chapter 20, in Water in polymers, ACS 
Symposium Series 127; American Chemical Society, Washington, DC, (1980) 
347-359. 
Klug, E. D. J. Polym. Sci. 36 (1971) 491-508. 
Knuth, K., Mansoor, A., Robinson, J. R. Advanced Drug Delivery Reviews, 11 
(1993) 137-167. 
Korsmeyer, R. W., Gurney, R., Doelker, E., Buri, P., Peppas, N. A. Int. J. 
(xxxvi) 
Pharm. 15 (1983a) 25-35. 
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., Peppas, N. A. J. Pharm. 
Sei. 72 (1983b) 1189-1191. 
Korsmeyer, R. W., Diffusion controlled systems: hydrogels, Chapter 2, in 
Polymer for controlled drug delivery, Ed. J. Tarcha, CRC Press, (1983) 15-36. 
Korsmeyer, R. W., Peppas, N. A., Swelling-controlled delivery systems for 
pharmaceutical applications: Macromolecualar and modelling considerations, 
in Controlled Release Delivery Systems. Ed. Mansdrof S. Z., Roseman T. J., 
Marcel Dekker, New York, (1983) 77-90. 
Kumar, V., Banker, G. S. Drug Dev. Ind. Pharm. 19 (1993) 1-31. 
Langer, R. Chem. Eng. Commun. 6 (1980) 1-48. 
Lapidus, H., Lordi, N. G. J. Pharm. Sci. 57 (1968) 1292-1301. 
Le Bas, G., Rysanek, N. Structural aspects of cyclodextrins, Chapter 3, in 
Cyclodextrins and their industrial uses, Ed. Duchene, D., Paris (1987) 108- 
132. 
Leung, S. H. S., Robinson, J. R., Lee, V. H. L., Parenteral products, Chapter 10, 
In Controlled Drug Delivery, Fundamentals and Applications, 2°d Edition. Ed. 
Robinson, J. R., Lee, V. H. L., Marcel Dekker, New York, (1987) 433-480. 
Lee, H. B., John, M. S., Andrade, J. D. J. colloid. Interface. Sci. 51 (1975) 558- 
564. 
Lee, H. K., Hajdu, J., McGoff, P. J. Pharm. Sci. 80 (1991) 178-180. 
Li, V. H. L., Robinson, J. R., Lee, V. H. L., Influence of drug properties and 
routes of drug adminstration on the design of sustained and controlled 
release systems. Chapter 1, in Controlled Drug Delivery, Fundamentals and 
Applications, 2°d Edition. Ed. Robinson. J. R., Lee, V. H. L., Marcel Dekker, Now 
York, (1987) 3-94. 
Lilienfeld, L., Chem. Abstracts, 73839 (1913). 
(xxxvii) 
Lin, L. Y., Monaco, A. L., Chowhan, Z., Hydroxpropylmethylcellulose, in 
Handbook of Pharmaceutical Excipients, Ed. Pharmaceutical Society of Great 
Britain, London, (1986) 138-140. 
Lin, S. Y., Amidon, G. L., Weiner, N. D., Goldberg, A. H. Proc. Intern. Symp. 
Control. Rel. Bioact. Mater., 19 (1992) 393-394. 
Lin, S. Y., Perng, R. I. S. T. P. Pharm. Sci. 6 (1993) 465-471. 
Linhardt, R. J., Biodegradable polymers for controlled release of drugs, 
Chapter 2, in Controlled Release of Drugs: Polymers and Aggregated Systems. 
Ed. Rosoff, M., VCH Publishere, Inc. (1989) 53-95. 
Lusciano, L. J., Breech, J. A., Angel, L. A., Franz, R. M. Pharm. Technol. Int. 1 
(1989) 34-46. 
Madan, P. L. Pharmacetical Manufacturing, 1 (1985) 23-27. 
Mannion, R. O., Melia, C. D., Mitchell, J. R., Harding, S. E., Green, A. P. J. 
Pharm. Pharmacol. 42 (1990) 23P. 
Marriott, P. H., John, E. G. J. Pharm. Pharmacol. 25 (1973) 633-639. 
Marriott, C., Rheology and the flow of fluids. In Pharmaceutics: the Science 
of dosage form design. Ed. Aulton, M. E., Churchill Livingstone, (1988) 17-37. 
Martin, A., Swarbrick, J., Cammarata, A., in Physical Pharmacy, 3'd edition, 
Lea and Febiger, Philadelphia, (1983) 522-543. 
Martindale: In Reynold, J. E. F., (Ed)., The Extra Pharmacopoeia, 30`h Edn, 
The Pharamceutical Press, London, (1993) 624-640. 
McKenzie, I. Z., Embrey, M. P. Br. Med. J. 2 (1977) 1381-1384. 
Melia, C. D., Binns, J. S., Davies, M. C. J. Pharm. Pharmacol. 42 (1990) 125P. 
Melia, C. D. Critical Reviews in therapeutic drug carrier systems. 8 (1991) 
395-421. 
The Merck Index, An encyclopedia of chemicals, durgs and biologicals. Ed. 
(xxxviii) 
Budavari, S. Eleventh edition, Merck & Co., Inc. U. S. A. (1989) 2724. 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., Hogan, 
J. E. J. Pharm. Pharmacol. 41 (1989) 59P. 
Mitchell, K., Sogo, T., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., 
Hogan, J. E. J. Pharm. Pharmacol. 43 (1990a) 124P. 
Mitchell, K., Ford, JtL., Armstrong, D. J., Elliott, P. N. C., Rostron, C., Hogan, 
J. E. Int. J. Pharm. 66 (1990b) 233-242. 
Mitchell, K., Sogo, T., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., 
Hogan, J. E. J. Pharm. Pharmaco. 43 (1990c) 127P. 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., Hogan, 
J. E. The effect of electrolytes and drugs on the cloud point of 
hydroxypropylmethylcellulose gels and the dissolution of drugs from 
hydroxypropylmethylcellulose matrix tablets. Pharmaceutical Technology, 
Controlled drug release, Vol. 2, Ed. Wells, J. I., Rubinstein M. H., Ellis 
Horwood Ltd., Chichester, (1991a) 23-33. 
Mitchell, K., Ford, J. L., Rostron, C., Armstrong, D. J., Elliott, P. N. C., Hogan, 
J. E. Presented at the 10th Pharmaceutical Technology conference, Bologna, 
Italy, (1991b). 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Hogan, J. E, Rostron, 
C. Int. J. Pharm. 100 (1993a) 143-154. 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., Hogan, 
J. E. Int. J. Pharm. 100 (1993b) 155-163. 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Hogan, J. E, Rostron, 
C. Int. J. Pharm. 100 (1993c) 165-173. 
Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Hogan, J. E, Rostron, 
C. Int. J. Pharm. 100 (1993d) 175-179. 
Narisawa, S., Yoshino, H. Hirakawa, Y., Noda, K. Int. J. Pharm. 104 (1994) 
95-106. 
(xxxix) 
Neau, S. H., Shinwari, M. K., Hellmuth, E. W. Int. J. Pharm. 99 (1993) 303- 
310. 
Ohno, H., Shibayama, M., Tsuchida, E. Makromol. Chem., 184 (1983) 1017- 
1024. 
Padmalatha Devi, K. P., Ranga Rao, K. V., Baveja, S. K., Fathi, M., Roth, M. 
Pharm. Res. 6 (1989) 313-317. 
Pagay, S. N. Drug Dev. Ind. Pharm. 14 (1988) 875-894. 
Peppas, N. A., Sahlin, J. J. Int. J. Pharm. 57 (1989) 169-172. 
Peppas, N. A. Pharm. Acta Hely. 60 (1985) 110-111. 
Perez-Marcos, B., Ford, J. L., Armstron, D. J., Elliott, P. N. C., Rostron, C., 
Hogan, J. E. Int. J. Pharm. 111 (1994) 251-259. 
Porter, S. C. Drug Dev. Ind. Pharm. 15 (1989) 1495-1521. 
Prasad, M. P., Kalyanasundaram, M. J. Control. Rel. 27 (1993) 219-225. 
Prescott, L. F., Historical review and perspective of rate control in drug 
therapy, Chapter 1, in Rate Control in Drug Therapy, Ed. Prescott, L. F., 
Nimmo, W. S., Churchill Livingstone, New York, (1985) 1-10. 
Prescott, L. F., The need for improved drug delivery in clinical practice, 
Chapter 1, in Novel Drug Delivery and its Therapeutic Applications. Ed. 
Prescott, L. F., Nimmo, W. S., John Wiley and Sons Ltd., Edinburg (1989) 1-11. 
Rajabi-Siahboomi, A. R., Bowtell, R. W., Mansfield, P., Davies, M. C., Melia, 
C. D. J. Pharm. Pharmacol. (Suppl. ) 45 (1993) 1110. 
Ranga Rao, K. V., Padmalatha Devi, K. Int. J. Pharm. 48 (1988) 1-13. 
Ranga Rao, K. V., Padmalatha Devi, K., Buri, P. Drug Dev. Ind. Pharm. 14 
(1988a) 2299-2320. 
Ranga Rao, K. V., Padmalatha Devi, K., Kubel, F. Buri, P. Proc. Intren. Symp. 
Control. Rel. 15 (1988b) 101-102. 
(xl) 
Ranga Rao, K. V., Padmalatha Devi, K., Buri, P. Proceeding of the APGI 
conference on pharmaceutical Technology, Paris, 5 (1989) 242-249. 
Ranga Rao, K. V., Padmalatha Devi, K., Buri, P. J. Control. Rel. 12 (1990) 
133-141. 
Rao, S. S., Ritschel, W. A. Int. J. Pharm. 86 (1992) 35-41. 
Rassing, J. J. Control. Rel. 1 (1985) 169-175. 
Rassing, J., Davis, S. S. J. Control. Rel. 3 (1986) 131-136. 
Rekhi, G. S., Jambhekar, S. S. Drug Dev. Ind. Pharm. 21 (1995) 61-77. 
Ritger, P. L., Peppas, N. A. J. control. Rel. 5 (1987) 37-42. 
Ritschel, W. A. Drug Dev. Ind. Pharm. 15 (1989) 1073-1103. 
Roy, G. M. Pharm. Technol. Eur. (1994) 24-35. 
Salomon, J. L., Doelker, E., Buri, P. Pharm. Ind. 41 (1979) 799-802. 
Sanghavi, N. M., Shiravadekar, H. S. Pharm. Technol. Conf. France, (1994) 
555-575. 
Sarker, N. J. Appl. Polym. Sei. 24 (1979) 1073-1087. 
Schwartz, J. B., Simonelli, A. P., Higuchi, W. I. J. Pharm. Sci. 57 (1968) 274- 
282. 
Shah, A. C. Design of oral sustained release drug delivery systems: In- 
Vitro/In-Vivo Considerations. Chapter 2, in Oral Sustained Release 
Formulations: Design and Evaluation. Ed. Yacobi, A., Walega, H., Pergamon 
Press, U. K., (1988) 35-56. 
Shaikh, N. A., Abidi, S. E., Block, L. H. Drug Dev. Ind. Pharm. 13 (1987a) 
1345-1369. 
Shaikh, N. A., Abidi, S. E., Block, L. H. Drug Dev. Ind. Pharm. 13 (1987b) 
2495-2518. 
(xIi) 
Shenouda, L. S., Adems, K. A., Zoglio, M. A. Int. J. Pharm. 61 (1990) 127-134. 
Sheskey, P. J., Cabelka, T. D., Robb, R. T., Boyce, B. M. Pharm. Technol. 9 
(1994) 133-150. 
Shivanand, P. Sprockel, O. L. Int. J. Pharm. 92 (1993) 35-45. 
Silber, B. M., Cheung, W. K., Yacobi, A., Utilizing pharmacokinetic principles 
in the design of controlled or sustained release fromulations. Chapter 1, in 
Oral Sustained Release Formulations: Design and Evaluation. Ed. Yacobi, A., 
Walega, E. H., Pergamon Press, U. K., (1988) 1-33. 
Skelly, J. P., Bioavailability of sustained release dosage forms-Relationship 
with in-vitro dissolution, Chapter 3, in Oral sustained release formulations, 
Design and evaluation. Ed. Yacobi, E., Walega, E. H. Pergamon Press, U. K., 
(1988) 57-82. 
Sprockel, O. L., Price, J. C., Jennings, R., Tackett, R. L., Hemingway, S., Clark, 
B., Laskey, R. E. Drug Dev. Ind. Pharm. 15 (1989) 1393-1404. 
Stamm, A., Tritsch J. C. Drug Dev. Ind. Pharm. 12 (1986) 2337-2353. 
Stauffer, D., Introduction to percolation theory. Talor and francis, London 
(1985) 11-13 
Sung, Y. K., Pulse NMR and thermal analysis of water-swelling polymers for 
biomedical and pharmaceutical applications. Polymer (Korea) 10 (1986) 576- 
583 
Sutinen, R., Urtti, A., Raatikainen P., Paronen, P. Proc. Intern. Symp. 
Control. Rel. Bioact. Mater., 19 (1992) 456-457. 
Sutinen, R., Urtti, A., Raatikainen P., Paronen, P. Int. J. Pharm. 92 (1993) 
177-181. 
Szejtli, J. Cyclodextrins and their inclusion complexes. Translated by 
Nogradi, M. and Horvath, K. Akademiai Kiado, Budapost, (1982) 13-235. 
Szejtli, J. Pharm. Technol. Int. $2 (1991) 15-22. 
(xlii) 
Taniguchi, Y., Horigome, S. J. Appl. Polym. Sci. 19 (1975) 2743- 2748. 
Theeuwes, F., Eckenhoff, B., Applications of osmotic drug delivery, in 
Controlled Bioactive Materials, Ed. Baker, R., Academic Press, Inc. New 
York, (1980) 61-82. 
Theeuwes, F., Triggered, pulsed and programmed drug delivery, Chapter 30, 
in Novel Drug Delivery and its Therapeutic Applications. Ed. Prescott, L. F., 
Nimmo, W. S., John Wiley and Sons Ltd., Edinburg (1989) 322-340. 
Tice, T. R., Cowsar, D. R. Pharm. Technol. 8 (1984) 26-36. 
Touitou, E. Donbrow, M. Int. J. Pharm. 11 (1982) 131-148. 
Tucker, I. G., Ahmed, G. H., Stewart, P. J. Aust. J. Hosp. Pharm. 18 (1988) 
196-199. 
Uekama, K., Narisawa, S., Hirayama, F., Otagiri, M. Int. J. Pharm. 16 (1983) 
327-338. 
Uekama, K., Otagiri, M., Cylodextrins in drug carrier systems. CRC Critical 
reviews in therapeutic. Drug carrier systems, 1 (1987) 1-40 
Uekama, K., Matsubara, K., Abe, K., Horiuchi, Y., Hirayama, F., Suzuki, N. 
J. Pharr. Sci. 79 (1990) 244-248. 
Upadrashta, S. M., Katikaneni, P. R., Hileman, G. A., Keshary, P. R. Drug Dev. 
Ind. Pharm, 19 (1993) 449-460. 
USP/NF, The United States Pharmacopoeia / National Formulary (USP23 
/NF18), New York (1995). 
Van Coillie, R., Applications of carboxymethylcell uloso and 
hydroxypropylcellulose in the food industry. in "Gums and stabilisers for the 
food industry 5", edited by Phillips, G. O., Williams, P. A., Wedlock, D. J., IRL 
Press, Oxford University Press, (1989) 414-435. 
Verrall, A. Manufacturing Chemist, June (1988) 26-27. 
Van Bommel, E. M. G., Fokkens, J. G., Crommelin, D. J. A. Acta Pliarm. 
(xliii) 
Technol. 36 (1990) 74-78. 
Walker, C. V., Wells, J. I. Int. J. Pharm. 11 (1982) 309-322. 
Wan, L. S. C., Heng, P. W. S., Wong, L. F. Int. J. Pharm. 73 (1991) 111-116. 
Welling, P. G., Dobrinska, M. R., Dosing considerations and bioavailability 
assessment of controlled drug delivery systems. Chapter 6, In Controlled 
Drug Delivery, Fundamentals and Applications, 2°d edition. Ed. Robinson, 
J. R., Lee, V. H. L. Marcel Dekker, New York, (1987) 253-291. 
Yasuda, H., Olf, H. G., Crist, B., Lamaze, C. E., Peterlin, A. Movement of 
water in homogeneous water-swollen polymers, in Water structure at the 
water-polymer interface, Ed. Jellinek, H. H. G. Plenum Press, New York, (1972) 
(xliv) 
Advanced studies 
One-day course on Microsoft Windows 3.1 and one-day course on 
Cricket Graph for Windows, held at Liverpool John Moores University, 
1993. 
(xlv) 
Conference attendance 
1. British Pharmaceutical Conference, Reading, 1993. 
2. British Pharmaceutical Conference, London, 1994. 
3. Liverpool School of Pharmacy Research Seminar, 1994. 
4. Attending all seminars at the School of Pharmacy, Liverpool John 
Moors University 
(xlvi) 
PUBLISHED COMMUNICATIONS AND PRESENTATIONS 
The following have been published or presented in advance of this thesis. 
Copies may be found in the pocket at the end of this thesis: 
1. The release of propranolol hydrochloride from matrices containing sodium 
carboxymethylcellulose and hydroxypropylmethylcellulose. 
Dabbagh, M. A., Ford, J. L., Rubinstein, M. H., Hogan, J. E. 
Presented to the British Pharmaceutical conference (Reading, 1993) 
Published: J. Pharm. Pharmacol. 45 (1993) 1134. 
2. Release of propranolol hydrochloride from mixed cellulose matrices. 
Hogan, J. E., Ford, J. L., Dabbagh, M. A., Rubinstein, M. H. 
Presented: 218` International Symposium on Controlled Release of Bioacive 
materials, (Nice-France, 1994). 
Published: Proc. Intern. Symp. Control. Rel. Bioact. Mater. 21 (1994) 732-733. 
3. Effect of polymer particle size and compaction pressure on drug release 
from matrices containing ethylcellulose 
Dabbagh, M. A., Ford, J. L., Rubinstein, M. H., Hogan, J. E. 
Presented to the British Pharmaceutical conference (London, 1994) 
Published: J. Pharm. Pharmacol. 46 (supp 2,1994) 1077. 
4. The effects of viscosity grade of sodium carboxymethylcellulose on drug 
release from matrix tablets 
Ford, J. L., Dabbagh, M. A., Rubinstein, M. H., Hogan, J. E. 
Presented to the 7th International Conference on Pharmaceutical Technology, 
Budapest, Hungary 
Published: Proc. 1st World Meeting APGI/APV, Budapest, May (1995) 173- 
174. 
(xlvii) 
5. An assessment of the performance of matrices containing 
hydroxypropylmethylcellulose, sodium carboxymethylcellulose and propranolol 
hydrochloride 
Ford, J. L., Dabbagh, M. A., Rubinstein, M. H., Hogan, J. E. 
Presented to the 7th International Conference on Pharmaceutical Technology, 
Budapest, Hungary 
Published: Proc. Ist World Meeting APGI/APV, Budapest, May (1995) 259- 
260. 
(xlviii) 
BOOKS IN ENCLOSURE 
AT THE BACK. UNABLE 
TO COPY. PLEASE 
CONTACT THE 
UNIVERSITY IF YOU 
WISH TO SEE THIS 
MATERIAL 
